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Abstract 
Tissue Engineering A Blood Vessel Mimic While Monitoring Contamination Through 
Sterility Assurance Testing 
 
Navid Djassemi 
Tissue engineering blood vessel mimics has been proposed as a method to 
analyze the endothelial cell response to intravascular devices that are used in today’s 
clinical settings for the treatment of cardiovascular disease.  Thus, the development of 
in vitro blood vessel mimics (BVMs) in Cal Poly’s Tissue Engineering Lab has 
introduced the possibility of assessing the characteristics of cellular response to past, 
present, and future intravascular devices that aim at treating coronary artery disease. 
This thesis aimed at improving the methods and procedures utilized in the BVM 
model.  Initial aspects of this project focused on using an expanded 
polytetrafluoroethylene (ePTFE) scaffold in conjunction with human endothelial cells to 
replicate the innermost intimal layer of a blood vessel.  Human umbilical vein endothelial 
cells (HUVECs) were pressure sodded onto ePTFE scaffolds through cell sodding 
techniques in an attempt to effectively and consistently replicate and assess the intimal 
layer.  Through each study ePTFE grafts were subjected to different culture times and 
steady flow rates to observe and compare the differences in the endothelial cell 
deposition.  Results were inconsistent, although moderate cell adhesion was noted 
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throughout each of the BVM setups.  Each study exhibited a range of cell sodding 
density rates. 
In the second phase of the thesis, contamination assessment protocols were 
implemented in the BVM lab.  The intent of this part of the project was to assess the 
relative sterility in the cell culture lab, a critical component involved with the success or 
hindrance of cell and tissue cultures.  Using microbiological validated methods, 
microbiological tests were conducted to examine the levels of microbial growth in and 
around the tissue engineering lab.   
Results were tracked over a two month period in the lab with several 
observations of aerobic microorganism growth on various counter and lab surfaces.  
Higher growth trends were found on surfaces outside the cell culture lab, in the general 
TE lab area.  These findings were used to provide overall suggestions on tracking 
microbes for long-term durations in ongoing BVM setups to directly improve the overall 
sterility assurance of the studies.   
As the project reached its conclusion a look back at all the BVM setups and 
contamination assessments lead to a few suggestions for improving aseptic techniques 
within the TE lab, such as monitoring microbial growth in the culture processes, creating 
limit specifications, and creating a standardized way to regulate quality control within the 
lab environment.  Furthermore, as the development BVM evolves, the findings from this 
report can be used with related research for improving the culture conditions of various 
BVM studies.  
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CHAPTER 1: Introduction 
1.1 Overview 
The demand for blood vessel substitutes is rapidly increasing as patients require 
the need to replace coronary and peripheral vessels due to circulatory diseases such as 
atherosclerosis.  The transition from using autologous and synthetic vessels to 
biologically engineered vessels is presently more foreseeable [1].  Tissue engineered 
vascular graft (TEVG) researchers have closely studied the intricacies of blood vessel 
fabrication in the past few years leading the way to the development of possible blood 
vessel substitutes in the laboratory.  Using tissue engineering (TE) cell culture protocols 
developed in recent years, progress has been made in understanding how blood vessel 
components work together and respond when cultured in tubular-shaped polymer 
scaffolds placed in various controlled environments [2].  However, the conclusions from 
past successful trials in tissue engineering experiments have yet to come together to 
consistently produce a fully functioning and clinically applicable tissue engineered blood 
vessel.  Recreating one native feature at a time is the first step of many to reach a 
highly valuable replicate biologic vessel.   
The overall goal of this thesis project was to improve current blood vessel mimic 
(BVM) methods developed in the Cal Poly TE lab through experimental trials looking to 
create the most consistent endothelium and introducing sterility assessment techniques.  
After initial background research, the focus shifted towards building a consistent BVM 
through a proven working protocol.  To accomplish this, the first aim was to explore the 
1 
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techniques for producing an in vitro replica of an endothelial using human umbilical vein 
endothelial cells (HUVECs).  A proposed confluent EC layer inside an expanded-
polytetrafluoroethylene (ePTFE) scaffold served to mimic the intima layer of a blood 
vessel.  This part of the project tracked specific changes in the BVM protocol to provide 
ideas on areas for possible protocol improvement.   
The second aim of this project was to initiate a contamination risk assessment of 
the TE lab, which was identified as one possible area for improvement within BVM 
cultivation.  Microbial contamination is a significant inhibitor of cell culture practices and 
thus a major key to the success of TEVG studies.  Therefore the testing practices 
introduced served to improve the concept of maintaining a controlled sterile working 
environment.  Microbiological approved USDA and AOAC methods were implemented 
for an extended period in the TE lab to compare and track results to assess the sterility, 
and overall cleanliness of the TE lab. 
To provide background on the aims of the project, as well as TEVGs and how 
they have contributed to the development of BVMs in the TE laboratory, several areas 
of interest will be covered in the introduction.  First, a review of blood vessel biology will 
be covered leading up to the discussion of TEVG methodology.  Then several topics are 
presented in hopes of linking key features of TEVGs and the importance of the 
experimental parameters that will be summarized in the methods portion of the BVM 
studies.  Finally, at the end of this chapter, an overall summary will be provided along 
with the specific goals of the thesis project. 
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1.1.1 Blood Vessel Biology and Atherosclerosis 
 There are three primary types of blood vessels: arteries that carry oxygenated 
blood away from the heart, capillaries that allow the transport of water and other 
nutrients between blood and tissue, and veins that carry deoxygenated blood from 
capillaries back to the heart.  Figure 1 shows the composition of a native blood vessel, 
which consists of three main layers; the adventitia, media, and intima [3].  As the 
outermost blood vessel layer, the adventitia consists mainly of connective tissue, vasa 
vasorum, and nerves that supply the muscular layer.  The middle layer called the media, 
consists of smooth muscle cells (SMCs), and elastin.  Making up the innermost intima 
layer is the endothelium, a thin layer of single squamous endothelial cells (ECs), and a 
basement membrane. The endothelial layer directly contacts shear stresses due to 
blood flow across the luminal surface.  Also, the endothelium is thought to provide 
tissue homeostasis, regulation of vascular tone, and inhibit thrombosis potential [1].  
What makes the endothelial layer relevant to cardiovascular therapeutics such as 
stents, are the critical EC responses that occur throughout the lumen region with an 
implanted device.  Thus, being able to fully understand the behavior of an endothelial 
lining and its characteristics in different environments is crucial to the future success of 
BVMs, and evaluations of applicable medical devices in a preclinical setting. 
3 
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1.1.2 Treatment Therapies and Justification of TEVGS  
Currently, a large focus in the medical field is concerned with the number one 
killer in the United States; cardiovascular disease [1].  A specific cardiovascular disease 
that is rising in the Western world is atherosclerosis [1, 2].  As blood flows away from 
the heart into arteries, it may experience resistance due to the buildup of plaque or fatty 
material.  When plaque accumulates along the arterial wall it can harden and eventually 
block the artery, leading to a potential myocardial infarction, which is commonly known 
as a heart attack.  
Figure 1:  Diagram of the 3 major layers of a blood vessel:  the outer adventitia layer, the 
middle media layer, and the inner intima which consists of an endothelium wrapped in an 
elastic internal lamina [3]. 
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 Improving the assessment of treatment therapies in cardiovascular disease is 
necessary to create a highly efficient and effective output of current cardiovascular 
medical devices therapies [4].  Tissue engineering cardiovascular tissue is just one 
example that can provide researchers with valuable information about how clinical 
treatments work in an in vitro setting prior to implantation.  This approach could 
eliminate a lot of medical research cost and reduce the amount of animal testing that is 
needed to justify the use of intravascular medical devices, such as the response of drug 
coated stents on human arteries [4].  Before an accurate evaluation can be made, small 
steps must be taken to replicate the dynamic biological actions and cellular components 
of living blood vessels; a hurdle that begins with the successful creation of an 
endothelial layer inside a tissue engineered BVM.   
 Ultimately, the scientific community is searching for reliable engineered 
replacement tissues for coronary or peripheral bypass procedures.  Until that day, 
current stent technologies provide patients of atherosclerosis the best possible 
alternative to invasive surgeries such as coronary bypass [2].  The figure below 
describes basic stent technology by using a deployed balloon catheter inside an 
occluded area of a coronary artery.  Once the catheter is removed, the stent is fixed in 
the artery and pushes the plaque buildup against the walls allowing blood flow to 
resume in that region of the artery [5].  This treatment procedure is not always a 
permanent solution to a clogged artery, but provides at least temporary relief to the 
patient, which could last a lifetime in ideal cases.  Problems that arise in stent 
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placements can vary from restenosis or reoccurrence of vessel narrowing, thrombosis 
near the stent position, and re-vascularization due to stent failure. 
 
                                                  
         
 
Understanding the problems of cardiovascular treatment therapies can be 
addressed from continued breakthroughs by TEVG research and related engineered 
blood vessel models.  Further investigations into various problems that develop inside 
Figure 2:  The first stages of the diagram show a coronary artery 
with plaque buildup.  Later, a stent mounted on a balloon is guided 
with a catheter and is inflated as illustrated.  Once inflated, the 
plaque is pushed to the side and blood flow through the area is 
restored [5]. 
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blood vessel substitutes will assist the development of TEVG cultures.  BVM modeling 
looks to develop methods for accurate vessel layer constructs and further assessment 
with stent-device interaction [4, 6] 
1.1.3 Tissue Engineering Impact 
 As scientific research advances, tissue engineering is forecasted as a field with 
limitless potential in regenerative medical therapy as seen specifically with current trials 
to develop optimal tissue grafts for clinical evaluation purposes [7, 8].  As the world of 
science and medicine becomes more complex, future research will play an increased 
role in the development of viable alternatives to pharmacological resources and 
assistive medical devices in repairing biological dysfunctions: inherited and non-
inherited.   
Tissue engineering pulls knowledge from multidisciplinary cell biology and 
engineering sciences to provide a potential solution for incurable diseases, failing organ 
systems, and age-related health problems.  Cardiovascular disease such as 
atherosclerosis is one example of many age-related health problems that continues to 
gain understanding through current TEVG experimental studies.  The following TEVG 
studies focused on various aspects of the culture process that were critical to the 
development of incorporated cell lines as well following up on studies with respect to 
previous TE trials in hopes of gaining vital information on the recreation of TEVG 
components. 
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1.2 The Aims and Methodology of Tissue Engineered Vascular 
Grafts 
1.2.1 Introduction 
Tissue engineered vascular graft (TEVG) research is crucial to successful vessel 
creation because it allows researchers to review what experimental conditions within a 
protocol affected the development of vessel components in a particular environment.  
Some current fields that are of interest at this point in TEVG research include: cell 
signaling mechanisms due to mechanical stimuli, and adaptability in different culture 
systems [2, 8].  However, a refined TEVG process can expand the blueprint for current 
researchers to reference, for example when examining the key factors required in 
producing a functioning endothelium; in this case within blood vessel constructs.   
1.2.2 Relevant Experimental Fields 
Exploring the complexity of TEVGs, a further look into specific parameters that 
are utilized in replicating blood vessels and related tissue constructs will be a prelude to 
the sections examining BVM methodology.  Moving forward, these related fields will 
supplement discussions for pertinent questions that surround the BVM model, and how 
endothelial formation can be improved within the vessel constructs created.   
After discussing a few intricacies of BVM modeling, important topics such as 
scaffold preparation, EC viability, endothelial layer development, and the types of cell 
culture systems will be reviewed.  These sections will summarize topics through TEVG 
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case studies; beginning with a recent BVM model and introducing the idea of graft 
compliance.  Later, cell sodding techniques and TEVG construction with EC cultures will 
be explored. 
1.2.3 BVM Research  
In recent years, there have been advancements in TEVGs as a unique preclinical 
assessment of how a stent will interact with a blood vessel in an in vitro setting [4, 6, 9].  
The endothelial layer is recreated, turning it into an in vitro “blood vessel mimic” (BVM) 
to evaluate stent endothelialization within a blood vessel.  Figure 3 shows a radiograph 
image of a deployed stent that was studied in a BVM that was cultured in a small-scale 
bioreactor system under steady peristaltic flow [4].  Scanning electron microscopy 
(SEM) verified a cellular lining and the presence of a luminal monolayer of ECs inside 
the BVM [4].  Such preclinical breakthroughs have helped the improvement of medical 
assessments of vascular cells with 21st century stents such as drug-eluting stents, 
protein coated stents, and stent grafts inside mimicked blood vessels.  However, before 
vital stent assessments inside a BVM can be universally accepted, the most appropriate 
biologic vessel must be recreated and reformed to give the best possible data regarding 
such therapeutic technologies.  
Further insight into BVM related research will be revisited in the following chapter 
as well as introductions to cell culture practices that have been employed in similar 
TEVG methods.  Leading up to studies of relevance; the topics discussed will relate 
concepts incorporated in BVM research that will collectively contribute to TEVG studies. 
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Figure 3:  A radiograph is used to help assess the stability and structure of a fully deployed stent 
inside the cultured BVM vessel [4]. 
  
 
  
 
 
1.2.4 Graft Compliance and Biocompatibility 
  Expanding on the idea of recreating the best possible TE blood vessel, the 
importance of a vessel’s compliance and mechanical properties can contribute in the 
degree of model accuracy of future stent evaluations.  An ideal scaffold should mimic 
the ability of a vessel to function properly within systems that have native co-cultured 
blood vessel cells [1].  Compliance mimicking from synthetic to native vessel properties 
revolves around understanding the mechanical system with which vessels respond to in 
dynamic blood flow, or a person’s physical body movement, and the adjustment of a 
blood vessel over time and stress. 
Generally, researchers have investigated what parameters influence the 
mechanical integrity of a TEVG over different culture periods.  Compliance mismatch of 
replacement vessels is correlated to the induction of intimal hyperplasia which is in part 
due to the limited elastin production in tissue engineering approaches [10, 11].   
Furthermore, an optimally designed replacement TEVG would be able to mimic the 
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native vessel’s compliance by recoiling appropriately after feeling compressive and 
distending pressure forces [11].   
The degree of compliance of a tubular graft relies heavily on the innate 
mechanical properties of the scaffold and the changes of those properties through its 
intended life time [2].  With the incorporation of biological components into TEVGs, 
there have also been synthetic and natural polymers used to represent the native 
vessel.  While compliance features such as burst strength and hyperplasia of cells have 
not been measured with the current BVM model, introducing compliance values during 
scaffold fabrication may enhance the culture environment by incorporating a scaffold 
that is more physiologically accurate and responsive to dynamic testing environments 
with respect to a native vessel.  
Expanding on compliance mimicking, the vasoactivity of native TEVGs continues 
to be a challenge to recreate in blood vessel substitutes.  With native blood vessels, 
ECs receive and send neuronal signals that modulate vascular tone, while smooth 
muscle cells (SMCs) generate the contractile force necessary to change vessel volume 
and blood pressure by responding to nervous and hormonal signals [2].  SMCs tend to 
undergo a transition to a synthetic phenotype, in which the cells lose their contractile 
function, when they have been cultured within in vitro constructs [12, 13].  A clearly 
defined set of compliance values can aid the endeavors of recreating these 
characteristics.  Most approximate values come from comparable values of specific 
biologic blood vessels that are modeled or tested.  Table 1 lists some characteristics of 
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an ideal small diameter blood vessel (SDBV) replacement including descriptions on 
compliance matching.  
 
 
 
Despite the best efforts of many researchers to implement autologous and 
engineered vessels as replacement options, there continues to be failures with 
biocompatibility that account for the distinct features of biologic vessels [2].  Although 
ePTFE compliance is not examined during the BVM culture, future testing 
configurations with bifuricated and abnormal vessel constructions with vessel shape-
movement, and volume capacity of vessels before and after culture periods could 
Table 1:  A review of key physical compatibility and 
processing features that a SDBV or generalized TEVG can 
contain.  The most critical characteristics are listed near the 
top and trend downward [7].   
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provide insight into possible modes of failure of constructs based on the mechanical 
properties of a scaffold. 
Looking to improve scaffold development based on geometry and material 
characteristics should improve the BVM model by making the assertion that the ideal 
scaffold will contain the physiological characteristics of compliance, biocompatibility, 
and porosity that will improve the development of a native endothelial layer within an 
ePTFE or natural polymeric vessel.  The following sections will look at scaffold 
development as well as the general characteristics of scaffolds, and how they respond 
in static and dynamic culture environments. 
1.2.5 Scaffold Development 
The following sections describe TEVG approaches to scaffold development and 
incorporation of chemical constituents found in blood vessels.  Without scaffold 
development, there would be little chance to solve issues that arise with compliance 
matching and maintaining endothelial stability and phenotype.  There is no single 
preferred method of how scaffolds are prepared or processed, but present day studies 
are looking to create scaffolds that closely mimic the mechanical/biological features of 
native vessels in a laboratory setting while developing viable cellular networks. 
1.2.5.1 Scaffold Development with Well-Plate and Electrospun Scaffolds in 
Static Culture Conditions 
There have been certain types and methods of scaffold creation that have lent 
themselves to an increase in cellular adhesion and tissue growth rates.  These studies 
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have been useful, specifically with understanding antithrombogenic modifications to 
vessels necessary to develop cardiovascular devices such as stents, grafts, and 
vascularized tissues [14].  Well-plate scaffolds have been a common method in TE 
studies of creating a semi-stable polymer mold in constructed wells to capture and 
cultivate mammalian cells in combination with usually a collagen or additional polymeric 
blend.  Researchers in the Netherlands sought to understand the regulations and 
influence of an endothelium based on an extracellular matrix (ECM) composition.  The 
mechanical properties of the tissue constructs were evaluated after creating an EC layer 
on rectangular 3D cardiovascular constructs using human venous cells sodded on poly-
glycolic acid (PGA) poly-4-hydroxybutyrate with EC media; within the studies the well 
plates proved to be a reliable method of a stable scaffold construction in the TEVG 
procedures [1]. 
The benefits of incorporating EC media to rectangular TE scaffolds revealed that 
a longer co-culture period between ECs, and myofibroblasts (MFs) had a positive 
outcome on cell retention when the cells were subject to shear stress [1].  To 
understand further significance of various ECM components on EC viability; polystyrene 
culture plates were used to compare the effect of angiogenic (AGF) and platelet growth 
factor (PGF) on remodeling the ECM statically in vitro [15].  This is based on the 
observation that ECs will upregulate junction and adhesion molecules after a long 
period of confluency [16].  After a week of culture, a confluent monolayer of ECs was 
found in both groups, so the process was maintained for an additional week to 
investigate the stability of the monolayer over time.  
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Throughout current TEVG studies, PGA, a biodegradable synthetic polymer was 
incorporated due to its ease in processing, and control of mechanical properties.  
However, biodegradable synthetic polymers suffer from poor cell adhesion, proliferation, 
and unwanted matrix synthesis [17].  On the other hand, natural polymers can replicate 
crucial features of their natural counterparts; such as surface free energy and 
hydrophilicity, and may improve cell adhesion [18].  Yet most natural polymers at the 
macro-size level do not have adequate mechanical properties to substitute as vascular 
tissue.  However, natural polymers like silk-fibroin grafts have demonstrated excellent 
biocompatibility, controlled degradability, and versatile processing [19-21].  A realization 
of the benefits that these polymers possess has culminated to putting the vessels on the 
forefront of current TEVG projects.   
Before moving into specific culture conditions of TEVG studies, it is worth 
mentioning electrospun tubular scaffolds.  Electrospun scaffolds have provided 
versatility with the use of natural polymers to provide proper porosity and fiber length.  
Electrospinning technology has shown to be successful in blending different polymer 
materials at the nanometer level for tissue constructs, as demonstrated by natural 
collagen-PCL blends to recreate human skin [22].  Previous cultures with 
nanostructured PLGA have also shown elevated EC adhesion, proliferation, and ECM 
synthesis when compared to nanosmooth surfaces [7].  Electrospun scaffolds for 
example can range in wall thicknesses of 100 µm to 500 µm depending on the 
configuration of the electrospinner instrument [23]. 
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Furthermore, the electrospun grafts have shown promising strength 
characteristics in terms of resistance to arterial pressure and comparable tensile 
strength, and most importantly the ability to support vascular cell function.  Shown in 
Figure 4 is a static and dynamic culture comparison of HCASMCs on an electrospun silk 
fibroin scaffold [23].  Distinguishable from the image is the cell alignment, with respect 
to flow conditions for the static and dynamic states.  Similarly, the TE lab has 
demonstrated the capability to develop a relatively controlled nano-fibrous topography 
that mimics the same quality of a native biologic vessel; making  electrospun scaffolds 
more common in recent TEVG and BVM studies [24].   
The effect of static culture environments on the mechanical properties of a TE 
vessel were also demonstrated in the latter portion of an EC culture utilizing well plate 
scaffolds.  Constructs cultured in EC medium for 2 weeks had a low Young’s moduli of 8 
MPa versus 11 MPa after a culture period of one week, suggesting that a shorter culture 
period in EC medium is advised for a stiffer construct capable of bearing more load [1].  
What was not demonstrated by this work was the use of dynamic culture settings to 
evaluate the endothelial formation in a TEVG under pulsatile flow.   
In each of the studies above the versatility of scaffold creation allowed the 
researchers to vary the concentrations of natural and synthetic components within the 
scaffold matrix to theoretically create a more physiological accurate TEVG construct.  
However, in many cases the drawback with TE constructs that utilize static cell cultures 
is they have exhibited less development potential versus scaffold creation using 
dynamic culture conditions in TEVGs;  this can be attributed to the lack of mechanical 
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stimuli found in a normal physiological setting [23].  Hence, it is worth introducing a few 
other TEVG studies using culture conditions that have shown to be more favorable for 
maintaining cellular growth, some of which has directly influenced the methodology of 
TEVG projects in the TE lab.    
1.2.5.2 Dynamic Shear Flow Environments 
As mentioned in the previous section, accompanying scaffold geometry and 
composition, the culture conditions that scaffolds experience is crucial for EC viability 
and endothelial development.  Dynamic flow conditions generally improve mass 
transport and improve aerobic cell metabolism, as proven by the measurement of 
glucose consumption, and formation of lactate in the EC culture medium [23].  An 
investigation examined dynamic culture conditions to generate vascular grafts using 
electrospun polyethylene oxide (PEO), which was expanded on previous pilot studies 
that indicate EC constructs require more than just TE medium to proliferate and adhere 
[1, 23].  Also, studies have demonstrated applications of steady flow in a BVM model 
and TEVG respectively with electrospun scaffolds under similar methods, while using 
increased and steady flow rates through their culture systems [23, 24].  Furthermore, 
changes in cell viability and morphology were tracked and analyzed with the various 
setups to better understand EC morphology, immunohistology, and cell coverage within 
the implemented experimental conditions. 
The findings that pertain to dynamic conditions in bioreactor systems will be 
recalled in hopes of distinguishing important observations, and any setup modifications 
used along the way.  After culturing HCASMCs and HAECs in a closed-loop perfusion 
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system under increasing flow rates it was seen that there was random spreading and 
some detachment of HAECs along the lumen; however, significant HCASMC alignment 
along the direction of flow was exhibited on the luminal surface [23].  Moreover, it was 
concluded that the enhancement of tissue formation, ECM production, cell alignment 
and the retention of differentiated cell phenotype was induced under dynamic culture 
conditions in contrast to static controls [23, 25].     
 Exposure and conditioning of ECs at a dynamic flow setting showed tremendous 
potential within the TEVG studies described.  At a low shear stress of 1.5 dyn/cm2 SEM 
images revealed ECs oriented to the pulsatile flow direction and cell elongation [25].  
Protein-modified stents exposed to a luminal flow of 15 mL/min showed a dramatically 
larger cell coverage compared to bare metal stents [4].  Although, earlier findings also 
revealed that proper cobblestone morphology of ECs was established at the same flow 
rate over a two week period on bare metal stents [6].  The cell elongation and typical EC 
protein expressions that was observed by the researchers warrants the idea that TEVG 
cultures under dynamic flow can lead to improved EC response and more accurate 
physiological TEVG models created in an in vitro setting [6, 21, 25, 26].  In many of the 
included setups the vessels were conditioned prior to cell incorporation to improve cell 
adhesion by conditioning the scaffold surface to better accommodate the ECs being 
introduced into the system [6, 25].  The benefits of these steps will be introduced to help 
justify more critical facets of the BVM protocol. 
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1.2.6 Vessel Conditioning  
For many TEVGs created in an in vitro environment, preconditioning is required 
for a successful replacement graft or BVM.  What remains missing in tissue engineering 
is the ability to develop TEVGs that closely resemble the native vasculature as well as 
the mechanical properties of biologic tissues in vitro.  Having a functional tissue 
construct that one day possesses receptor-mediated signal systems will help reach a 
Figure 4:  A-D represent SEM images of HCASMCs seeded on the luminal surface for 7 
days under static and dynamic condition while E-H represents the respective cultures at 
14 days.  Cell alignment (double white arrows) is seen along the flow direction (red 
arrow) for HCASMCs under pulsatile flow condition.  Scale bars are: (A, C, E, G) 20 µm; 
(B, D, F, H) 10 µm [17]. 
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more optimal replacement vessel; still, there has been no in vitro developed TEVG 
capable of smooth muscle contractility [27].   
Major problems with commonly used synthetic grafts are the rigidity of the 
vessels and the subsequent inflammatory responses of introduced cell lines; this 
compliance mismatch with native vessels induces hyperplasia at the anastomosis which 
leads to variation between turbulent and low flow resulting in thrombotic stenosis or 
occlusion of the graft [8].  However, pre-conditioned grafts have shown to improve 
compliance of TEVGs as well as cell retention [27].  For example, cell adhesion has 
been improved by pre-conditioning ePTFE vessels with 15% FBS solution by capping 
the distal end of the graft and forcing the solution through the interstitial pores [28].  
 The maneuverability of preconditioning stages in the culture process can be 
valuable in developing new schemes within TEVG development; such as the static co-
cultures of SMC-EC, a study that implemented a conditioning stage that was attributed 
to the increase of EC retention and nitric oxide production, a crucial signaling chemical 
[29, 30].  During another culture study pre-treatment of glass cover slips with gelatin and 
fibronectin coating was done prior to HUVEC incorporation and seen to improve 
confluency [31].  Consequently, improving ways of maintaining long-term EC viability 
through preconditioning steps are crucial for a tissue-engineered blood vessel models 
because of the dynamic capability of ECs to modulate normal homeostasis, and 
pathologic conditions by balancing antithrombotic and prothrombotic properties [26].   
Some important observations and results from TEVG studies have been 
summarized to help describe some of the important methodologies and goals that have 
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had an impact on current TE fields.  The subsequent few sections will explore cultivation 
techniques of HUVECs, and studies that directly used HUVECs to evaluate particular 
cell responses.  To close out the chapter further insight into cell delivery methods with 
ECs and HUVECs will be drawn upon as well an overall summary of the aims and goals 
of the studies entailed within the project. 
1.3 Isolation and Cultivation Techniques of HUVECs 
 Throughout this section, specific isolation and cultivation techniques of human 
umbilical vein endothelial cells (HUVECs) will be examined.  Based on the ease of 
obtaining and passing HUVECs, HUVEC culture development onto synthetic and other 
polymer blends is becoming a more common approach in TE studies.  Current 
biomedical engineering research using EC culture protocols in either a co-culture or 
isolated environment is worth further examination.  Later, findings from these 
experiments and future focuses of HUVECs in TEVGs will be discussed. 
1.3.1 Isolation Methods 
 Much of the attention thus far has been focused on general TEVG procedures 
and revelations that have led to the progressive development of more physiologically 
accurate TEVGs.  Now the focus of TEVG experiments shift towards HUVECs in 
replicating an endothelium within a tubular polymer scaffold vessel.  HUVECs have 
proved reliable in their ability to form a quiescent endothelium in BVMs and are a 
common EC cell type used because of cost and availability [32]. 
21 
38 
 
 As the name suggests HUVECs are derived from donated human umbilical cord 
veins.  After the umbilical cord is isolated it can be packaged and frozen for later 
retrieval of HUVECs and other cell types such as SMCs.  The isolation of the 
endothelial cells from the primary vein of the umbilical cord has been standardized by 
biological practices, and will be summarized primarily from the technique demonstrated 
by Jaeger Davis of the Molecular Biology Department at UC Davis [33].   
  First, the umbilical cord is laid on a table and fresh cuts are made on both ends 
of the cord.  Then a ½ inch gauge needle with a plastic sheath is inserted into the vein, 
the vein is the located at the largest opening on the cord end while the smaller openings 
are arteries.  A needle is clamped in position just inside the vein opening, and then a 20 
cc syringe filled with hanks solution is attached to the needle.  Hanks solution is pushed 
through the needle with moderate pressure; the Hanks solution flushes out red blood 
cells and other waste out of the vein.  The process is repeated through the other end of 
the cord.  After a few minutes the 20 cc syringe is removed and a 10 cc syringe is 
attached to the needle [33]. 
Moving forward the 10 cc syringe is filled with collagenase and pushed through 
the vessel until there is slow rhythm of droplet solution coming out the open end.  The 
collagenase serves to rinse out any residual Hanks left in the cord and free the ECs.  
Once a droplet streak is observed the open end is re-clamped and filled with 
collagenase until moderate distention in the vein is observed.  The cord is then laid back 
on a table and messaged gently to dislodge the HUVECs.  This step requires sensitive 
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application of fingers to massage the cord; too much pressure will risk smooth muscle 
cell contamination.  At this stage the cord is attached with a hemostat, needle, and 
syringe and are put inside a beaker of Dulbecco’s Phosphate Buffered Saline (DPBS) 
and incubated at 37°C for 15 min.  The DPBS serves as medium to keep the pH level 
within physiological range as well providing cells with water and bulk organic ions 
crucial for normal cell metabolism [33]. 
 After incubation, the cord is taken out of the beaker and held over a 50 mL 
conical tube, the cord end is cut above the bottom clamp.  All the outgoing fluid must be 
collected into the conical.  The remaining collagenase is pushed through the cord and 
then the 20 cc syringe is reattached to the needle filled with Hanks solution.  Once more 
the Hanks solution is pushed through vein with moderate pressure.  Next the conical 
tubes are spun in a centrifuge at 1200 rpm for 5 min.  Once removed from the 
centrifuge, the solution is aspirated except for the bottom 1-2 mL.  The pellet observed 
at the bottom of the conical is now composed of some remaining red blood cells and the 
precious HUVECs.  Now 5 ml of PHEC+ solution is added to the pellet and is flushed 
back and forth with a pipette until it has dissolved back into the remaining solution. This 
solution is transferred over to a T25 flask and incubated at 37°C at 5% CO2 overnight 
[33]. 
The next day the supernatant solution is removed and replaced with fresh 
solution.  If red blood cells are still present the solution is washed with M199 and PHEC 
and then incubated again in the same manner until a confluent plate of HUVECs is 
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observed.  Once confluent, the solution is transferred into a gelatin-coated T75 flask, 
and once that flask is confluent the solution is separated into two vials and frozen for 
preservation and sterility assurance [33].  Finally, the HUVECs are ready for cultivation 
and experimental usage.    
1.3.2 Characterizing Viable Culture and Growth Techniques  
Cell culture techniques for HUVECs in TEVG methods vary based on slight 
differences in the types of medium-supplements implemented in specific research 
studies.   Normally cell medium used in TEVG development are used to saturate the 
said scaffold(s) being used in the experiment with favorable growth reagents that 
improve cell attachment, viability, and minimize thrombogencic attributes [14].  Typically 
included growth supplements/medias include 1% penicillin/streptomycin, fungizone, L-
glutamine, Fetal Bovine Serum (FBS), and M199; all agents are incorporated and 
directed towards maintaining HUVEC viability over long culture durations, and passages 
in TEVG studies including the current BVM model.  Some agents are also directed at 
limiting microbial growth in the bioreactor/culture system [6, 25, 27]. 
A few essential factors play a key role when trying to analyze the success of a 
new culture technique implemented during the course of a TEVG study.  A good starting 
point is asking what specific feature of a previous protocol is trying to be improved.  Is 
the goal to compare the obtained results to a previous study under the same 
conditions?  Are the types of cells being used in the research appropriate for the results 
being sought?   
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Over the next few sections, studies regarding culture media and supplement 
usage in HUVECs will be reviewed.  It is important to note that the significant findings 
from the researchers also presented opportunities for conceptualizing and expanding on 
future TEVG studies specific to BVMs in the TE lab with regards to serum usages, 
media incorporations, and exposure times of culture media specific to EC cultures. 
1.3.2.1 Application of Different Growth Media Conditioning 
The media reagents and supplements that have been described thus far all have 
certain purposes and benefits in terms of cell proliferation and viability.  However, 
specific publications have been aimed at whether substituting or eliminating specific 
culture media all together can have a profound impact on the cells ability to maintain 
viability within a population.  Certain publications have claimed the development of a 
serum-free media for vascular EC and HUVEC cultures [34-36].  Also, various case 
studies have studied the long-term cultivation of HUVECs with the presence of serum-
free medium versus prepared conditioned medium to observe the adverse effects of 
both styles of EC cultures [37].  
The serum free medium utilized by researches in Germany was called TUD-1, a 
further development of a previously described medium optimized for growing HUVECs 
with IFs (intermediate filaments) as a basal medium [38].  What was unique about TUD-
1 were the high levels of glutamine, serine, the inclusion of acetylcysteine, and 
phosphoascorbic acid.   
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 Another key issue with non-serum cultures deals with the factors experienced by 
HUVECs and other types of ECs in slightly atypical culture conditions.  With vessel 
modeling fetal bovine serum (FBS) was growth was compared after being substituted by 
patient-derived 2% AB human serum to establish a confluent HUVEC-Fibroblast co-
culture in a 3-D spheroid culture.  To evaluate EC network formation, CD31-positive 
areas were quantified; tubular network formation under human serum w/ incorporated 
EGM-2 media was significantly higher than in the 2% FBS control [39].  This implies that 
EC cultures were more confluent in EGM-2 incorporated cultures.  ECs cultured in 
M199 over extensive passages have shown a different morphology, with irregular size 
and shape, compared to ECs cultured in EGM-2 [31].  Comparisons from the earlier 
studies indicate that an essential serum component in the normal media was not 
substituted by TUD-1 medium, and in the latter experiment by 2% FBS [37, 39].   
Throughout expanding work it has been revealed that selective media may 
enhance the growth of different ECs, but the differentiated functions of the cells are 
quickly lost if high amount serum is added to the medium [31, 37].  With the use of 
selective medias it was observed that commonly used fibroblast growth media, resulted 
in lumenosis; the loss of the lumen formation within a TEVG [40].  This helped 
researchers continue further research into establishing the correct genes responsible of 
the lumen formation of native vessels.   
Below are a few respective SEM images (Figure 5) of HUVEC morphology at the 
sixth passage stage, and HUVEC confluency using TUD-1 versus serum free media 
(Figure 6).  Beyond the sixth passage, HUVECs cultured in EGM-2 maintained a 
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monolayer with distinct boundaries, whereas the cells in M199 appeared irregular in 
morphology.  
 
 
 
  
Although results are varied, these results indicate that alone, EC growth factors 
(ECGFs) and serums are not sufficient for culturing and maintaining HUVECs, and that 
the presence of hormones and other ECGFs are critical to maintain higher level cell 
passages [37, 41, 42].  Nonetheless, it was revealed that tubular network formation 
Figure 5:  SEM images of HUVECs at a P6 (sixth passage).  In the upper 
figure (A), EGM-2 cultured HUVECs show homogeneous flat cells 20 – 40 
µm in size, while the lower view of ECs cultured in M199 show cell size 
increased to 90 µm with no distinct cell boundary [41]. 
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under human serum was concentration dependent, with 2% AB serum giving the best 
results [39].   
For a well-rounded perspective, repeated studies with similar protocol settings 
need to be executed to look at media impact on TEVG systems.  It seems that certain 
combinations of culture medias and growth supplements has given the best TEVG 
results when ECs are used for blood vessel construction.  The current BVM model has 
built on the use of certain culture media usages at different stages of the cell culture 
process to better assess the attributes of cell culture parameters.  
 
 
Figure 6:  A summary of HUVEC cultivation in TUD-1 and in serum-containing 
medium.  The cultures were passaged every 4-5 days with reseeding at a cell 
density of 20,000 cells/cm
2
.  Each bar represents the final cell density before the 
culture was split as the arithmetic mean of three individual flasks; error bars 
depicts the SEM [37]. 
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1.3.2.2 HUVEC Cultures 
Revisiting the vital effect of mitogens and serum concentration on HUVECs, it 
was explained that EGM-2 maintained normal gene and phenotype expression and 
more viable HUVECs than M199 when cells were doubled over several passages.  The 
researches in addition examined the expression of sICAM-1 by ELISA on the primary 
and 6th passages of HUVECs [31].  No significant difference in sICAM-1 concentration 
was found in primary cultures of HUVEC in M199 media and EGM-2.  However, by the 
time the cells were passed to a sixth stage, concentration of sICAM-1 was decreased 
4.2 fold in HUVEC cultured in M199 media compared to those cultured in EGM-2 media 
[31].  Conversely, when M199 was used as the bioreactor media in the shear flow effect 
study, population doublings occurred up to eight times without any adverse negative 
effects that could be attributed to the media alone [43].  While the main objectives of this 
study focus on consistent usages of cell medias during the BVM culture, it is interesting 
to note that the mentioned research initially cultured ECs in EGM-2, and then in M199 
for the cell seeding and flow loading stage.   
The cultivation of HUVECs has become more sophisticated in recent culture 
systems.  What drives the continual pursuit of perfecting the cultural environment and 
maintenance of HUVECs is the inherent difficulty of preserving ECs when they are 
subjected to tissue engineering conditions.  ECs used to create an endothelial layer into 
multilayer tissue structures in TEVGs are just a few of the in vitro and in vivo 
applications that are currently being pursued.  Nonetheless, HUVEC protein 
expressions, morphology, and viability outcomes in specific environments still serve as 
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a solid representation/model of vascular ECs in general.  It is for this reason and the 
ready availability of HUVECs that allows the cells to be utilized with respect to other 
types of isolated ECs.  The following sections explore more specific TEVG applications 
using HUVECs. 
1.4 HUVEC Development in TEVGs 
 Although the various protocols that exist for HUVEC cultures have similar 
techniques, the manners in which they are used in TEVG experiments will depend on 
the specific attribute of the cell being observed.  A few practical fields that are well 
studied in tissue engineering HUVECs include cell morphology and phenotype analysis 
in various culture environments, endothelium formation with HUVECs in in vivo 
applications, the effects of different flow conditions on HUVEC adhesion on scaffolds, 
and co-culture development with other cell types.  It is worth addressing the parameters 
used in these topics to supplement the previous sections and provide the reader with an 
idea of how different areas in TEVG development come together as a segue-way into 
the main objectives.  
1.4.1 In Vivo Studies 
Past and current research in scaffold development, isolation, and use of culture 
medias of ECs all play a role in proposed testing models surrounding TEVGs aimed at 
creating medical alternatives to severe health complications.  To better understand the 
EC phenotype shift under haemodynamic and stromal microenvironments, Luu et. al 
compared neutrophil recruitment of HUVECs, human umbilical artery ECs (HUAECs), 
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and human coronary artery endothelial cells  (HCAECs) after exposure to static and 
dynamic culture [42].   A further response of the study comes from the lack of current 
understanding of the rare combined effects of stromal haemodynamic factors [44].   It 
was for this reason the ECs were tested to observe any differences among the cell lines 
in their ability to support adhesion of flowing neutrophils, and whether this depended on 
the culture media and or conditioning by shear stress [42].  The significance of the 
results from shear and static environments along with comparable research on stent 
materials will be brought to attention in the subsequent section. 
It is simple to picture the near limitless applications that HUVECs serve for a 
variety of TEVG research in the tissue engineering and the medical field.  The 
antiangiogenic therapies involving HUVECs and vascular endothelial growth factor 
(VEGF) upregulation is another example of an in vivo application using past research to 
better understand the potential of a therapeutic protein (VEGF) for antiangiogenic 
therapy [45-48].  Also, the concept of incorporating HUVECs with microencapsulation 
scaffolds, and the timed release of accurate dosages of angiogenic inhibitors 
encompass newer forms of creativity behind in vivo scaffold technology [49].  Of course 
these mentioned studies would not have been possible without the culmination of 
previous biochemical and culture testing of ECs in similar physiological environments.  
Hence, in the next passage, HUVEC TEVG applications in flow environments, as well 
as validation of perfusion systems for high cell density cultures will be presented. 
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1.4.2 HUVEC Development and Response in Static and Shear Environments 
The studies mentioned thus far have used HUVEC cell lines to gather research 
on the adaptive responses of the cells in various culture environments.  From some of 
the initial studies presented it can be suggested that the type of shear imposed flow on 
HUVECs will have just as large of an impact on correct cell phenotype expression than 
the culture duration of HUVECs.  To demonstrate the effect of gradually graded shear 
stress on HUVEC-seeded grafts, an electrospun PLCL tube was preconditioned by 
forcing 0.2% neutral type collagen I through the micropores of the tube [25].  In a 
different HUVEC culture, a fibrin gel was created to examine pulsatile flow vs. static 
culture.  Chouinard et. al added fibrinogen to a HUVEC cell suspension to obtain a 
transparent and homogenous fibrin gel [43].  These gels were attached to an in-house 
bioreactor and examined for HUVEC growth in a culture media perfusion with an 
applied flow rate of 70 mL/min with a pulsated 40/20 mmHg static pressure [43]. 
Within the HUVEC-seeded SDVGs there were significant morphological 
differences between the static and shear stress controls [25].  HUVEC-seeded tubes in 
the static group demonstrated almost identical morphological features irrespective of 
culture time. Most of the luminal surface was covered with polygonal cobblestone 
shaped HUVECs as exhibited in Figure 7 (A-D) [25].  This is an indication of proper EC 
morphology shift observed in EC mono-layering with correct shear stress characteristic 
resistance [50, 51].  Under similar growth conditions, at an initial concentration of 1x 106 
cells/ml, both dynamic and static cultures revealed few living HUVECs on the top of the 
gels in static culture, and on the bottom of the thick gels only dead cells were present 
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[43].  Conversely, in samples cultured only under pulsatile conditions, HUVECs were 
found homogenously distributed within the cell and tissue culture chamber with very few 
dead cells [43].  This data reaffirms some of the benefits of shear imposed conditions on 
EC cultures. 
  The assessment from each study showed that hollow fiber bioreactor chambers 
under pulsatile shear induced conditions produced and maintained the best HUVEC 
morphology, viability, as well as nutrient concentrations and transport in the extracellular 
region [25, 43].  Further cell structure observations seem to warrant the claims by the 
researchers.  A key cytoskeletal component actin, was observed as being oriented 
randomly as observed in Fig. 8 (E) and VE cadherin, a principal cell-to-cell adhesive 
protein, was found at adjacent contact regions during gradually applied shear stress on 
HUVEC vessels in Fig. 8 (F) [25]. 
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There were also some further revealing comparisons among static and dynamic 
HUVEC cultures in the discussed studies.  It was apparent from the system that the 
available oxygen concentration in static cultures resulted in lower cell numbers after two 
days versus the dynamic culture setup; cell proliferation numbers were much higher 
with fibrin gels seeded with HUVECs [43].  What is important about Inoguchi’s work is 
the demonstration that a stepwise increase in graded shear stress resulted in full cell 
retention with cell morphology and alignment consistent with native ECs; furthermore, 
shear stresses with the appropriate magnitude may be the key to enhance the synthesis 
Figure 7:  Morphological images of the luminal surface of HUVEC-seeded graft under 
24 hours of static culture.  Images A and B are SEM snapshots, while C and D are 
CLSM images with DiO-labeled cells; E shows actin fibers and VE-cadherin, F [24]. 
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and secretion of bioactive substances such as endothelial cell nitric oxide synthetase 
(eNOS) [52, 53]. 
A second key finding from Luu et. al added weight to the idea that changes in 
shear stress as well as stromal factors contribute to variations in EC gene 
characteristics in different locations of vasculature [42].  Primary HUVECs cultured for 5 
days in static cultures exhibited a different phenotype from cells isolated freshly from the 
umbilical vein, as observed by expressions of inflammatory related genes [42].   With 
long term HUVEC cultures, deposition of a basement membrane was associated with 
changes in neutrophil migration induced by TNF-α, and changes in matrix proteins 
influencing EC response to shear exposures [54, 55].  Taking this into account, results 
indicate that site-dependent responses to inflammatory stimuli may arise from changes 
in flow conditions and stromal or cell tissue structures in local vessels [42].   
While most of the findings support the idea that shear flow helps the overall 
development of an endothelium in TEVG constructs, the continued pursuit of HUVEC 
culture evaluation on various materials in either static or dynamic environments 
continues today.  Since the ground work of what desirable characteristics a recreated 
endothelium should possess regarding morphology and phenotype expressions, the 
following section will briefly describe studies that analyzed HUVEC viability on various 
stent metals with different culture and media exposures.   
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1.4.3 HUVEC Development on Stent Materials 
HUVEC studies with stent materials have assisted the evaluation of material 
selection of stent devices, and learning how to tailor the device to the surrounding 
endothelium of a native blood vessel.  Previous reports have showed that TiN and TiO2 -
have good biocompatibility characteristics with other types of cells [56, 57].  Here, the 
effect of cell viability on stent metals was examined as well as stent modification on 
HUVEC profiles under static conditions. 
It was noted that several crucial stent features such as thickness, edge angle, 
drug coatings, and surface grooving affects the injury and regeneration capabilities of 
HUVECs [58, 59].  However, in an attempt to better characterize HUVEC phenotype on 
stent metals, HUVECs were seeded on metallic sheets and placed in a 35 mm tissue 
culture-treated polystyrene dish filled with M199 culture medium containing fetal cattle 
serum, containing several previously listed growth reagents [60].  Furthermore the goals 
of the study evaluated eNOS, and VWF with HUVEC expression, along with other EC 
markers represented below, and found that HUVECs seeded on the metallic sheets 
regardless of the coating had higher values of cellularity, but lower expression levels of 
Cx43, eNOS and VWF (von Willebrand Factor) [60].  
Yet, because TiN and TiO2 coatings did not change the down regulation of Cx43 
gap junctions (which is associated with a decreased expression of eNOS), suggests 
that the overlying of endothelial cells had a functional defect [60].  Although this 
hypothesis was not analyzed here, the possible detriment of a static environment of 
HUVECs may have accounted for the clustering of ECs on metallic materials and lower 
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expression levels of eNOS and VWF.  However, a proposed study of dynamic cultures 
of HUVECs on stent materials may have been worth investigating by the researchers to 
determine if any differences would have occurred at those chosen seeding densities. 
   
 
Nonetheless, the finding was still significant because the down-regulation of 
Cx43 gap junctions is closely linked to endothelial dysfunction [61].  Since it is known 
that endothelial dysfunction predisposes the vascular wall to inflammatory cells 
infiltration, platelet aggregation, and SMC migration and proliferation; the presence of 
endothelial dysfunction in stented arteries can lead to unwanted complications such as 
in-stent thrombosis and restenosis [62-64].  Also, what was not mentioned in the study 
was the effect, if any, the inherent surface roughness of each metal and polystyrene 
Figure 8: A growth index of HUVECs on metallic materials.  Comparisons are made within 
experiments using the same starting seeding density.  p < 0.05 and p < 0.01 compared to 
each of TiN, TiO2, and control (YEH). 
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control had on the overall adaptability and behavior of the HUVECs.  What is 
summarized in the following passage are specific cases of scaffold surface roughness 
and modification of polymers used in TEVG studies with HUVECs. 
1.4.4 Effects of Scaffold Surface Roughness  
The evaluation of surface roughness and material quality along the inner lumen 
wall of polymer scaffolds is another important facet of improving the endothelium in 
potential TEVG/BVM setups.  Scaffolds modified at the surface level with manipulated 
polymer frames have exhibited excellent EC response in various studies, but still, it is a 
relatively new field of research.  In order to have a general grasp of cell adhesion 
potentials on different surface roughness degrees, these studies looked at pinpointing 
any differences in HUVEC expression within various characterized scaffold surface 
properties.  
Previously, the development of ECs on various PMMA surface roughness was 
concluded to show a larger degree of surface roughness may have positive effects on 
EC adhesion due to the triggering of sub-confluent cells to secret secrete extra-cellular 
proteins which allow anchorage of cells to their substratum [65].  Another source 
reported that the degree of roughness of a titanium metal surface can modulate the 
product of cytokine and growth factors of vascular chicken embryo ECs, but with 
reduced cell numbers [60].  However, the tracking of cell adhesion within in vitro models 
was the critical aspect of the following studies. 
Modifying scaffold topographies even at the nanometer scale has shown clear 
benefits to transanastomtic cell migration and the recruitment of biomolecules for 
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circulating ECs and EPCs [14, 66].  From previous reports it was noted that various 
factors of scaffold composition can also influence cell affinity, such as surface 
morphology and chemical composition [66].  When looking back at the cell adhesion 
and growth of HUVECs on PU-PEG films, statistically rougher surfaces were better than 
that of smooth surfaces for both GRGD grafted and un-grafted surfaces, respectively; 
increasing roughness of a scaffold surface even at 10-100 nm scales was shown to 
enhance HUVECs adhesion and growth on the surface of GRGD surfaces [67].  In 
addition, research has revealed that small active sequences in ECM proteins exert an 
influence on cell-matrix interactions, so structural atom modification could be an 
effective strategy for promoting the cell affinity of biomaterials [68].   
Liu et. al discussed the role of these ECM proteins and the influence on cell-
matrix interactions, by including the Pro-His-Ser-Arg-Asn (PHSRN) peptide in HUVEC 
adhesion and growth to study modified polymers in vascular synthesis development 
[32].  The PHSRN and GRGDS containing polymers responded well under culture 
incorporation of HUVECs.  The polymers that were synthesized containing these 
peptides (P-PN5 and P-GS5, respectively) had similar results of HUVEC adhesion and 
proliferation to PLMA (p <0.05) as seen in in Figure 9 [32].  However, a steady increase 
in the cell confluency on P-PN5 was found from day one to seven when cell seeding 
was done at 4 x 104 cells/mL in accordance with previous literature [69].   
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In review of the studies of adhesion and proliferation, results indicated that 
certain compounds and peptides such as PHSRN are capable of enhancing cell affinity 
of the materials.  When PHSRN was modified to a longer hydrophilic linker such as 
PEG, the longer PEG chain could mask the peptides available to the cells [70].  
Although, modified hydrophilic peptides attached to the hydrophobic polymer backbone 
may allow the peptides to be more accessible for the binding of EC surface receptors 
[32].  Also, stated throughout the studies was that rougher surfaces at a very specific 
Figure 9: HUVEC number on polymer modified materials after 1, 3, 5, 6, and 7 days.  
Cell seeding density at 4 x 10
4 
cells/mL.  *p < 0.05 [62] 
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and controlled degree became beneficial to cell viability over long culture durations.  
This interpretation is relevant to BVM setups that are currently utilizing new conditioning 
methods, and polymer creations to improve EC adhesion.    
So far topics of in vitro HUVEC development and their use in TEVG experiments 
have been discussed.  Although this study is also done in an in vitro setting, it is 
important to remember that the eventual goal of BVM modeling and tissue regeneration 
is testing clinical arterio-related devices for eventual in vivo applications.  If there is not 
a high level of vascularization in the transplanted grafts, the majority of cells fail to 
survive the early post-transplantational phase [71].  In the following discussion a few 
relevant applications of HUVEC-seeded grafts are compared by media parameters that 
influenced the success or failure of TEVGs in a long-term culture.   
1.4.5 Growth Factor Influence in HUVEC Cultures 
The serum-free trials of HUVEC cultivation mentioned previously will be 
examined with more focus on the direct impact of HUVEC confluency and phenotype 
expression in various setups.  The serum-free trail discussed in section 1.3.2.1 resulted 
in two distinct HUVEC morphologies when TUD-1 (a non-containing serum) media was 
used versus conventional serum medium.  HUVEC shape in TUD-1 resulted in an 
extended elongated formation while the serum containing culture shows an expected 
prominent cobblestone pattern with the final cell densities of both cultures between 0.8-
1.1 x 105 cells cm-2 [37].  Interestingly enough there was a difference in the appearance 
of normal endothelial markers such as the von Willebrand factor among the 
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implemented growth medias, where TUD-1 media showed slightly increased vWF 
expression. 
With respect to the influence of serum usage on passage rates, the serum free 
media allowed for up to 20 cumulative population doublings without significant 
differences in final cell density compared to controls with HUVEC cultivation under 
serum media [37].  These advantages seemed to reduce the overall cost and 
interjection of biochemical components to the cell culture, a possible benefit that needs 
more investigation. 
 Up to now the emphasis of HUVEC culture and TEVG procedures have 
summarized important attempts in the tissue engineering field to better characterize the 
behavior and reaction of EC morphology, and roles within various in vitro and in vivo 
environments.  A major contributing factor to the success of these studies has to do with 
cell engraftment or the execution of delivering the HUVECs along with other vascular 
cell types into the scaffold vessels utilized.  The methodology of incorporating cultured 
cells onto scaffolds will be discussed in an attempt to optimize the process of cell 
sodding during the methods portion of Chapter 2.  
1.5 Methods for Cell Delivery onto Scaffolds and TEVGs 
 There is not one single superior method of delivering cells onto a scaffold graft.   
A host of cell seeding and sodding techniques will therefore be discussed prior to the 
main objectives of this study.   
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1.5.1 Cell Sodding/Seeding Techniques 
Cell sodding requires the input of the correct number of cells at a high population 
base into a natural or synthetic host vessel.  At this point the cells have gone through a 
desired passage or population doubling(s) that have brought the culture to a confluency 
that requires no additional time for the cells to divide once they have been transplanted 
to the host graft [72].  However, cell division may occur within the scaffold structure itself 
during the culture duration of the TEVG. 
Cell seeding is a process that uses fewer cells initially, meaning that at the 
deposition stage onto the graft there is still time required to allow for the cells to divide 
and proliferate further, this is the key difference between the two techniques.  A 
commonly used technique, termed static seeding or sodding, consists of pipetting a 
concentrated cell suspension to a porous scaffold; leaving the user with less control and 
standardization in the process [72].   
With respect to silk-based vascular grafts constructs, cell seeding methods have 
utilized HCASMCs by cell injection into the lumen of the scaffold from one end using 
syringes [23].  Once the bioreactor openings were closed after being filled with smooth 
muscle CM, the seeded scaffolds were placed on a roller apparatus to promote 
homogenous cell adhesion on the scaffolds (Figure 10).  In a static cell seeding trial, 
decellularized vessels were seeded with VSMCs, with the most optimal conditions 
resulting from increasing the cell concentration value to 50 x 106 cells/mL, while the 
scaffolds were submerged in the culture medium [27].   
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 Cell encapsulation, a more controlled form of capturing cells through seeding 
injection methods, has shown suitable potential in TEVG applications.  The concept 
itself literally revolves around capturing the target cells within a biocompatible polymer 
that can adequately maintain structure as well as cell viability.  Hahn et. al used a 
modified PEG polymer hydrogel to capture cells 10T-1/2 mouse smooth muscle 
progenitor cells at desired cell concentrations [73].  The earlier investigation of HUVEC 
nueutrophil recruitment used seeding methodologies to capture HUVECs on rectangular 
glass capillaries which were coated with collagen/gelatin [42].  With an introduction of 
cell seeding-sodding methods, the sodding methods presented in chapter two will use 
similar injection schemes in a BVM specific environment.   
Within the course of literature found in TEVG studies, cell seeding is the 
specified term for most cell delivery processes while cell sodding techniques seem to be 
less used.  Hence, the type of study itself can play a role into which method would be 
Figure 10:  A dual-loop bioreactor used in TEVG cultures.  
HCASMCs and HAECs were sequentially seeded onto the 
luminal surface of the tubular scaffolds under pulsatile flow 
[27]. 
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more beneficial.  Many of the studies start with an initial specified concentration of cells 
and look to see if cell expansion takes places or not.  Contrarily, in BVM studies the 
goal remains to see if adhesion and lining can be established through sodding methods; 
cell pressure sodding was performed using HMVECs in a BVM study by restricting the 
luminal flow path and creating an outward transmural direction of the cells into the 
prepared ePTFE vessel [6].  This technique in essence forces the incorporated cells to 
go one direction; which is outward or transmurally through pores of the fixed scaffold.   
The various initiations of cultured or modified mammalian cells into TEVGs as 
described, can take many forms.  Whether the TEVG study looks to compare static vs. 
dynamic flow settings in EC monolayer development, or various preconditioning steps, 
the final outcome requires repeated studies to examine if a correlation of a specific 
parameter or technique relates to the success or failures of a desired vessel. 
1.5.2 HUVEC Sodding Trials in ePTFE Scaffolds 
 Since ePTFE was the material used in the BVM studies moving forward, it is 
worth taking one more peripheral view of the TEVG studies that have used ePTFE 
scaffolds at the time of EC/HUVEC injection.  In this regard, HUVECs were transferred 
to living tissue conduits grown in the peritoneal cavity of dogs subjected to static 
cultures for two days followed by dynamic exposure for two days at 1.5 dyn/cm2 which 
seemed to improve the monolayer confluency and resistance to shear stress [74].   To 
follow up on earlier techniques, studies focused on HUVEC morphology investigated   
shear stress and modified serum environments [25, 31].  What differentiated the two 
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studies are the techniques of the cell incorporation.  An electrospun 6 cm PLCL tube 
was immersed in 70% ethanol overnight for sterilization and prewetting, and then prior 
to cell incorporation the tube was incubated for 30 min at 37ºC to allow gel formation; 
the process was repeated four times as the tube was rotated horizontally 90º  into a cell 
rich solution [25].  A standardized version of rotating the scaffold vessel before cell 
injection was proven to be successful in maintaining a confluent endothelium.  Similar to 
cell sodding methods, cell plating has utilized the protocols looking at HUVEC 
proliferation and growth.   
1.6 Summary and Aims of the Thesis 
 So far a review of pertinent components in TEVG methodology has been 
explored.  Use of HUVECs in vitro, including isolation and cultivation practices, 
alongside research in HUVEC-based TEVGs was summarized.  Cell seeding/sodding 
practices were detailed from a host of tissue engineering experiments that involved the 
use of a particular scaffold graft and culture mediums.  The rest of this project will focus 
on the experiments that have drawn principles from these fields to attempt a successful 
tissue engineered BVM; in addition to previous research, quality control techniques will 
be implemented to assess preliminary lab contamination risk, with a goal of 
standardizing the performed protocols. 
 Moreover, the overall objective of this project is to improve BVM construction, 
and the consistency of endothelial monolayers constructed with HUVECs under 
peristaltic flow conditions inside a perfusion bioreactor system.  Close observation of 
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HUVEC adhesion, coverage, and morphology will take place on the post analysis 
assessment of the BVMs at the conclusion of each study.  
The first study will start with a BVM protocol for vessel development that was 
established much earlier in the tissue engineering lab.  First, six BVM models will be 
cultured to examine if proper cell adhesion develops on the lumen of each ePTFE and 
to further review the changes of endothelial growth for the three culture durations.  After 
cell coverage is observed from multiple grafts, the latter setups will look to focus more 
on system parameters.  Adjusted model parameters will be tracked to see what effect 
they will have on the endothelial formation.  Changes in the luminal endothelium with 
and without the application of media flow will also be discussed, and compared 
accordingly based upon the results.  Through BBI and histological staining the 
differences in overall cell coverage and endothelium formation will be reviewed for each 
vessel.   
 In the second part of the project, microbiological assessments of the BVM culture 
will be made by examining the sterility of the surrounding tissue engineering lab 
environment.  This goal of this part of the project is to track any microbial growth that 
may be growing around the cell culture area and hence be detrimental to the overall 
BVM development.  Further reasoning and limitations behind the microbiological testing 
will be examined in detail in the coming sections. 
  A summary of the work and experimental findings will be presented in the 
conclusion chapter.  All significant information regarding the initial BVM setups and later 
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microbiology experiments will be presented in a manner as to present the reader with 
an idea of how the BVM model was influenced from the various parameters within the 
BVM setups, including discussion on the possible long-term benefits from sterility 
assurance tracking and controlling microbial growth through improved culture practices.  
Future insight into the field will be explained in such way as to provide potential 
endeavors in the BVM field to help improve how the best physiological BVM replica can 
be created in the tissue engineering lab. 
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Chapter 2:  Blood Vessel Mimic (BVM) Set-Ups Over 
One, Three, and Seven Days 
2.1 Introduction to Blood Vessel Mimics 
The concept of reconstructing the essential features of a tissue engineered blood 
vessel has made enormous strides in the last decade from the evolution of the research 
areas that were mentioned in Chapter 1.  As scientists continue the pursuit of an ideal 
blood vessel, the testing provides a way to assess the development of an endothelial 
lining; from the preparation involved with experimental trials, and the post analysis 
results that reflect the goals of the BVM concept. 
2.1.1 History of Blood Vessel Mimics 
While the desired outcome of the BVMs in this study is to obtain an appropriate 
endothelium within a biocompatible ePTFE scaffold, the bigger goal of creating BVMs in 
the tissue engineering laboratory is to create ideal physiological environments to study 
intravascular device interaction with a TE blood vessel.  Previous BVM research 
demonstrated the culturing of HUVECs onto 4-mm-ID ePTFE grafts to establish an 
endothelial cell lining to assess a stent-intima interaction and co-culture development 
with SMCs [24, 75].   
 Knowing that past BVM trials have shown signs of successful EC deposition 
along the luminal lining leads to inquiry on how will HUVEC cells behave in a modified 
setting, and how consistent the endothelium can be made in these environments?  
Since there are multiple culture parameters, one of the main focuses for the BVM 
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setups throughout this study was to begin to track any alterations to the protocol that 
may have affected the overall HUVEC coverage during the BVM culture period(s).  This 
chapter summarizes important facets of three different BVM studies and the results 
associated with the BVM setups.  Study one will be summarized independently, with 
more specificity described in the methods as to provide the major overall aspects of the 
processes involved.  Studies two and three are presented more briefly due to their 
similarity in post analyses, with highlights of the methods, and differences that were 
noted in the setup.  After the results of each study are examined, a summary of the 
experimental system will be presented and discussed, as well as what adjustments 
were suggested for future studies.  
 
2.2 Materials and Methods 
2.2.1 Materials and Methods for Study One 
Human umbilical vein endothelial cells (HUVECs) were obtained at passage 1 
level from Lonza.  The HUVECs were frozen and preserved in a HC34 Taylor Wharton 
nitrogen (N2) gas tank (Figure 11).  After HUVEC transfer into the EC media, the T75 
was put back inside the Shel Lab incubator (Figure 12) at a 37 °C, 5% CO2 conditions 
until the following day for appropriate cell passage.   
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The HUVECs were previously prepared by Dr. Kristen Cardinal to 4 population 
doublings.  To expand the cell population to a 5th passage (P5), the prepared HUVECs 
at P4 (4th passage) were transferred between T75 culture flasks.  The cells were 
observed under an Olympus CKX31 Optical Microscope (Figure 13).  Initial confluency 
was recorded at 40 percent.  The confluency describes the relative percent coverage of 
HUVECs on the observed area by the optical microscope.  During the follow up passing 
stages the P5 HUVECs were ultimately passed to P8 with a final expected cell count of 
10 x 106 cells per T225 flask.  Six total BVMs were constructed from the P8 HUVECs.  
Detailed protocols of each passing stage are presented in Appendix A.   
 
Figure 11:  A HC34 Taylor-Wharton N2 Tank for 
the preservation of various HUVEC cell 
populations. 
Figure 12:  Shel Lab Incubator operating at 37 
°C and 5% CO2. 
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To obtain proper sterility assurance for the BVM system all bioreactor materials, 
tools, scaffolds, and tubing (Figure 16-17), were either steam sterilized or passed 
through an ethylene oxide (EtO) gas sterilization by the Cal Poly Vet Clinic.   
 
 
Figure 13:  CKX31 Optical Microscope used 
to track HUVEC confluency and observe 
morphological conditions of HUVECs during 
the cell culture duration. 
 
 
 
 
Figure 15:  A bioreactor chamber with 
attached flow valves.   
 
 
 
Figure 14:  A media reservoir assembly 
consisting of a series of connecting silicone 
tubes that feed into the reservoir chamber.   
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Figure 16:  Here the M9 Ultraclave is 
closed and operating at the conditions 
described above.   
 
 
Figure 17:  The M9 Ultraclave in open 
position; a media flask covered in foil 
wrapping with water level present on side.   
 
 
For steam sterilization the appropriate materials were placed inside a M9 
Ultraclave.  The machine was adjusted to 30 minutes of steam sterilization process and 
an additional 30 minutes for drying (Figure 16-17).  After the sterilization stage all sterile 
culture materials were ready for vessel preparation and BVM setup.   
                
 
To adequately prepare for the BVM culture, ePTFE grafts, 3.5 cm long and 3 mm 
in diameter were used as the scaffold.  The graft material was mounted onto barbed 
fittings and tied using silk suture around the edge of the bioreactor fitting for proper 
insulation during the denucleation and BVM culture stages.   
As a preconditioning exposure, the denucleating process helped remove trapped 
air from the interstices of the ePTFE grafts.  10 ml vials of 70% and 100% ethanols 
were prepared for the grafts, along with 10 ml vials containing degassed conditioning 
media (CM) that was prepared in advance.  CM helped aid the scaffolds with prior 
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protein exposure while seeking to potentially improve cell adhesion once HUVECs were 
sodded to the ePTFE scaffold during cell injection.  Ingredients for culture medias used 
in the BVM setups are listed in Appendix I. 
Through the applied protocol (in Appendix A) HUVECs were sodded on the 
ePTFE vessels and cultured in a perfusion bioreactor system.  Two BVM vessels each 
were cultured at the one, three, and, seven day points.  Illustrations of the bioreactor 
systems under the laminar flow hood and Shel culture incubator are depicted in Figures 
18– 20. 
 
  
 Upon completion of the respective cultures, each BVM was fixed and preserved 
in histochoice solution at one, three, and seven days for image analysis.  Peristaltic flow 
rates were increased accordingly at the three and seven day takedown points for the 
remaining BVMs.   
Inlet 
Port 
Outlet 
Port 
Bioreactor Chamber 
Trough 
Lumen 
Valve 
Transmural 
Valve 
Figure 18:  A view of the Bioreactor setup underneath the hood 
during the scaffold priming stage.  Troughs are located at the inlet 
and outlet of the bioreactor ports.  ePTFE scaffolds were primed 
with conditioning media. 
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One week after the original BBI preparation, the vessels were removed from 10 
ml vials for image analysis with a fluorescent microscope.  The microscope used a filter 
Figure 19:  Multiple views of the completed BVM setup, 
including: the peristaltic pump with 8 roller trays, the 6 
BVM bioreactor setups along with 6 media reservoirs 
composed of silicone tubing and thin pump tubing.   
 
Figure 20:  Each bioreactor system is configured with 1 
respective media reservoir.  Here the system is operating 
at 14 rpms. 
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to portray a wavelength of fluorescent light to correctly reflect HUVECs that were tagged 
with BBI along the BVM lumen.  A complete protocol of the BBI image analysis can be 
found in Appendix G. 
The histology staining protocol was specifically carried out as described in 
Appendix D.  In summary, just prior to the series of staining procedures the vessels 
went through a few crucial steps of preparation.  First, each of the six halves of the 
BVMs was embedded into wax blocks.  The wax blocks were sliced using a microtome 
at 7 µm sections and placed onto glass slides (see Appendix J).  Once an adequate 
number of slides were prepared for each of the BVM cross sections, the slides were 
ready for H&E staining. 
2.2.2 Materials and Methods for Study Two 
For study two, cryopreserved P8 HUVECs were used as the initial cell passing 
point.  An included adjustment was the preparation of culture flasks containing 
prewarmed HUVEC media at 37°C.  Allowing the EC media to warm up to physiological 
temperatures allowed critical proteins to coat the flask surface to improve the 
adaptability of HUVECs upon transfer to a culture flask.   
One passing stage was sufficient for the second BVM study since only one 
vessel was being incorporated with HUVECs.  The HUVECs at the P8 level was 
sufficient to use after expanding the HUVECs to P9.  Furthermore, the HUVECs were 
transferred into the T75 and put back into the Shel Lab incubator until the first passage 
was performed.     
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 The BVM culture was carried out through a similar stepwise process used in 
study one that is detailed in Appendix B.  However, study two sought to examine the 
parameters within the culture process of a static BVM setup with the goal of improving 
the HUVEC lining adhesion through standard cell sodding techniques, and tracking 
adjustments amongst the parameters of the culture setup.  Specifically, in study two, the 
BVM was cultivated for 24 hours at static conditions.   
2.2.3 Materials and Methods for Study Three 
For the third BVM study, P4 HUVECs were utilized to create an endothelium in 
four ePTFE scaffolds.  Following standard cell passage methodology, the HUVECs 
were passed from a P4 all the way to P7 by at the time of cell sodding.  Two sets of 
BVMs were cultured under different flow conditions for one day durations.  Specifically, 
2 BVMs were exposed to increasing flow up to 15 RPMs for 24 hours, while the other 
two were cultured at a constant 15 RPM steady flow condition.  The details of the BVM 
protocol for each set of vessels are described within Appendix C.  Cell density counts 
and image analyses were performed as described previously. 
2.3 Results and Observations 
2.3.1 Results from Study One 
In study one; six BVMs were constructed with various sodding densities prior to 
final incubation at 37°C, 5 % CO2.  To help characterize endothelial cell sodding 
densities, the expected cell densities were determined just before cell sodding onto the 
ePTFE scaffolds.  This property of the cell culture was based on a few factors including 
57 
74 
 
original P5 HUVEC population rates, cell confluency observations throughout the vessel 
setup, and final cell population.  The surface area of the ePTFE scaffold was also taken 
into account to calculate the expected number of cells that were introduced into the 
BVM system at the point of cell sodding.  The surface area of the graft was found from 
the equation, Surface Area (SA) = 2πr*L, where r is the radius and L is the length of the 
ePTFE graft; 1 cm of the initial scaffold length was subtracted from the total length of 
the graft that was not exposed to the cell sodding regions.  Confluency values are 
presented in Table 2 as well as Appendix K. 
 
 
 
 
 
 
 
 
 
 
 
 
                 Cell suspension  Surface Area  Cell Confluency  Sodding Density   Culture Time                                                                                  
Vessel A     10 X 10
6
 (cells)    2π.15*2.5 = 2.36 cm
2
        70%                3.0 x 10
6
 (cells/cm
2
)         24 hours                                                            
Vessel B                                                                           70%                          3.0 x 10
6  
                24 hours 
Vessel C                                                                           80%                          3.4 x 10
6   
                48 hours 
Vessel D                                                                           80%                           3.4 x 10
6  
                48 hours 
Vessel E                                                                          100%                          4.2 x 10
6 
                  1 week 
Vessel F                                                                          100%                          4.2 x 10
6  
                  1 week 
Table 2:  Summarizes the range of cell confluency and cell sodding densities for each 
of the BVMs in study one.  A greater confluency was observed for the later cultured 
vessels; including vessels E-F. 
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The images presented illustrate cell coverage along the vessel lumen.  The 
scarcity of HUVECs observed on the lumen from study one made it too difficult to 
discernibly calculate cell coverage values.  
 
2.3.1.1 BBI Imaging 
2.3.1.1.1 Vessel A, 24 - HR at 3.0 x 106 (cells/cm2)           
 
 
 
 
 
Figure 21:  The proximal-middle region of vessel A (24 
hour culture) is shown.  Very few cells appear to be 
present from the lack of cell fluorescence seen on the 
cross section. 
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2.3.1.1.2 Vessel A and B, 24 - HR at 3.0 x 106 (cells/cm2)           
     
 
2.3.1.1.3 Vessel C, 72- HR at 3.4 x 106 cells/cm
2 
 
 
Figure 23:  A similar viewing of vessel A at the 
distal region of the graft with respect to flow. 
 
 
Figure 22:  Here, the middle-distal region of 
vessel B is shown.  Not many cells were observed 
throughout the various regions B. 
 
Figure 24:  Vessel C cultured for 72 hours.  Several faint 
cell type specs appear to fluoresce in the mid region of the 
vessel.  Still, it is hard to conclude the presence of any 
established cell layer based on this BBI image. 
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2.3.1.1.4 Vessel D, 72 - HR at 3.4 x 106 cells/cm
2 
 
 
 
2.3.1.1.5 Vessel E, 1-week at 4.2 x 106 cells/cm2 
 
 
Figure 25:  Vessel D cultured for 72 hours.  Similar 
to Vessel C, few cells appear to fluoresce visibly in 
the mid-distal region of the vessel. 
 
 
Figure 26:  Vessel E shows a mid-proximal image 
of the lumen surface.  A possible series of cells 
fluoresce in the upper left area of the image. 
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2.3.1.1.6 Vessel E and F, 1-week at 4.2 x 106 cells/cm2 
        
        
 
2.3.1.2 Histology   
2.3.1.2.1 Vessel A and B, 24 - HR at 3.0 x 106 (cells/cm2)           
            
 
Figure 27  A mid-distal shot of vessel E confirms 
some presence of HUVECs, however the count 
was too low to obtain an accurate cell average 
count based on the viewing area.  
Figure 29:  Vessels A at 4x magnification.  
HUVECs are not Vessel B at a cell sodding 
density of 2.5 x 10
6
 cells/cm
2
.   
Figure 30:  Vessel B at a cell sodding density 
of 2.5 x 10
6
 cells/cm
2
.  No attributable lining 
was present from the above image.  Vessel A 
observed at 4x magnification.  
Figure 28:  Vessel F shows minimum cell 
coverage on the distal end of the graft.   
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2.3.1.2.2 Vessel C, 72- HR at 3.4 x 106 cells/cm
2 
       
 
Figure 33:  Here a left angle proximal view of 
the lumen cross section of vessel C with a 
cell lining development.   
 
Figure 34:  Vessel C at 4x shows further 
structured lining indicated by the presence of 
a red stained strip of cells alongside the right 
side of the mid-proximal area.   
Figure 32:  Right proximal view of Vessel B at 
10x.  Although pinkish globules appear along the 
lining, it was still inconclusive to say any 
endothelial layer was present on the graft. 
Figure 31:   Left proximal section of Vessel A at 
10x.   
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2.3.1.2.3 Vessel E and F, 1-week at 4.2 x 106 cells/cm2 
       
 
Figure 35:  Another view of Vessel C from the 
center region of the vessel cross-section.  Here 
cell lining is evident and points to the 
consistency of the HUVEC layer that was 
established in this section of the vessel.   
Figure 36:  Vessel C at 10x, the thickness of the 
lining can be more easily differentiated from the 
ePTFE vessel.   
Figure 38:  A separate isolated section of the top 
proximal area of Vessel E shows little sign of cell 
deposition along the lumen.    
Figure 37:  Vessel E cultured for 1 week with a 
shows consistent cell lining along what remains 
of the left proximal end section at 4x.   
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Figure 40:  No presence of cells is seen on a 
separate cross sectional view of Vessel F. 
Figure 39:  The arrows on Vessel F show 
penetration of HUVECs into the ePTFE 
interstices.  
Figure 42:  A right centered proximal view of 
Vessel E appears to have an endothelial lining 
consistently down the cross section.   
 
Figure 41:  On a separate slide, Vessel F at 4x 
shows a top-proximal view covered by a thin 
endothelial lining along the lumen area.   
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2.3.2 Results from Study Two 
To characterize the cell sodding densities in study two, careful observations of 
cell confluence were made on setup day; 60 percent confluency was noted for the T225 
culture flask for vessel 1.  As previously calculated in study one, the expected number 
of viable cells incorporated into the vessel prior to the BVM culture was determined.   
Since a clearer amount of cells was seen from the BBI images, the cell density of cells 
per cm2 was calculated along the lumen of each sample.    
Since the study only utilized one BVM, the following images cover the cross 
sectional regions of the single vessel that was developed.  The order of the imaging is 
presented in order of the media flow into the bioreactor and subsequently through the 
tubular scaffold along the graft; starting with the proximal to mid-proximal area which 
was closest to the inlet port of the bioreactor chamber.  Eventually, the middle to distal 
Figure 43:  Shows vessel F at 10x magnification 
with arrows pointing toward endothelial lining 
down the lumen. 
 
Figure 44:  Vessel E cultured at 10x indicates 
cell stacking evident among the middle region. 
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areas of the half sections is presented (Figure 45-52).  The experimental culture 
parameters of study two are presented in Table 3. 
 
 
 
 
2.3.2.1 BBI Imaging 
2.3.2.1.1 Vessel 1, 24 - HR at 2.5 x 106 (cells/cm2) 
 
 
                   Cell suspension     Surface Area     Cell Confluency     Sodding Density       Culture Time                                                                                  
Vessel 1     10 X 10
6
 (cells)    2π.15*2.5 = 2.36 cm
2
        60%                2.5 x 10
6
 (cells/cm
2
)          24 hours                                                            
Figure 45:  The BVM shows increased cell 
coverage relative to the proximal regions from the 
vessels in study one.   
Table 3:  Summary of the cell confluency and cell sodding density for the statically 
cultured BVM in study two.   
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Figure 47:  A mid-proximal view of the BVM.  
This photo shows the vessel region just right of 
the very proximal region.   
Figure 46:  Shows the BVM just next to the mid 
region, cell coverage stays fairly consistent 
between the two photos. 
Figure 48:  Vessel 1 image of the right-distal 
region shows good cell coverage for being near 
the vessel middle edge.  
 
Figure 49:  Here the BVM is at the near 
proximal-mid region at 4x magnification.  The 
most significant cell coverage was observed in 
this region. 
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Shown below (Figure 52) is an enlarged BBI image of the proximal-mid region of 
the BVM lumen.  A 1 x 1 cm2 grid was placed on the image to take the average cell 
count per cm2.  Since the length of the viewable portion of the BVM is around 1 cm, the 
number of images from the viewing area with 4x scope was limited to specific viewable 
regions away from the cut ends of the vessel.  Cell average counts for the other vessel 
areas of study two can be located in Appendix F. 
Figure 50:  Shows the BVM at a mid-distal 
range near the incision from the attached male 
barb ending. 
Figure 51:  An outer edge BBI shot of the 
BVM where minimal cell coverage was 
observed.  Due to the bending of the scaffold, 
the outer edges appear unfocused.   
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2.3.2.2 Histology  
The second half of the BVM was preserved in glutalderhyde until the appropriate 
time for histology staining.  As oppose to the first BVM study, histological analysis on 
the BVM cross section occurred exactly one week after the BBI images were taken 
rather than a 2-3 week period.   
6           8        6        5        8        
5 
6          7        5        10         7 
  6       8        5        8        6        
Figure 52:  Vessel 1 towards the mid-distal region shows consistent cell adhesion near the vessel edge.  
The image shows the BVM at the proximal-mid region at 4x magnification with an average cell count of 
three random areas to make a better approximation.  The most significant cell coverage was observed 
in this region with the vessel averaging 6-7 x 10
6
 cells/cm
2
. 
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The histology was carried out as described in Appendix D.  Before the series of 
staining procedures, the vessels went through same preparation steps as in the first 
study.  Once an adequate number of cut cross sections were prepared for the BVM, the 
sections were transferred onto glass slides via forceps.  After twenty-four hours the 
slides were ready for staining and further processing.   
2.3.2.2.1 Vessel 1, 24 - HR at 3.0 x 106 (cells/cm2) 
 
Figure 53:  The image taken was of the left proximal 
area of the cut cross section.  The arrows point to the 
endothelial formation of HUVECs along the lumen 
lining.  A consistent lining was present along this area 
of the vessel which was towards the proximal side of 
the bioreactor entrance port. 
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Figure 54:  A bottom mid-proximal view of the 
vessel along the BVM cross section.  No strong 
indications of endothelial formation along this 
portion of the cross section was found. 
Figure 55:  On the contrary, along the top region 
of the vessel cross sectional area of the BVM, 
there were stronger signs of endothelial 
development from the histology stains. 
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Figure 57:  Cell grouping is less prominent 
compared to other stained sections of the 
proximal-mid region, as seen from the examples 
of scarce HUVECs within the ePTFE vessel. 
Figure 59:  From the histology it appeared 
that cell numbers were less distinguishable 
in the right region of the vessel walls 
compared to the top-middle cross sections. 
Figure 58:  The 10x view of the vessel shown 
here was a weaker development of HUVEC 
groups.   
Figure 56:  The BVM histology presented at a 10x 
view.  Cell arrangement along the lumen was 
harder to distinguish among these cross sectional 
shots.   
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Figure 61:  The endothelial lining from these 
images was more indicative of the stacked 
effect of the sodded HUVECs on the scaffold 
lumen. 
Figure 60:  A zoomed view of the mid-top area 
of the cross section shows an easily 
distinguishable cell arrangement from the rest 
of the scaffold. Cell penetration was seen to 
some extent within the outer layer.   
Figure 62:  This adjusted shot of the lining gives a 
better representation to the extent of the 
thickness of the ePTFE vessel.  The endothelial 
linings along the intima layer alone represent only 
a fraction of the conduit thickness itself. 
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2.3.3 Results from Study Three 
 During study three, the four BVMs were constructed with cell confluency values 
that ranged from 60 - 80%.  Similar to study two, the cell sodding density was estimated 
as cells/cm2 from observing the final HUVEC confluency prior to cell sodding.  
The P4 HUVECs in study three were cultured into P7 HUVECs to approximately 
10 x 106 cells.   A notable change was the amount of EC media used to resuspend each 
pellet prior to sodding from the previous studies.  The culture flasks for vessel 1 and 
vessel 2 exhibited lower cell confluency around 70%.  Vessels 3-4 were more confluent 
near 80%.  Tables 4 highlights the cell density, flow, and take down points for vessels 1- 
4.  A complete list of the cell sodding densities along with resuspension densities for 
study two and three are presented in Appendix K.   
 
                 Cell suspension  Surface Area  Cell Confluency  Sodding Density  Culture Time   Flow Rate                                                                          
Vessel 1     10 X 10
6
 (cells)    2π.15*2.5 = 2.36 cm
2
        70%                2.5 x 10
6
 (cells/cm
2
)          24 hours          10-15 RPM                                            
Vessel 2                                                                           70%                          3.0 x 10
6  
                 24 hours          10-15 RPM                                            
Vessel 3                                                                           80%                          3.4 x 10
6   
                24 hours           15 RPM                                            
Vessel 4                                                                           80%                           3.4 x 10
6  
               24 hours            15 RPM                                            
Table 4.  BVM culture parameters for Study Three 
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2.3.3.1 BBI Imaging 
 Following the same procedures of study two, the vessels in study three were 
preserved in glutalderhyde until the day of imaging.  Imaging occurred two days after 
takedown and preservation of the four vessels.  Below are the images of BVMs 1-4. 
 
2.3.3.1.1 Vessel 1, 24 - HR at 2.5 x 106 (cells/cm2)           
         
Figure 64:  Vessel 1 at the proximal-mid region.  
The focused area of the image only shows a 
few viable cell adhesion points. 
Figure 63:  Shows vessel 1 at the distal end of 
inner wall with minimal cell coverage. 
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2.3.3.1.2 Vessel 2, 24 - HR at 3.0 x 106 (cells/cm2)           
          
 
            
 
Figure 65:  Any cell reflection is too difficult to 
distinguish and appears mostly bare; with 
minimal coverage across the prox-distal area. 
Figure 66:  A mid-distal shot leaves little to 
examine.  Not much cell reflection from the 
surface was visible from the BBI photographs.   
Figure 68:  A few visible cells fluoresce in the 
proximal area of the vessel fragment. 
Figure 67:  This image of the mid-distal area 
of vessel 2 follows along the line of the above 
images.  Not much evidence can be drawn 
from magnitude of HUVEC adhesion success. 
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2.3.3.1.3 Vessel 3, 24 - HR at 3.4 x 106 (cells/cm2)           
          
 
            
Figure 69:  The distal regions of vessel 3 with 
a few HUVECs spotted alongside the edges.   
Figure 70:  The middle region of vessel 3.  
Slightly more cell adhesion can be observed 
with these two images, however, the 
coverage remains too low to obtain any 
significant coverage count. 
Figure 72:  Shows vessel 3 a little further along 
the vessel, there are slightly more focused and 
distinguishable cells in this capture. 
Figure 71:  Unlike the above images, this view 
of the prox-mid region of the vessel can give a 
clearer count of cells.   
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3         2         1           2         2 
Figure 73:  This image is an expanded view of the prox-mid region; a cell average count is taken here 
to demonstrate the process of counting.  Since the coverage is rather scattered than uniform, the cell 
count ranges in different areas but averages around 2 x 10
6
 cells/cm
2 
in this vessel shot. 
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2.3.3.1.4 Vessel 4, 24 - HR at 3.4 x 106 (cells/cm2)           
          
 
         
Figure 75:  The BBI images from vessel 4 
showed the most prominent and substantial 
cell adhesion, a view of the distal end of the 
BVM.   
Figure 74:  The continuity of HUVEC presence 
across the ePTFE graft near the proximal 
region.    
Figure 77:  A clearer shot of the prox-mid 
region shows the significant cell development 
formed on the lumen layer. 
Figure 76:  Similar to the BVM in study 2, the 
proximal end of the vessel shows cell stacking 
among the denser areas of HUVEC population.   
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Figure 78:  This expanded view shows a middle view of 
the prox-mid area of the BVM.  Clearly, cell average 
counts become much easier to obtain within the focused 
area of the vessel.   
Figure 79:  Here the bottom area of the mid-distal 
region of the vessel is flattened out with a pair of 
forceps to assist in impeding the graft from curving 
upwards too much.  A heavy cell population can be 
seen along the visible area of the ePTFE graft. 
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2.3.3.2 Histology 
Assessment of cell adhesion with the scaffold was assessed through histology.  
The initial BBI preparation of the BVM cross sections occurred exactly seven days after 
capturing the BBI images.  From the BBI images of study three it was expected that 
there would be signs of endothelial linings on the lumen of the scaffold.  Similar to the 
earlier studies, the mid-distal half of the BVM was used for histological analysis, and 
was preserved in glutalderhyde during the week prior to examination. 
  5          3         8          6          4 
  4         5           3          4         3 
  5          3         8           6          3 
Figure 80:  Here the average cell count was taken along 3 regions of the proximal-mid area of the 
BVM vessel.  From the grid placement the average count of cells was between 6-7 x 10
6
 cells/cm
2
 
across the presented area.   
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The histology was carried out in a slightly modified manner compared to the 
protocol in Appendix D.  A few changes were made with respect to exposures of the 
slides in certain staining reagents; the protocol is summarized in Appendix E.  Before 
the series of staining procedures, the vessels went through the same preparation steps 
as described in the sampling preparation of the first two studies.  One day from the 
initial preparation, the slides were ready for staining and further processing.  
Furthermore, a more significant subset of images was taken for vessel 3 and vessel 4 to 
help demonstrate a more typical BVM based on the initial BBI images, and cell density 
counts observed across the entire lumen section. 
2.3.3.2.1 Vessel 1, 24 - HR at 2.5 x 106 (cells/cm2)           
         
 
Figure 81:  These snapshots of the cross 
sections of vessel 1 do not provide conclusive 
signs of endothelial presence. 
Figure 82:  Although a thin lining may be 
apparent from the first image, it is too hard to 
decipher the presence of cells from other 
staining reagents. 
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2.3.3.2.2 Vessel 2, 24 - HR at 3.0 x 106 (cells/cm2)           
         
Figure 84:  Another angle of the right mid-
proximal side of vessel 1 shows a lack of 
endothelial formation. 
Figure 83:  Vessel 1 at 10x view.  Histology 
reagent is displacement around the lining 
formation is evident.  Cells look present, but 
again are hard to clearly define from the stained 
reagent spots on the cross section.   
Figure 86:  Shows a top-mid shot of the BVM.  
A closer examination indicates a structured cell 
lining formed at a lower cell density. 
 
Figure 85:  A right mid-proximal view of vessel 
2 taken at 4x.  A narrow endothelial lining is 
evident from the image.   
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Figure 88:  As images were taken further up the 
vessel, more evidence of cell adhesion was 
observed. 
Figure 87:  Vessel 2 exhibits inconsistent cell 
lining development from top to bottom along 
the inner lumen.   
Figure 89:  HUVEC adhesion is minimal and but 
consistently lines the outer interstitial pattern of 
the ePTFE grafts. 
Figure 90:  Vessel 2 cross sections cultured at 
10x.  A thinner looking endothelial lining was 
present along the outer side of the BVM.   
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2.3.3.2.3 Vessel 3, 24 - HR at 3.4 x 106 (cells/cm2)           
     
 
Figure 91:  Substantial HUVEC grouping was present 
in fewer portions along the cross sectional views of 
vessel 2.  Here the 10x image shows the red stained 
cell sections along the inner lining. 
Figure 93:  The circumferential images of vessel 3 
demonstrate the consistency of the HUVEC lining 
with respect to the entire circular section of the 
graft. 
Figure 92:  HUVEC lining seen along vessel 3.  
Here the 10x image shows the endothelium along 
the inner intima lining. 
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Figure 95:  A continuation of the previous 
figure, where a moderately developed cell 
lining was observable across the bottom to 
right wall area of the scaffold lumen. 
Figure 94:  Vessel 3 at a lower left view of the 
lumen cross section area at 4x.  The 
extraneous bubbles were formed during the 
slide cover placement procedure 
Figure 96:  The cell confluency of HUVECs 
used in study three led to a more noticeable 
lining along the mid-proximal regions of vessel 
3. 
Figure 97:  Easily distinguishable HUVECs 
have formed a consistent cell lining along the 
middle top luminal area of the vessel.   
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2.3.3.2.4 Vessel 4, 24 - HR at 3.4 x 106 (cells/cm2)           
            
 
Figure 99:  In similar fashion the endothelial 
development of vessel 3 was observed to span 
the entire region along the lumen sides of the 
vessel cross-sections. 
 
Figure 98:  The noted HUVEC lining can be 
seen down in the entire right lumen section 
cultured at 24 hours.   
Figure 101:  Vessel 4 is presented from top 
mid-view where the graft was noticeably folded 
during the staining procedure.  An endothelial 
lining was observed down the lumen. 
Figure 100:  With denser cell sodding usages, 
vessel 4 showed more established cell lining 
networks along the lumen wall.   
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Figure 103:  From a mid-low angle view the 
endothelial remains consistently developed 
along the luminal lining. 
Figure 102:  Vessel 4 is presented from the 
bottom mid-region view where the graft was 
folded during the staining procedure.  A thinner 
endothelial structure was seen here. 
Figure 104:  A brightly lit 10x view of the bottom 
rim of the vessel shows nicely formed cell 
deposition.   
Figure 105:  The coverage was not confluent 
in all locations.  Here the HUVECs appeared 
to penetrate into the graft interstices/pores.  
Cell stacking was evident at various levels of 
HUVEC adhesion. 
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2.4 Conclusion of BVM Studies 
2.4.1 General Observations of BVM Studies  
Throughout each of the BVM studies observations were made that included any 
discrepancies that may have affected the end result of the endothelial lining confluency; 
for this reason and other details, the vessels were cultured with varied success between 
them.   
With regards to addressing or improving the upkeep of the system, the 
experience from study one helped grasp possible situations that may occur at any point 
during a study in real time; such as bioreactor leakage, discontinued flow paths, or 
maintaining consistent flow regulation throughout the media reservoir tubing.  The 
quicker turnaround time on the BBI imaging and histology in the latter studies proved to 
Figure 107:  A closer view of the left mid-proximal 
vessel wall shows the consistently developed 
endothelial lining along the lumen. 
Figure 106:  Vessel 4 images just above the 
folded region of the graft cross section.  HUVECs 
are slightly displaced from the inner lining.   
 90 
107 
 
be beneficial.  Although the setups were performed in almost the same respective 
manner, there were still notable differences between each of the three studies with 
regards to cell adhesion consistency.    
2.4.2 Study One Discussion 
Each of the six cultured BVMs of study one showed minimal cross-sectional cell 
coverage from observations of the BBI images.  The distal ends of the grafts showed 
even less evidence of coverage based on the lack of cell fluorescence on most of the 
viewable surfaces; these areas represented the ePTFE inner (lumen) surface.  Also, it 
was not possible to approximate an average cell density value to the said scaffolds 
based on the ambiguity of the BBI images.  However, based on the prior approximated 
cell sodding densities in Table 2 it was reasonable to predict that the increased 
concentration of HUVECs assisted the endothelial growth among vessels E and F. 
 Looking at the expected cell density values there are a few possible explanations 
for the lack of cell adhesion seen throughout each BVM in the BBI images.  One factor 
may have to do with the two week time delay between graft enrichment in BBI solution, 
and when the fluorescent images were taken under the white light fluorescent 
microscope.  Also, since BBI solution is mostly composed of highly deionized and 
purified milli-q water, it is possible that the DNA present among the cell population did 
dissolve or deteriorate to some degree based on the chemical properties of DNA.  
Furthermore, these conditions when combined, may have largely contributed to the 
voidance of HUVECs among BBI images.   
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In contrast, the histology images exhibited cells to an extent, but were still 
inconsistent in terms of lining cohesion around the scaffold circumference.  The 
histology results for Vessels A-F showed signs of HUVEC adhesion along the inner 
lumen of the scaffolds.  Although Vessels A and B could not confirm sustained 
endothelial development from the histology images, Vessels C-F had indications of cell 
adhesion and structured cell networks along the lumen layer.  However, as noted before 
these findings also came with inconsistency, as a majority of the vessels had sectioned 
areas that possessed only short lengths of endothelial lining rather than uniform 
coverage, hence it was difficult to make reasonable assertions on specific parameters 
influence during the BVM trials.   
  Lack of cell presence or confluency in the cell cultures was also a considerable 
factor from one BVM to the next; this led to an undesirable variation in cell sodding 
density that was incorporated amongst the sets of vessels during the cell sodding 
procedure.  Overall, cell adhesion was seen to some extent but the inconsistent 
endotheliums’ of study one showed that closer examination of the BVM process was 
needed to attempt further reasoning behind the success or failures of future BVM 
setups. 
2.4.3 Study Two Discussion 
Expanding on the observations of study one, further examination of the effects of 
culture parameters on endothelial lining potential was carried out for study two with the 
hope of better understanding the complete BVM system.  The characteristic differences 
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in the endothelium formations of the BVM constructs in the earlier study led to the 
specific questions of how cell densities, media flow adjustments, and volume changes 
of cultural media effects the end result of the endothelial lining.   
The 24-hr culture period for the BVM in study two showed considerable increase 
in cell adhesion based on the BBI images.  The post setup BBI imaging of study two 
occurred approximately 24 hours after the vessel was placed in 5 ml of glutalderhyde for 
preservation.  The freshness of the BBI solution was also worth mentioning; a new 
batch of BBI was prepared relatively close to the imaging day.  Moreover, the greatest 
areas of cell coverage were located towards the proximal-middle region of the BVM 
indicating the possible effects that gravity may have on cell migration within the vessel 
in correspondence with the flow rates of the culture media.   
 Histology results further reassured the presence of an endothelium along the 
luminal region of the BVM cross section.  Most of the observable areas of the stained 
cross sections were covered with HUVEC deposition along the luminal lining.  Despite 
the fact that the bioreactor chamber and media reservoir tubings/chamber were not gas 
sterilized in this study, there did not prove to be an adverse effect on the HUVEC 
adhesion or endothelium based on both imaging techniques.  The relative success of 
cell adhesion and presence of a more consistent endothelial lining helped validate the 
installed protocol of the BVM setup, however the use of only static conditions allowed 
for further revaluation of applied steady flow rates on the culture system.   
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2.4.4 Study Three Discussion 
 Using information from developed BVMs on U-shaped ePTFE grafts by Dalton 
Chavez at the Cal Poly Tissue Engineering lab, certain procedural steps related to flow 
speed and ramp up in the U-shaped BVM development was compared with a variation 
of the implemented protocol from study two.  The four BVMs in study three had varied 
results based on the BBI and histology images.  BVMs 1 and 2 exhibited inconsistent 
cell coverage along the luminal lining.  The BBI images for each vessel indicated some 
presence of cell adhesion but not enough to establish a consistent lining; as discovered 
from the histology images.  It was worth noting that the bioreactor chambers for vessel 1 
had leaks around the tubing connections.  The top region of the ePTFE vessel was also 
exposed to air due to the drop in media.  This occurrence may have not directly 
impacted the adhesion of HUVECs along the vessel, but may have imposed added 
stress that had some impact on the coverage of HUVECs.   
 BVMs 3 and 4 showed a substantial improvement regarding endothelial 
development and cell adhesion.  These vessels were sodded at a slightly higher density 
then BVMs 1 and 2 and no complications occurred during their setups.  However, the 
difference in cell sodding densities cannot completely explain why there was such a 
dramatic improvement with the overall endothelial coverage.  Other factors may have 
included the overall effectiveness of the trypsin media to remove the cells from the T225 
flask.  A slightly higher volume and more vigorous shaking procedure of trypsin was 
introduced for the latter vessels based on the success or lack thereof from the previous 
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studies.  This step may have increased the physical amount of cells that were 
introduced into each vessel.   
2.4.5 Future Outlook/Next Steps 
The major comparisons between the setups examined cell adhesion and 
possible factors that may have an impact on the HUVEC development in the current 
BVM system.  Study two showed that a preconditioned ePTFE vessel at static 
conditions was able to sustain a minimal amount of HUVECs for 24 hours along the 
interior luminal lining.  On the other hand, BVMs 1 and 2 of study three did not respond 
as well to the flow ramp up introduced during the transmural to luminal flow period.  
BVMs 3 and 4 in study three were vastly improved in cell coverage and cultured at a 
constant flow rate of 15 RPMs during the entire 24 hour culture period.  Again, as 
discussed there are a number factors that may have contributed to the hindrance of cell 
adhesion for these vessels.   
 As the thesis progressed, it was necessary to initially expand on the 
implemented parameters from study one, and to look specifically at improving cell 
coverage on the lumen layer as well as consistent cell sodding densities for each 
vessel.  Inconsistency of endothelial development across the ePTFE grafts indicates 
some flaw associated with the set-up or the assessment of the vessels and the setup 
processes involved with BVM setups. 
It was reasonable to speculate a sudden introduction of high speed EC media 
was detrimental to the organization of HUVECs directly after sodding along the lumen 
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area of the scaffold.  This in turn could be one cause of the drastically inconsistent 
results of study one.  The BVM from study two as well as the latter BVMs from study 
three were successful at more consistent endothelial development with peristaltic flow 
rates around 10-15 RPMs.  Nonetheless, the experimental parameters worth looking 
close at within the BVM setup such as flow-ramps, media usages, and cell population 
need more testing to examine the direct impact between these parameters and the 
growth of the endothelium. 
 After performing the preliminary BVM set-ups described in this chapter, it was still 
of emphasis to improve the methods involved with creating consistent BVMs.  There 
were many experimental parameters that could have been further explored, such as 
flow rate, sodding density, media composition, etc.  However, the thesis looked to bring 
a new approach to the tissue engineering lab with aims at improving sterility assurance 
throughout all facets of the lab.  Moving forward, a quality control mindset was taken to 
analyze possible contamination routes that can potentially impact the BVM system and 
sequential processes, concepts such as sterility of materials, cell culture contamination, 
and evaluating cleanliness of the surrounding lab environment were closely scrutinized.   
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Chapter 3:  Sterility Assurance of BVM Systems 
through Microbiological Practices 
3.1 Introduction to Microbial Testing Significance and 
Microbiological Assessments  
 An undervalued component of TEVGs is the extreme delicacy that encompasses 
the growth, passage, and treatment of mammalian cells used in cell cultures.  Whatever 
lineage the cell may be genetically, the conditions of the physical environment in which 
the cells are exposed to plays a huge role in either the success or hindrance of a 
scientific experiment.  Having good sound knowledge in the field of sterility assurance 
and managing testing methods through microbiological analysis will be a beneficial tool 
to improve the BVM process within the TE lab.  Therefore, the basic fundamentals on 
the growth of microbes will be explored along with the long-term significance of 
microbiological tracking in highly sensitive environments such as cell culture 
laboratories.   
3.1.1 Early Forms of Microbiological Testing and Bacterium Growth 
 There are many pioneers to consider when looking back at the history of 
microbiology and early forms of testing practices.  Many consider Louis Pasteur the 
“father” of microbiology.  His ability to explain the concept of immunization and 
pasteurization has profoundly changed history.  At the request of a distiller Pasteur was 
also able to demonstrate that alcohol fermentation is carried out by specific 
microorganisms (MOs) [76].  There were early scientists who came up with a plethora of 
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techniques that are taken for granted today, such as Robert Koch, who came up with 
Koch’s postulates and demonstration of media use and sterilization, as well as the 
staining and sterilization of cells [76].  As more and more studies focused on MOs and 
their inherent characteristics, the concepts of bacteria growth and contamination risk 
became better understood.  
3.1.2 Testing Bacteria Presence in Modern Era 
When the science of microbial growth was better characterized, advancement in 
the areas of testing for microbes consequently followed.  The temperature, available 
oxygen and nutrients, and competing bacteria in an environment are known as the most 
immediate extrinsic factors that affect the growth of bacteria [76, 77].  There are 
however attributes of MOs related to cell adaptability that were not well understood until 
the more recent modern era [77]. 
 Traditional micro testing has outgrown many of the early techniques of sample 
collection and assessment in the last 20 years.  While complex agars are still used for 
desired growth in controlled nutrients, selective agars that are used for the growth of 
select MOs with differential media are being phased out because of the inconvenience 
related with costs, time, material storage, and the emergence of microbial detection 
technology.  While microbiology practices still rely on standard plate counts (SPC) for 
cultural growth to detect the presence of bacterial contamination in sensitive 
environments such as food process facilities, the shift towards rapid detection testing 
has become widespread [76].  Tools such as automated Polymerase Chain Reaction 
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(PCR), enzyme-linked immuno-sorbent assay (ELISA), gas chromatography (GC), and 
mass spectrometry are among the many methods used to discover the chemicals and 
living constituents present in food products, environmental samples, or in a various 
laboratory settings.   
In addition to the evolving detection methods in today’s science, the initiation of 
good laboratory practices (GLPs) has come a long way.  Implementing sound regulated 
standards has become more common and expected among a variety of industries, 
including ones that test for the quality and chemical safety of consumer products.  ISO 
accreditation of research and testing laboratories has established a scientific community 
that now sets a high standard of controlled and integrated systems in several fields of 
importance [78].   
Expectations of the microbiological testing methods are to improve the sterility of 
the TE culture lab that is used for the creation of TEVGs.  Through increased 
awareness of microbial contamination routes and knowledge of various bacteria testing 
methods used in many ISO approved testing facilities the prevention of cell culture 
contamination can be greatly reduced.  Over time through microbial tracking feedback, 
the efficacy of the testing will be determined and adjusted as need be to create the most 
beneficial system of sterility assurance around the cell culture lab area. 
3.1.3 Endothelial Cell Responses to Bacteria Exposures and Contamination 
 Endothelial exposures to various bacteria including, E. coli and S. Aureus have 
been well documented and is worth a closer look to help give some insight on some 
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possible outcomes of contaminations within a TE BVM.   The capacity of these toxins to 
cause cell activation and mediator release in human endothelial cells was investigated 
and compared with the reaction of thrombin among such interfaces [79].  Hemolysin 
induced from E.coli and the alpha-toxin from staph was observed to be potent inductors 
of inflammatory and vasodilatory mediators in human endothelial cells; the elicited 
effects proceeded predominantly via activation of the phosphatidylinositol hydrolysis-
related signal transduction pathway [79].  Furthermore, these toxins have shown to 
contribute to vasoregulatory and inflammatory disturbances and could potentially cause 
infection of an endothelium encountered in sepsis.  
3.2 Cell Culture Contamination:  Identification and Testing Methods 
The biological contamination of mammalian cell cultures is alarmingly more 
common than one would imagine.  In the mid-90’s, statistics reported that between 11 – 
15 percent of cultures in U.S. laboratories were infected with Mycoplasma species [80].  
In 2010 a surprising 8.45 percent of cultures commercially tested from 
biopharmaceutical sources were contaminated with fungi and bacteria, including 
mycoplasmas [81].  In the following sections a variety of common bacteria groups and 
contamination sources will be examined to provide an overview of the remedial control 
methods of the initial microbiological testing routine introduced to the TE lab. 
3.2.1 Contamination Sources 
There are many basic preventative measures that are taken in various 
environments to reduce the risk of contamination, but contamination issues still occur.  
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Contamination may enter a laboratory or cell culture system through a variety of 
physical, biological, and chemical means.  However, there is no substitute for practicing 
proper aseptic technique.  Hence, understanding the routes of contamination as a 
practicing cell culture scientist is critical to the success of studies within a TE lab.  The 
following passages will take a closer look at some of the more characterized routes 
through which cell culture laboratories may be contaminated 
3.2.1.1 Biological Sources 
Biological contaminants can be divided into two subgroups depending on the 
ease of detecting them in cell cultures.  One group is easier to detect, which is 
considered most bacteria and fungi, while the more difficult to detect sources include 
mycoplasmas, viruses, and cross-contamination by other mammalian cells [78].   
Contaminations can initiate a cascading series of metabolic events unique to each cell 
culture system and the contaminants [77].  There are multitudes of tests that can be run 
in order to confirm the identity and contamination status of each cell line.  
In addition to direct bacterial intrusion, water that is routinely used in a cell culture 
lab can pose as a severe biological risk for contamination.  Designated areas such as 
water pans under incubators, water baths, vortexes, and centrifuges are all subject to 
be splashed or contain water that can potentially lead to the microbial growth of aerobic 
MO’s; in turn creating a cesspool for contamination risk.  A common source of 
contamination is entry by a liquid “bridge” that forms when a droplet of culture medium 
remains between the culture vessel and its lid or on the neck of a culture medium bottle 
 01 
118 
 
[82].  There are however, more difficult to detect issues that are also introduced prior to 
the methods summary.  
3.2.1.1.1 Mycoplasmas  
Common biological contaminants such as Mycoplasmas, are a known threat 
within mammalian cell cultures.  Mycoplasmas are the smallest (0.3 – 0.8 µm diameter) 
prokaryotes that reside in endosomes of mammalian cells [78].  Around 30 percent of all 
cell cultures are reportedly contaminated with mycoplasmas [83].  Mycoplasmas lack 
rigid cell walls, making them resistant to penicillin and related antibiotics.  Since 
mycoplasmas lack a cell wall combined with their small size, they can sometimes slip 
through the pores of filter membranes used in sterilization [78].  In turn, attachment of 
mycoplasmas may cause host cells to leak and interfere with membrane-receptor 
function as well as signal transduction [77].  These problematic consequences of 
mycoplasma contamination have required in-depth research into various preventative 
measures of the species. 
3.2.1.1.2 Mycoplasma Contamination Testing with PCR methodology 
 Since mycoplasma contamination is so prevalent in cell culture laboratories it is 
worth evaluating the significance of mycoplasma detection from specific methods.  
Although, the testing methods involve detection methodologies beyond the scope of 
introduced microbiological testing, the capabilities of these practices have relevance in 
the evolution of reliable testing capabilities-detections in a cell culture environment. 
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 Polymerase chain reaction (PCR) testing methods will amplify a known sequence 
of DNA present in a sample and can relay various types of information depending on 
the desired analyses.  To identify or distinguish a set of MOs or bacteria, PCR methods 
will generate a characteristic DNA sequencing of the sample which can be used to 
indicate the presence of a bacteria in a particular sample based on very sensitive 
logarithmic scale that quantifies DNA sequence detection [76]. 
Detection and elimination of mycoplasmas is time consuming and involves 
elaborate laboratory work.  Treatment of mycoplasma in cell cultures was done 
experimentally through the incorporation of BM-Cyclin antibiotics being used in the 
research [84].  Some undesired effects of antibiotic contamination treatments in cell 
cultures were described, including; strong cytotoxicity leading to loss of culture, growth 
inhibition under treatment, loss of special cellular characteristics, and clonal selection of 
treated cells [77, 78, 85].  Among the obvious long-term detriments to a practicing cell 
culture laboratory, mycoplasma contamination is unfortunately a continuous downfall of  
many experiments that deal with reproduction and expansion of mammalian cell lines 
[78].   
3.2.1.2 Aerobic Microorganisms (MOs) and Coliform Groups  
 Many industry standards have made aerobic plate count (APC) testing a 
mandatory procedure in facility inspection or water quality testing.  APC levels in a given 
environment cannot indicate whether more harmful pathogens or viruses are present 
but can give an overall perspective on the cleanliness of tested areas or products, and 
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whether concern should be justified for further testing of specific microbes [76].  Some 
specific microbes that became a highly worrisome problem in the earlier 20th century 
included coliform contamination.   
The term coliform has no taxonomic validity because the groupings are not 
based on genetics or biochemical reaction, but in general coliforms are aerobic, gram-
negative, and non-sporeforming rods that ferment lactose; there are currently close to 
20 or more species that may be classified as coliforms [76].  Within this chapter the 
main of focus is the detection of general coliforms; in addition includes the detection of 
Escherichia Coli (E. coli).  Since the source of E. coli and other general coliforms would 
most likely come from a source outside the cell culture lab, the testing of this species 
allows an additional test for possible untreated contaminations of coliforms. 
 The Escherichia Coli species falls into the coliform species group that is 
classified under the name enterobacteriaceae; which categorizes fecal coliforms, E.coli, 
and other bacteria with the same family name.  Escherich originally observed the 
ubiquity of the organism now known as Escherichia coli in human stools in 1887 [76].  
Similar to the presence of total coliforms, the detection E.coli has served as a standard 
of sanitation and hygiene indication within processing facilities, water quality and food 
safety industries.  
3.2.1.3 Staphylococcus Aureus (S. Aureus) 
 Another potential contaminant of concern in cell culture facilities is 
Staphylococcus Aureus (S.aureus).  S.aureus bacteria is part of the normal bacterial 
flora found on human skin [76, 86].  The staph test is sometimes used with 
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corresponding TPC and coliform testing for a broader range of sterility feedback.  
Accordingly microbial tracking of S.aureus in work environments has helped serve as an 
additional mode of sterility and hygiene indication [86].  Similar to the protocols of the 
aerobic and coliform bacteria plating, testing for S.aureus will take place throughout 
regions of the cell culture lab area.  Confirmation of the specific staph species requires 
additional culture work; however, the petrifilm disk method for the detection of S.aureus 
provides a consistent barometer of species presence in desired testing points.   
3.2.2 Chemical and Physical Sources   
 In one way biological contaminants are related to chemical and physical sources 
of contamination because the chemical contamination can be due to a biological-
microbe influence on a physical or chemical entity within the lab.  To better differentiate 
the two ideas, some common examples of physical and chemical contamination within a 
cell culture laboratory will be provided.  
 With respect to the physical sources of sterility risk, the role of CO2 incubators 
plays a very profound role in maintaining the correct conditions for keeping cells viable, 
and thus is a liability to facility contamination.  Mammalian cell cultures typically have 
settings most optimal for cell viability: a stable temperature of 37°C, a controlled pH 
around 7.4, with a controlled CO2 level and a relative humidity of 95 percent [76-78].  
The problem with these conditions is that it also provides an ideal environment for a 
range of biological contaminants that are considered normal flora (MO-bacteria) in and 
on human bodies [82].   
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 In effect, when a researcher interacts with any part of the CO2 incubator, flora 
from the skin or MO’s on the clothing of an individual can transport a range of bacteria 
from outside the lab.  Door handles, outer incubator, and chair surfaces are all common 
physical sources that harbor MO’s from researchers’ over time [78, 82].  Autoclaves, 
while intended to sterilize experimental materials can actually result in incomplete 
elimination of microbes if the device is overcrowded [78].   A cell culture can fail 
however based solely on the physical dimensions or design of the cell culture-ware and 
its influence on properties such as gas exchange, humidity, saturation density, and 
sterility [86].  A few examples of chemical risk exposures will be discussed. 
 Chemical contaminations are more severe and many times overlooked in cell 
culture practices.  Culture media, bovine sera, reagents, residue on plasticware, or 
glass materials are the major sources of such cell culture contaminants of chemical 
nature [77, 78].  Unfortunately, many times chemical contaminations are not detected 
until the cell culture project is completed.  This can obviously ruin the interpretation of 
results and the credibility of a research facility.   
 Contamination can come at any time of the media or serum lifetime.  The raw 
materials used to make the base media as well as additional reagents, additives, and 
supplements can cause contamination if improperly stored or handled.  It is vital that all 
chemicals/materials entering a cell culture system be of the highest purity, and 
preferably certified for cell cultures by a qualified vendor [87].   As mentioned previously, 
water baths, washing stations and other areas of a facility that house reagents used in a 
cell culture are susceptible to microbial contamination. 
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3.2.3 Consequences and Effects 
While there are several types and forms of contamination, the effects from 
compromised cell cultures on the overall cell system can vary depending on the nature 
of the contamination exposure.  Contaminations within a cell culture can alter the 
metabolism of the cell culture by producing metabolites and consume nutrients and 
essential amino acids [77].  Individual mycoplasma species are capable of fermenting 
sugars, oxidizing pyruvate, or metabolize urea and glutamine which can initiate a 
cascading series of metabolic events that may result in altered levels of protein, RNA 
and DNA synthesis [88].  Consequently, the regulation of cellular growth within a 
contained flask or culture system may be altered. 
The regulation of cellular growth is based upon many characteristics including 
various enzymes, cytokines, and differentiated cellular functions.  All these inherent 
traits of a particular cell line may be either induced or suppressed depending on the 
duration of the contamination and the actual alterations occurring in nucleic acid 
metabolism and chromosomal breakage [77].   Reiterating the severity of unnoticed 
contaminations, a few control and preventative measure techniques are discussed.   
3.2.4 Control, Prevention, and Sterile Barrier Systems 
Before utilizing any treatment or prevention techniques, the first approach should 
begin with determining the nature and extent of the existing contamination problem.  
Once the extent of the contamination is understood there are different treatments that 
can maintain desired cell function.  For example, there are routine usage of antibiotics 
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for serial subcultures: including turning the cell culture system into a selective process 
for antibiotic-resistant bacteria and mycoplasmas [89].  So in order to be able to better 
assess cell culture treatment requires understanding the type of cells being dealt with 
and to remove any antibiotics from the system to accurately evaluate the incidence of 
bacterial or mycoplasmal contamination.  
 Prevention methods can be practical and if applied in a systematic methodology 
can prevent the compromise of sterile entities in the lab.  This form of managing a cell 
culture laboratory is crucial for the successful creation of sterile barrier systems.  The 
idea of sterile barrier systems comes in many forms of practice.  Sterile pouches, 
laminar flow hoods, and even sterile gloves are a means to keep a controlled sterile 
environment regardless of laboratory size [78].  A look at basic techniques that minimize 
general bacteria growth within incubators and laboratory areas will showcase the highly 
sensitive nature of cell culture laboratories. 
3.2.5 Assurance Techniques and Limits 
With contamination routes and detection abilities reviewed, the microbiological 
testing methods being incorporated into the tissue engineering lab are a means to 
reduce the probability of a contamination occurring.  The word “sterile” can be thought 
as an absolute term, but the confirmation that a product is sterile can only be defined in 
terms of a probability function [90].  Hence, a negative sterility test with no indication of 
microbial growth in samples of cell flasks, media, or the environment is not an absolute 
guarantee of sterility. 
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Contamination levels in media, media supplements, and sera can be reduced 
through preventative measures; such as by processing and storage.  When it comes to 
media preparation, standard protocols should be put in place for the preparation of 
media and reagents to avoid common errors such incorporating the wrong component 
or amount of a particular ingredient.   Other media preparation mishaps, such as the 
unintentional use of nonsterile supplies or solutions can be avoided with standardized 
procedures.  If media is to be checked for sterility, large volumes of media should 
always be tested since a validated test may yield a false-negative as a result of random 
distribution of a contaminant [87].   
An example of potential error in laboratory analysis of sterility is the testing of an 
end product or culture media that has been distributed to individual units such as bottles 
or cryovials.  For example, if 5% of the bottles or cryovials are contaminated and 20 
samples are tested, there is a 36.6% probability of getting a negative result [87].  The 
main emphasis being stressed is that one test of a single unit of a particular sample for 
any microorganism contamination is inadequate.  Ideally, multiple samples should be 
tested and tracked over a period of time if contamination is detected at even the 
smallest of levels.   
 The sterile barrier systems used for related medical devices in a recent study 
demonstrated that microbial detection can be effectively examined at the sterility 
assurance level (SAL) of 10-6.  The SAL 10-6 level is currently required for sterilization 
procedures, i.e., a probability of not more than one viable MO in one million sterilized 
items of the final product [91].   Since MOs can be smaller than the pore size limits for 
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paper pouches, there was a need to evaluate the risk bacteria could penetrate the 
packaging slips.  Microbial contamination issues with packaging depend on the 
environmental conditions such as storage conditions and transport, which may be 
associated with environments of high microbial load or meteorological pressure, and 
temperature changes [92].   
In general the SAL level changes depending on the nature of a medical device 
product or tool, the inherent problem with the SAL level is evaluating the success of the 
proposed sterilization.  At final inspection of a product it is nearly impossible since to 
evaluate contamination rates on the order of 10-6 since it cannot be quantitatively 
evaluated in experiments [90].  Since the aims of this chapter focus directly on 
improving the sterility of the laboratory area as a whole and not one single entity, such 
as a medical device, the application of SAL limits and studies aimed at suitable 
antimicrobial treatments can be used in conjunction with the sterile assurance 
techniques to formulate a sound testing design in eliminating specific microbes. 
Specifically, the goal of the work presented in this chapter was to implement methods to 
allow for the examination of microbial detection throughout the TE cell culture lab as 
well as the general research lab.  
3.3 Testing Implementation 
 Before moving forward with the microbiological testing being presented to the 
tissue engineering lab, a summary of the expectations, goals, and desired feedback will 
be presented.  To determine if there will be a direct correlation between the tracking of 
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microbes in the lab and the outcome of tissue engineering experiments is pretty limited 
and is more suited towards comparison testing among many studies over an extensive 
period of time.  Rather, based on the research presented, the documented failures of 
cell cultures due to contamination from said examples will look to drive the methods 
portion of the study in hopes to control contamination for future cell culture studies 
based on the information involving the growth and tracking of MOs.  Using methods 
formulated by accrediting bodies will also create a clearer and distinct set of protocols 
that will help the lab in the long term.  Although the introduced styles of testing and 
prevention methods have been relatively consistent with microbial detection, there has 
been a shift towards accredited and approved testing regiments guided by larger 
regulatory agencies such as ISO, USDA, and HACCP.  
3.3.1 ISO Testing Methods 
 Beyond the methods introduced in this chapter for microbial growth tracking, it is 
important to give a general summary of where some of these methods originated from 
and how they became an established rule in the modern era of science.  The 
international organization of standards (ISO) body has a played a large role in many 
industry practices to maintain and improve standardized processes and testing.  The 
influence of ISO in microbiological testing has a broad spectrum, but is constantly 
shifting to meet today’s difficult industry challenges.  Examples of industries that utilize 
microbiological testing include the food safety industry, water quality testing, and cell 
culture facilities [76].  Most companies in these fields are shifting towards ISO 
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accreditation in all testing practices from the overwhelming push by the industry cliental 
requiring such certification.   
3.3.2 AOAC, and HACCP Testing 
A further expansion of ISO regulations specifically looking at microbiological 
methods, the Association of American Chemists (AOAC), Hazard Analysis and Critical 
Control Point (HACCP) systems, and USDA have shaped the principles and limits of 
chemical, physical, and microbiological limits with regards to testing consumer produce, 
processing facilities, and hazards within sensitive environments [93].  Below is a 
representative flow chart created by HACCP that summarizes the crucial control 
protocols applicable to a variety of quality control schematics.   
Many of the methods incorporated in this chapter originate from models that 
begun with these institutional bodies.  The role of the FDA is also worth mentioning as 
they have also set a standard of regulatory practices that is initiated today depending on 
the industry type, and the specific type of testing desired.  The following section 
presents a summary of the methods for the types of microbes being analyzed and 
tracked around the tissue engineering cell culture lab.   
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3.4 Materials-Methods 
3.4.1 Overview 
 As the methods portion is introduced and described, the main areas of the testing 
model will be summarized in an attempt to present the reader with a clearer overview of 
the protocols incorporated in the TE lab.  Different procedures within and the swab and 
sponge contact method will only be highlighted; complete step-by-step procedures are 
presented in Appendix H.  
 
 
Figure 108:  The flowchart represents key points of a control system that starts from 
the verification process and goes through application of HACCP controls, from the 
verification plan to creating a corrective action plan. 
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Two of the major sources for these procedures come from the Compendium of 
Methods for the Microbiological Examination of Foods and 3M Microbiology.  3M testing 
kits included step-by-step instructional insert kits with most of the materials used in this 
chapter.  A brief cost analysis comparison between the BVM setup and individual swab 
and sponge environmental sampling shows the cost effectiveness of implementing 
these practices to help save valuable resources and time.  An average BVM setup cost 
including culture costs is nearly one hundred and ten dollars for one vessel [75].  With 
respect to the costs to do one swab or sponge sample with Petrifilm for the bacteria 
described in this chapter, using 3M materials costs only six dollars.  In terms of required 
man hours the BVM setup from start to finish is at least a week long process that will 
require no less than 20 to 30 hours in the laboratory.  Clearly this is a worthy justification 
to do sterility assurance checks of critical laboratory areas with the minimal amount of 
time required to do the environmental sampling.  These simple processes can aid in 
preventing a contamination outbreak from ruining an entire setup. 
3.4.1.1 Swab Contact Method 
 Letheen broth swab tubes were purchased from 3M microbiology for the swab 
sampling procedure.  The method has been approved by the AOAC for use with 
disinfectants containing cationic surface active materials which make it convenient to 
swab areas that have been recently cleaned with such cleaning agents [93].  After all 
areas of the surface or object were swabbed, the swab was mixed in the letheen broth 
that was subsequently plated onto petrifilm which was incubated for further analysis.   
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3.4.1.2 Sponge Contact Method 
 Similar to the swab contact method the sponge sampling method used the same 
basic principles but allowed for the assessment of larger surface areas over a 
designated testing area.  The target areas that were sampled were over a one square 
meter area using each side of the sponge to wipe the surface.  After proper sample 
collection, plating procedures were performed based on the following methods.    
3.4.1.3 Aerobic Plate Count (APC)  
 The commonly deployed aerobic plate count method is used as an indicator of 
aerobic bacterial population in a sample.  These tests are based on the assumption that 
the cell will form a visible colony when mixed with appropriate nutrients in either an agar 
or today’s rapid testing petrifilm test kits [76].  Also known as total plate coliform (TPC) 
or standard plate count (SPC), the test does not differentiate between the types of 
bacteria present and is only an indicator of bacteria that grow aerobically in mesophilic 
conditions [76].   
 Once the sample inoculum was distributed onto the gelatin surface, the petrifilm 
was transferred to a dry oven incubator at the conditions near 37ºC without CO2 -
conditions.  Standard growing incubators for petrifilm growth include 5% CO2 and 
optimal humidifying conditions for bacteria; these conditions were not used for the 
culture durations of the inoculated petrifilms due to possible cell culture contamination 
risk with other TE studies.  Nonetheless, relevant bacteria counts that were made will be 
presented and described in the results portion. 
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3.4.1.4 Coliform Count, E.Coli, and Staph Plate Count  
 The coliform count and E.Coli enumeration methods using the 3M petrifilm 
plating techniques followed nearly the same procedure as summarized in section 3.4.4.  
For this methods section 3M total coliform count and E.coli count petrifilm were used.  
This single petrifilm is able to detect both bacteria on the same petrifilm based on the 
family singularity of both bacteria groups [76].   
 Total coliform and E. coli colonies are observed to produce gas production from 
the presence of bubbles on the petrifilm surface.  This is due to the fermentation of 
lactose by the coliform family.  In addition, the identification of E.coli specifically entails 
gas production as well as the observation of the colony appearing blue.  This chemical 
reaction is based upon the uptake of triphenyltetrazolium dye which produces the 
illumination [76].  Moreover, the remaining sections look specifically at the types of 
environments, and other significant areas in the culture lab that were tested either using 
swab and sponge contact methods.  
3.4.2 Cleanliness Testing of Researchers Hands & Gloves 
 Cleanliness testing of hands and gloves was specifically introduced to track one 
of the most direct routes of contamination; the researchers hands.  In general the 
researcher wants to maintain the most sterile interaction possible with any material that 
will directly contact cellular bodies and potential vascular conduits.  While most cell 
culture practices take place with plastic gloves worn, this testing procedure compared 
the growth of the specified bacteria on hands with or without gloves used, as well as 
before and after cell culture procedures.  Furthermore, the protocols described for this 
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specific type of testing in Appendix H will hopefully provide a long-term assessment of 
researchers’ ability to keep the most sterility assured environment.   
3.4.3 Sterility Testing of Glassware, Equipment, and Media  
 The sterility testing of all laboratory equipment can be done primarily through 
swab and sponge contact methods.  This method also introduces general specifications 
that are mentioned in the compendium of methods for food microbiology for glassware 
and equipment safety.  Concepts such as using hot water to wash equipment, pH 
testing of glassware or plasticware, and removal of “milkstone” and other residue 
deposits are some of the procedures that are looked into in further detail.  In general the 
methods looked to add a line of security in aseptically sensitive environments such as 
cell culture and food testing laboratories.  Further types of microbial evaluation methods 
are examined in Appendix H. 
  
3.5 Results - Tracking 
3.5.1 Interpretation 
 The following presentation of results is the culmination of two separate 
investigations into sterility assurance in and around the tissue engineering lab.  Typical 
microbial colony counts for the petrifilm analysis were recorded as:  cfu/ml for direct 
media or water sampling, cfu/50 sq cm for swab testing, and cfu/sq m for sponge 
analysis.  Any discrepancies or mistakes in the protocol were recorded by the 
participants of this study and will be addressed in the discussion portion.  All 
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participating researchers in this study were trained from microbiological testing models 
implemented in a food safety company that heavily utilizes these methods stemming 
from HACCP, AOAC, and USDA methods to test process lines, facility equipment, and 
multiple types of water sources.   
3.5.2 APC Analyses, EC/TC Counts, Staph Counts 
 The initial sterility check study tested several key areas around the cell culture 
lab for any aerobic MOs that may have been present.  Similar to the methods of the 
APC analysis, the EC/TC petrifilm was utilized to capture any potential growth of 
coliforms around the lab (Figures 109-110).  The other type of microbe analyzed was S. 
Aureus.  After an example demonstration of the swab and sponge contact method, the 
researchers performed the exercises individually.  Some of the areas that were sampled 
included the laminar flow hood, cell culture counter surfaces, warm water bath, small 
and large culture incubators, and general lab areas.  Subsequent follow-up studies were 
completed after the initial study; however Tables 5-6 document the initial and most 
recent study of recorded entries from petrifilm counts of APC, EC/TC, and S. Aureus 
over the designated areas. 
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 Aerobic MOs Total Coliforms E.coli S. Aureus 
209 Side Counter Clean 115 cfu/sq m <1 cfu/sq m < 1 cfu/sq m < 1 cfu/sq m 
209 Side Counter As Is 25 cfu/sq m < 1 cfu/sq m < 1 cfu/sq m < 1 cfu/sq m 
209a H2O Bath < 1cfu/ml N/A N/A N/A 
209a CO2 Small Incubator 10 cfu/50 sq m < 1 cfu/50 sq m < 1 cfu/50 sq m < 1 cfu/50 sq m 
209a Flow Hood <1 cfu/sq m <1 cfu/sq m <1 cfu/sq m <1 cfu/sq m 
Table 5:  Noted areas of microbial growth include the small CO2 incubator as well 
the counter surfaces in the general lab area.  However, other critical areas in the 
TE culture lab such as the flow hood or water bath showed no indication of 
microbial growth.  Mixes of the sponge (cfu/sq m) and swab (cfu/50 sq cm) 
contact methods were initiated for the set of data. 
 
 
 
Figure 109:  No growth of E. Coli or 
total coliforms was observed based 
on the lack of gas production.  The 
white bubble areas on the grid 
represent air that was trapped 
underneath the petrifilm cover when 
plating occurred.  
Figure 110:  The APC petrifilm was 
utilized for the detection of 
aerobically growing MOs.  Here a 
petrifilm reading of the cell culture lab 
counter shows bacteria growth to 
obtain the average bacteria count of 
the general lab side counter.   
 
 19 
136 
 
 
 
 
 
 
 
 
 
 
 
3.6 Discussion 
 The examination of the cell culture laboratory showed some signs of foreseeable 
problems that may come as a result of unclean surfaces.  From the high counts of APC 
in the cell culture incubators to the general counters throughout the lab, a tangible 
improvement can be set for future studies.  One well known contamination prevention 
method includes limiting the number of people sharing an incubator which will ultimately 
reduce the number of sources of contamination [82].  This goes hand in hand with the 
 Aerobic MOs Total Coliforms E.coli S. Aureus 
209 Side Counter Clean 320 cfu/sq m < 1 cfu/sq m < 1 cfu/sq m 65 cfu/sq m 
209 Side Counter 2 Clean < 1 cfu/50 sq cm < 1 cfu/50 sq cm < 1 cfu/50 sq cm < 1 cfu/50 sq cm 
209a H2O Bath < 1 cfu/ml < 1 cfu/ml < 1 cfu/ml  < 1 cfu/ml 
209a CO2 Large Incubator   11 cfu/sq m < 1 cfu/sq m < 1 cfu/sq m < 1 cfu/sq m 
209a Flow Hood < 1 cfu/50 sq cm  < 1 cfu/50 sq cm < 1 cfu/50 sq cm   < 1 cfu/50 sq cm 
Table 6:  While a high TPC count for the general lab count was observed, the 
remaining test areas showed almost little to no growth.  The presence of S. aureus 
on the side counter was a good indication of lingering issues that may be present in 
that given area.   
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idea that anytime an incubator door is opened by the user the risk of contamination 
increases.  Since any one contaminant is liable to interfere with a tissue engineering 
experiment, the specification limits of any microbial count should center on the standard 
of keeping the lowest possible count of bacteria through the methods introduced; which 
is at less than 1 cfu/g.   
 Over the span of a few months two discrepancies were found throughout the 
protocols; including determining the average cell count on a petrifilm with high bacteria 
growth and the proper storage of an opened petrifilm package.  The impact from these 
errors was hard to judge short term but would not have misconstrued the final counts of 
the first study since the petrifilm was brand new and no high bacteria counts were 
observed.    
More testing and comparisons of microbial detection from un-cleaned to cleaned 
surfaces will assist in creating a protocol that will establish a more sterile cell culture 
environment. Any future laboratory specifications will have to be created around set 
limitations desired in the tissue engineering lab and what type of MO counts would be 
deemed acceptable or not.  Discussions related to possible BVM testing incorporation is 
expanded on during the next chapter. 
Finally, as the world of rapid detection technologies evolves so too will the 
various evaluations of detection design and versatility in cell culture systems.  The 
current areas of TE experimental research will also take on a bigger impact in the 
medical world as more functionality of replacement vessels and organs progresses 
through modern science.  Furthermore, the various sterility assurance parameters 
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introduced in this thesis are all worth giving closer scrutiny to as the lab continues 
forward.    
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Chapter 4:  Discussion/Conclusion  
4.1 Discussion of BVM Studies  
 The BVM studies presented in this thesis looked to expand on early research that 
presented a unique way to assess new and upcoming stents in a preclinical in vitro 
setting that could presumably evaluate endothelialization.  There were unique obstacles 
that presented themselves within each study that required extra attention of the 
experimental parameters that were tracked during the BVM setup.   
 In the initial study, six BVM vessels were cultured over a one week period that 
evaluated intima layer development at time points of one, three, and seven days.  
Results were certainly mixed in terms of EC adhesion to the ePTFE scaffolds.  With the 
first study each of the six vessels had a varying degree of HUVEC adhesion; from 
almost no cells present to slightly more cell adhesion based on the observed BBI and 
histology image references.  Other factors to consider included setup experience, the 
incomplete removal of HUVECs from the culture flask, and subpar confluency of the 
HUVECs prior to cell sodding; these were some of the attributed discrepancies involved 
with the lack of cell density rates. 
 The latter studies presented built upon the first study with adjusted conditions of 
the BVMs to try and better understand the types of parameters of interest when 
reviewing the final results of TEVG constructs.  The static flow conditions of the 
bioreactor system in study two showed that HUVECs were fairly spread on the lumen 
face of the ePTFE grafts.  Thus, it was a fair question to ask whether or not the impact 
 123 
140 
 
of the steady flow conditions had an adverse effect on the HUVECs ability to maintain 
adhesion on the vessel lumen.  In comparison the HUVEC confluency was also higher 
in this study and the procedures were more fluent in execution throughout the BVM 
process.  Also, the single vessel setup did lower the risk of multiple setup errors, or flow 
pump issues that arose in dynamic and multi-vessel BVM studies.  These are some of 
the observations that may have possibly contributed to the higher cell density value of 
the study two BVM with respect to the vessels of study one. 
 The final BVM study looked to expand on study two by developing four vessels 
with different flow parameters utilized by other researchers.  Two of the four vessels 
were cultured at a constant 15 RPMs for 24 hours, while the other vessels were 
exposed to 10 RPM conditions for one hour under transmural flow and then increased 
to 15 RPMs for the remaining 23 hours under luminal flow.  Notable problems with the 
setup were bioreactor leakages in the first two vessels setup under increasing flow, and 
a discontinuation of the media through the inlet port coming from the media reservoir.  
This may have resulted in the lack of consistent cell growth seen in vessels one and two 
of study three.  The inconsistent flow application and even low cell confluency may have 
been additional factors as to why cell coverage was lower in the first two vessels.  
Vessels three and four were higher in cell density coverage, especially vessel four, were 
there no problems with leakage or flow, and the confluency of these cultural flasks were 
slightly higher than the flasks used for the first cell sodding procedure.   
 After careful observation of vessel four, which was the most confluent HUVEC 
lined vessel of all the BVM studies, it can be suggested that a constant flow rate did not 
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bare a negative effect on the cell adhesion process itself or lining development.  
However, the degree to which a steady flow system impacts HUVEC viability and 
morphology with regards to the imposed shear stresses under peristaltic conditions 
needs further classification.  This is not to say that a very gradual increase in flow rate is 
detrimental to the BVM development, as was demonstrated in study one that showed 
increased flow rates on TEVGs had development of inconsistent endothelial linings [25].  
However, a crucial observation was that more cell stacking and adhesion was observed 
in vessel four, a trait that can be investigated for further optimization in cellular 
consistency to utilize in conjunction with stent deployment in the current tissue 
engineering BVM model.   
4.2 Progression of BVMs studies and Bioreactor Culture Systems 
As the studies moved forward the key desired traits of the TEVGs seemingly 
improved as the studies progressed; yet there was still a gap within the results that 
could have been improved based on the individual processes of the BVM.  Adding 
additional feedback and research into the current BVM protocol will continue to help 
future studies develop a culture process that consistently creates uniform endothelial 
layers on BVMs.  Through the knowledge gained more accurate and precise assertions 
can be made as it relates to the impact that flow rates, cell densities, and cell 
confluency have on the overall BVM. 
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4.3 Discussion of Sterility Assurance Monitoring with BVM 
Utilization 
 The sterility assurance portion of the work looked to pinpoint areas of the culture 
lab for microbial examination.  The various species analyzed were aerobic MOs, generic 
E. coli, total coliforms and S. Aureus.  Methods approved by AOAC and USDA bodies 
were used to capture and analyze the lab areas for possible target bacteria groups. 
After a couple of studies the research indicated that a low level of microbial growth was 
evident in and around the cultural lab.  Although not surprising, the APC counts in the 
general lab area, as well as the incubators in the tissue engineering region indicate that 
there is room for improvement.  Hence, further research can be introduced to 
incorporate possible testing during BVM trial studies on surfaces or equipment that is 
directly used in the cell culture process.  Furthermore, sterility lab maintenance in 
between TE studies or at specific points in the BVM culture can indicate at when 
contamination may have occurred, and whether or not the sterilization procedures are 
being effective.    
With the micro methods now implemented there are quality assurance checks 
that can be developed by the research group to create more flexibility in assessing the 
areas of the TE lab in conjunction with the BVM development.  Since the focus of the 
tissue engineering lab remains to improve the direct methodologies involved with 
successful cultivation of vessels that can serve as intravascular device evaluators; a bi-
weekly or monthly inspection of the facilities may be the most reasonable long-term 
incorporation of the microbiological methods.  Moreover, this will assure that there are 
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no areas of the lab that are severely compromised, and hence potentially ruin TEVG 
setups in the future.  It also provides a safeguard against any faulty aseptic techniques 
that may occur with people that have been newly introduced to TE lab.   
While the general lab area outside the culture room is not exposed to tissue 
engineering construction, the concept of bacterial contamination from outside influences 
still raises concerns on what should serve as sufficient sterility control measures.  If a 
sample returns a positive result for microbial growth several steps can then be 
formulated to best treat or assess the situation.  Creating a quality control standard that 
develops a system where routine cleaning is performed and logged in is a simple yet 
effective type of control that can lead to modifications that best suits the TE lab.  To do 
retesting of microbial presence in the same cell culture scenario with the same 
researcher may be a formidable avenue, as well as re-cleaning and testing in the area 
the researcher just completed culture work.  The counter surfaces in the lab had a 
noticeable difference in colony counts between cleaned and un-cleaned surfaces which 
was expected initially.  However, longer term tracking of microbial growth may 
demonstrate that further sanitation measures need to be implemented in the lab.  Since 
the ideal laboratory surface would contain no indication of MOs through staged or 
random testing, this phase of the study can lead to further inquiries about developing 
the most optimal cleaning regiment while incorporating preventative measures of 
contamination routes to obtain consistently low bacteria counts.    
 Incorporating a consistent testing regiment the continued tracking of microbial 
growth can serve as a good indicator for the true cleanliness of the laboratory areas.  
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For example, the follow-up methods for tracking MO growth on a subject’s hands or on  
bioreactor components presents limitless ways to test certain scenarios, but should be 
constructed in a way that best identifies the root cause of the contamination with respect 
to specific steps executed in BVM related protocols.  Having to replace crucial 
bioreactor parts during a culture can be a detriment to keeping a sterile barrier system 
as described in the efforts targeting the validation of pulsatile perfusion bioreactors with 
HUVEC cultures [43].  Since there are dozens of individual steps within the BVM 
protocol and earlier parts of culture stages, there is a potential of many different testing 
points that can be established in conjunction with current TE studies.  
 Specifications can be set by the researchers accordingly; in highly sensitive 
areas such as the laminar flow hood and warm water bath there should be a low 
tolerance level, and would optimally be tested at multiple points during the cell 
passaging stages.  If the initial testing shows an aerobic count of greater than one, then 
the researcher can perform the proper cleaning procedure and retest the area one day 
later, and test the area again during the final passing stage.   
The amount of testing can be adjusted based on a consensus of acceptable 
average bacteria counts found over specific areas of the culture lab.  Media testing, 
glassware, and plastic-ware testing are critical materials that also deserve more 
attention regarding contamination routes.  These items can be carefully tested before 
and after being autoclaved as well as during the cultural duration of TEVG studies.  
Hopefully the research and methods described here can serve the TE lab in the 
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management of cell culture practices, and research that revolves around the sterile 
environment of the TE lab.    
4.4 Future Goals 
 From the dozens of BVM related projects dealing with cellular development, 
scaffold construction, and bioreactor modeling; the TE lab has now started to transition 
to studying BVMs and their interaction with various stent constructs of newer generation 
models.   Moreover, the success in repeatability of the BVM protocol within the TE lab at 
Cal Poly has allowed for the continued pursuit of improving modern metallic stent-intima 
assessments for 21st century medical devices.  
 An increasing trend in output demand of intravascular health devices will in turn 
require the continued sophistication of preclinical testing models to confirm safety 
standards.  In essence, this need will continue to provide new goals and opportunities in 
TEVG research alongside the relentless pursuit of developing more realistic tissue 
models to evaluate medical device and drug delivery technologies.  Improvements to 
the current BVM model through enhanced vessel mimickry by co-layer development, 
improved physiological conditions, and further tissue components found in blood 
vessels, are all realistic goals as the progression of blood vessel tissue engineering 
experiments moves forward. 
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Appendices 
 
Appendix A – Study One BVM Setup - Fall ’09:  December, 2009 
PART I:  Culture Process 
Thawing HUVECs 
The necessary experimental materials needed for the thawing stage included: 
one sterile T75 flask, one bottle of HUVEC media, and one vial of unfrozen HUVECs.  In 
order to retrieve the frozen HUVEC vial a pair of thick custom woven mitten gloves were 
used to remove the vial from the N2 tank.  After retrieving the cells, the HUVECs were 
thawed by placing the small vial inside a Shel Lab warm water bath at 37°C.  It was 
critical not to submerge the HUVEC vial completely in the water bath to avoid 
contamination through water submersion around the vial cap as well as from possible 
aerobic microorganisms in the water. 
Later a T75 flask was brought under the flow hood where 20 ml of EC media was slowly 
pipetted into the T75 flask.  The HUVECs were transferred from the cryovial into a T75 
culture flask.  Finally, as with the conclusion of every cell culture stage, the hood 
surface was cleaned with 70 percent IPA and all material waste was disposed of 
accordingly into biohazard containment.       
Passing Stages 
Next, the previously prepared and thawed HUVECs were removed from the 
incubator.  After recording the confluency the flask was brought underneath the hood.   
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When the confluency was recorded, the media solution was aspirated out using a 
vacuum operated pump and an aspirating pipette.  Afterwards, 2 ml of (DCF-PBS) was 
added to the flask of the harvested HUVECs.  To dislodge any clumped or scattered 
areas of HUVECs on the flask surface, 3 ml of trypsin was pipetted into the T75.  Prior 
to the addition of trypsin, the media was put on a vortex to ensure that vital proteins 
were thoroughly mixed prior to its introduction to the HUVEC population.  
At this stage the flask was observed for dislodged HUVECs floating throughout 
the trypsin solution.  When the cells appeared to be in a free suspended state, 7 ml of 
EC media was pipetted into the flask to counteract the effect of the trypsin media.  The 
amount chosen was slightly arbitrary; however, at a minimum, the equivalent amount of 
EC media to trypsin was required to be added to deactivate the trypsin.  A prolonged 
exposure to trypsin has shown detrimental signs to cell walls and vitality rate [42].  To 
recap, the HUVECs were suspended inside 10 ml of total cell media (7 ml EC media + 3 
ml trypsin); the cell solution was then thoroughly mixed and shaken with a pipette aid for 
proper inoculation of media.  After adequate mixing, the entire amount of cell solution 
was transferred into a prepared T75 with fresh media.  
However, during the procedure the HUVECs were mistakenly transferred to only 
one separate T75 flask instead of two.  Moreover, the 1st passing stage failed to expand 
the volume or population of HUVECs as intended, but instead only served as a media 
replacement for the HUVECs already housed in the T75 flask.  In other words this stage 
did not improve HUVEC confluency in means of population doubling; a characteristic 
that was confirmed through the white light microscope.   
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To increase the HUVEC population, a population doubling to a P5 was performed 
the following the day as the HUVECs were transferred into a new T75.  The goal of this 
passing stage was to perform a 1:6 pass by properly transferring the HUVECs inside 
the T75 into two T225 flasks.  Upon observation after the first passage, the HUVECs 
were recorded at 100 percent confluency.   
 Later, standard cell culture techniques were performed on the HUVECs within 
the T75s.  The crucial step was ensuring proper removal of HUVECs from the flask 
surface with the incorporation of trypsin solution in an adequate amount of time.  During 
this passing trial EC media was used to deactivate the trypsin.  To capture as many 
HUVECs as possible from the flask, the cell media solution was mixed and shaken with 
a pipette aid across the flask.   
Following the thorough mixing, the cell solution was pipetted and transferred into 
T225 flask with fresh EC media.  An equal amount of HUVEC solution was pipetted into 
each prepared T225 flask.  The HUVECs were successfully passed from a P4 to P5 and 
as they were returned to the Shel Lab incubator.   
The final stage of passing for the initial BVM setup passed the HUVECs from a 
P5 to a P6.  For a HUVEC population at P6 the expected outcome was to obtain a cell 
population of 1 x 106 cells/cm2, although this amount may have been lower than 
expected because an extra day was present in between passing stages of the 1:6 pass.  
Confluency of both flasks was recorded at 100% just prior to passage.  As before, 
similar cell culture techniques were performed on each T225 containing HUVECs for 
this passing point. Now the T225 was shaken and observed for HUVECs floating 
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around in the trypsin solution.  Finally, the HUVEC media solution from each T225 flask 
was pipetted and evenly distributed into two separate T225s.  The HUVECs were 
successfully passed into four new T225 flasks at a P6 population.  
Feeding Cells 
Maintaining the desired environment for HUVECs during each culture stage was 
a key ingredient to acquiring a healthy and confluent population of cells.  Although the 
EC media provides the proper nutrients and chemical environment to preserve the 
integrity of the HUVECs, it was required that the EC media be replaced between 
passing stages to maintain the adequate nourishment needed to keep the HUVECs in 
exceptional health.  With each flask devoid of EC media with the aid of a vacuum pump, 
fresh EC media was pipetted into each T225 respectfully.   
Preparation and Preconditioning of ePTFE Grafts 
The denucleating process helps remove trapped air from the interstices of the 
ePTFE grafts.  10 ml vials of 70%, 100% ethanols were prepared, along with six 10 ml 
vials containing CM that was properly degassed in the appropriate flask.  Soaking 
scaffolds in CM helped with protein adsorption, which improved cell adhesion of 
HUVECs to the ePTFE scaffold during the BVM development.   
Materials and Sterilization 
In order to correctly configure the BVM setup all bioreactor materials, scaffolds, 
and tubing, was either steam sterilized or passed through an ethylene oxide (EtO) gas 
sterilization.  Other accessories that were autoclaved included forceps and cutting 
scissors as well as a degassing media flask.   
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Materials included six separate biochambers, accompanying tubing and valves, 
and with modified fittings assembled inside the bioreactor to create the appropriate 
spacing for the ePTFE graft (Figure 16-18).  A separate 50 ml media conical that served 
as the media reservoir chamber was packaged into sets of two.  All materials were 
dropped off at the Vet Clinic one week prior to preparing and condition the ePTFE 
grafts.   
To prepare the culture media used in the BVM experiment, crucial growth factors 
and chemical agents were mixed and filtered into a sterile media bottle.  All steps had to 
be performed underneath the flow hood and carefully executed using aseptic technique.  
Two bottles of BR media and one bottle of EC media was needed for the six BVM 
setup.  All media bottles were previously autoclaved prior to preparation.   
 
PART II:  BVM Protocol: Vessel A-F Preparation 
1. Wash hands, spray down gloved hands with IPA, spray down the hood, and 
maintain aseptic area. 
2. Retrieve Bioreactor media and conditioning media, spray down with IPA, and bring 
into hood. 
3. Bring in sterilized packaged bioreactor chamber under hood.  Pull out chamber from 
package by tugging on outside valve (Do not ever run hands over sterile chamber 
body once opened). 
4. Fill chamber with bioreactor media, go just over the fitting level. 
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5. Bring in sterilized packaged ePTFE grafts into hood.  Open package carefully and 
dump graft into bioreactor chamber (1 graft per chamber).  Do not let graft fall onto 
hood surface or nonsterile area. 
6. Obtain sterile-sterile gloves from cabinet.  Insert right hand first carefully, use left 
hand to navigate the non-sterile bottom portion of the glove over right hand.  Then 
carefully use your gloved right hand to navigate left hand properly into glove.  Avoid 
any contact w/ nonsterile surfaces during this process! 
7. Insert fingers into chamber and secure grafts into fittings.  Twist the barbed fittings 
onto the female ends of the grafts, not the other way around. 
8. Dispose of sterile-sterile gloves and put on regular latex gloves.  Obtain sterilized 
packaged bioreactor chamber lids and open under sterile hood; again avoid 
contacting inner surface of the lid, instead use the lid flaps to grip the lid and 
navigate it onto the bioreactor chamber, snap the lid closed. 
9. Prepare reservoir chambers; obtain packaged reservoir tubing/pump tubing along 
with clean 50 ml media vials (1 per package).  Open tubing package under hood.  
Assemble accordingly to optimize distance of pump tubing relative to peristaltic 
pump (see diagram).  *Brown pump tubing should be attached to the inlet port side 
of the media vial cap. 
10. Fill media vial w/ 40 ml of conditioning media (CM). 
11. Allow CM to prime the tubing by opening the valves on the tubing and turning the 
media vial upside down. 
12. When it is seen that CM has flowed all the way back to the media vial, clamp off both 
ends of tubing.  Set aside media vials w/ properly attached tubing until the 
conditioning stage. 
13. Now it’s time to prime the attached ePTFE graft with CM. 
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14. Obtain two troughs per ePTFE graft being primed (per bioreactor chamber), one for 
catching the fluid from the exit port, the other trough is used to hold the CM at the 
entrance port as you suction it up with a syringe pump. 
15. Fill “inlet” trough with 6-7 ml of CM, and use syringe pump to suck up all the media. 
16. Before injecting CM with syringe pump, it is crucial to have valve orientations 
opened in the following order:  inlet stopcock (white) pointed away /opposite (left) 
from fluid flow, exit valve open (turned parallel to tubing), and lumen valve 
open/transmural valve closed. 
17. Insert syringe into inlet port and start slowly applying constant pressure on syringe; 
when media in syringe reaches 1-2 ml, close lumen valve to allow flow transmurally, 
and apply pressure to push remaining fluid transmurally through graft.  STOP 
pushing on the syringe right before the last bit of media is pushed through to avoid 
pushing air through the tubing and into the ePTFE graft pores. 
18. Now close off transmural valve, exit valve, and inlet valve to avoid spillage (in 
preparation for the next step). 
19. Now the assembled bioreactor with the primed ePTFE graft is ready for its first 
conditioning pump run. 
20. Bring in peristaltic pump beforehand into the large incubator; spray down with IPA 
before doing so. 
21. Transfer assembled bioreactor from underneath the hood and into the large 
incubator as well as the media reservoir assembly. 
22. Assemble bioreactor setup with media reservoir and tubing appropriately onto the 
peristaltic pump.  **Make sure gray tubing part is fitted into the pump trays correctly.  
This tubing should be attached to so that small intermediate tubing attaches to the 
inlet port of the bioreactor chamber. 
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23. Now, with setup complete, open lumen and exit valve and make sure inlet stopcock 
is oriented upwards so as to flow through the tubing.  (Transmural valve should be 
closed initially). 
24. Turn on peristaltic pump and then push start button.  Run pump at high speeds (150 
RPMs) for 10 minutes for luminal conditioning.  Make sure you see a drip in the 
media chamber.  After 10 minutes of pumping, stop pump. 
25. Now allow transmural flow conditioning (by closing off lumen valve).  Start pump 
again w/ transmural flow and run pump at slightly lower speeds for 5 minutes (70-
100 RPMs).  70 rpms was used as operating speed.   
26. Stop pump, close off all valves, clamp off media reservoir tubing to avoid dripping 
media everywhere during the transfer stage of the bioreactor setup back underneath 
the hood.   
27. Now ready for cell sodding stage. 
 
PART III: Cell Sodding and Incubation 
28. Obtain your culture flasks (T225s) from small incubator, check cell confluency prior 
to sodding.  
Observations: 
 Vessel A:  60 - 70% 
 Vessel B:  60 - 70% 
 Vessel C:  80% 
 Vessel D:  80% 
 Vessel E:  100% 
 Vessel F:  100% 
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29. Use standard cell culture techniques to isolate cells to eventually get a pellet of 
HUVECs. 
30. First, aspirate out media from T225 flask, rinse w/ DCF-PBS, aspirate out again, 
than add 6 ml of trypsin-EDTA (this amount can vary) to flask.  Then add 7 ml of CM 
(or equal-greater than amount of trypsin used) to detrypsinize.  (Use BR media if CM 
is low).  Pipette solution up and down a few times to make sure most of the cells are 
captured. Beat flask with palm of hand for 3-5 minutes to further release cells (Check 
cells again under microscope to reaffirm presence of cells in media and that the 
trypsin worked). 
31. Pipette media from flask into a 50 ml media vial/conical. 
32. Place conical inside centrifuge machine. 
33. Balance conical w/ another conical (could be cell media conical or just plain water). 
34. Run centrifuge for approximately 4 minutes on setting 4. 
35. Once complete, take conical out slowly to avoid dispersing pellet back into solution, 
and bring conical into hood! 
36. Now aspirate fluid from vial carefully, making sure not to suck up the pellet! 
37. Now resuspend pellet with 5 ml of HUVEC/EC media per bioreactor chamber  If you 
plan on sodding multiple grafts with a single pellet (for example if you want to sod 2 
grafts, resuspend pellet with 10 ml of HUVEC media, and evenly divide the HUVEC 
cell solution per chamber/5 ml per graft). 
38. With 10 ml pipette suck up all of the media with dispersed pellet, make sure the 
entire pellet has been resuspended. 
39. Now obtain two troughs again per bioreactor, add the crucial sucked up cell solution 
into the inlet trough located in front of the inlet port.   
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40. Try and maintain sterility here; avoid running hands over trough once cell media has 
been dispersed. 
41. Now with 4-5 ml of EC media in trough, the vessels are ready to sod.  Once again 
make the valves are oriented are correctly. 
42. Lumen valve should be closed!!  Exit valve should be open and be set on top of the 
exit trough.  Inlet port should be pointed away from graft (left) so that cells flow into 
ePTFE graft.   
43. Using a clean syringe, suck all media, avoid sucking up air. 
44. Attach syringe to inlet port, slowly apply pressure: stop applying pressure near the 
end to avoid pushing air bubbles through the ePTFE graft pores! 
45. Once the graft has been sodded, “chase” the HUVEC cell solution injected by 
injecting 3 ml of HUVEC media into graft to ensure that the HUVECs were properly 
placed inside the interstities of the ePTE grafts.    
46. Now ready to transfer bioreactor setup back into large incubator and connect to 
pump and media reservoir (media reservoir should be switched out so it contains 
fresh HUVEC media instead of the previous CM media!). 
47. Close off exit valve and inlet stopcock to avoid spillage of media during transfer. 
48. Reassemble bioreactor system:  bioreactor chamber to media reservoir and media 
reservoir tubing into pump and back into the inlet port. 
49. Now start pump at very low speeds:  Maintain 14 rpm transmural valve flow for 1/ 2 
hr.   
50. Once a consistent circular flow has been established close incubator door and turn 
on CO2 tank; this is not necessary for 24hr cultures). 
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51. After 30 minutes, come back and open lumen valve (thus disallowing transmural 
flow). 
52. Gradually ramp up flow speeds accordingly over course of one, three, and seven 
days.   
53. Repeat process for other vessel(s) being sodded. 
54. Come back on scheduled predetermined days to ram up flow (if necessary) 
accordingly and eventually take down/fix vessels. 
Fixing/Flow-Ramp Up 
 
 The following sections describe the stepwise procedure involved with the steady 
flow ramp-up of the BVM vessels for the setups described in study one. 
Fixing BVMs and Flow Ramp-Up One 
 
After 24hr two of the six BVMs were taken down from the bioreactor culture 
conditions and stored in 12 ml of histochoice until further examination, while the 
peristaltic pump speed was increased for the remaining vessels.  Flow was ramped up 
to 35 RPMs for the four remaining BVMs at this stage.  After two hours the flow was 
increased to 70 RPMs.  Finally, two and half hours later, the flow was increased to 120 
RPMs.   
 Also, it was preferred that EC media be used inside the media reservoir chamber 
instead of CM during the BVM process.  To compensate for this change in the BVM 
protocol, the CM for the four remaining media reservoirs was replaced with four conical 
vials containing 40 ml of EC media.  This required a stoppage in flow and an absence of 
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applied shear stress on the HUVECs.  The remaining vessels were cultured with flowing 
EC media for the duration of study one. 
 To remove the BVMs from the bioreactor chamber a clean razor was used to cut 
the vessels from the barbed fittings and sutures.  Bioreactor media was disposed of into 
a hazard waste bag as well as any remaining CM inside the reservoir chamber; also any 
non-disposable equipment was cleaned and flushed with hot water.  Finally the vessels 
were put inside a small vial containing histochoice.  The vial was labeled with the time of 
take down and location of the distal and proximal ends of the vessel with respect to its 
position inside the bioreactor chamber.   
Fixing Two BVMs and Final Flow Ramp-Up  
 
At the 72 hour mark, two more BVMs were fixed and preserved in histochoice.  
After the BVMs were removed from the peristaltic pump system, the latter two BVMs 
were exposed to increased pump speeds of 200 RPMs for the remainder of the BVM 
culture.   
Fixing Final Two BVMs 
  
One week after the initial BVM setup, the final two vessels were taken down and 
fixed in histochoice for examination.  The peristaltic pump was taken down and cleaned 
down with IPA as well as the CO2 incubator shelves.  Other materials and media were 
disposed of accordingly.  The six BVMs were now ready for further analysis through BBI 
and histological examination to assess the cellular growth and adhesion along the 
lumen or interior walls of the grafts.  
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Appendix B - Study Two BVM Setup - Summer ’10:  June, 2010 
PART I:  Culture Process 
Thawing HUVECs 
In study two, cryopreserved P8 HUVECs were used as the initial cell passing 
point.  Furthermore, the HUVECs were transferred into the T75 and put back into the 
Shel Lab incubator until the first passage was performed.     
Passing Stages 
 Moving forward in standard fashion, all steps carried out were performed in 
sterile aseptic technique.  The cell passage steps in this procedure were performed in 
identical manner to study one (see Appendix A passing stages). 
Notable differences between study two and study one came from the amount of 
trypsin and HUVEC media applied.  More trypsin was used this time around to ensure 
that the entire T75 was adequately covered to help dislodge as of much of the HUVECs 
as possible.  Instead of the 2-3 ml, 6 ml of trypsin was used in study two.  Initially the 
first study of HUVEC passages into T75s used 20 ml of prewarmed (EC) HUVEC media 
per flask, however, all precoating stages for study two and study three consistently uses 
12 ml of prewarmed HUVEC media for T75 flasks and 36 ml for T225 flasks.  Now, a 
T225 with P9 HUVECS was prepared and returned back into the incubator were they 
were subsequently fed with fresh HUVEC media after 48 hours, and then ready for cell 
sodding on setup day. 
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Feed Cells 
 Cell media replacement was only done 1x during study two.  After 24 hours of 
incubation following passing stage 1, the HUVEC media within the T225 was replaced 
with 36 ml of fresh prewarmed HUVEC media.  The HUVECs coated on the surface of 
the flask were now replenished with fresh nutrients and growth factors provided by the 
HUVEC media.  Finally, the T225 was returned to the incubator in preparation for 
ePTFE denucleation. 
Preparation of ePTFE Grafts 
ePTFE grafts, 3.5 cm long and 2 mm in diameter were used as the BVM scaffold 
structures for study two from Bard incorporation.  Similar to study one, the graft material 
was mounted onto barbed fittings and then sutured around the fitting for proper closure 
and insulation.  Once the graft was prepped, it was inserted into an autoclave package 
with an indicator strip and autoclaved for 30 min at 250° F with an additional 30 minutes 
for drying inside the Ritter M9 Autoclave.  The graft was later retrieved before 
implantation inside the BVM model were they were denucleated and conditioned in a 
series of treatments in graded ethanols and CM.    
After the autoclave process was complete, the ePTFE graft was ready for 
denucleation.  As in the previous study for the ePTFE scaffold, corresponding 10 ml 
vials were filled in advance with 70 percent ethanol, 100 percent ethanol, and CM. 
The ePTFE graft transfer procedure strictly followed the steps of study one.  An 
important modification on the priming procedure from study one to study two came at 
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the final step; instead of leaving the vessel under the flow hood, the scaffold was 
transferred into the incubator to remain at more physiological conditions until setup day.  
Materials and Sterilization 
 Setup materials in study two were not gas sterilized based on the minimized 
culture time involved.  Yet, aseptic sterile techniques were still maintained throughout all 
phases of the experiment.   The materials listed in table 5 represent the materials 
involved with the study two and three systems.  It is worth noting that any media bottle 
used in the project was autoclaved individually prior to media preparation.  Autoclaving 
any used material or accessories/tools that directly or indirectly was involved with the 
development of the HUVEC culture was a constant necessity in the BVM setups to 
maintain an aseptic-sterile environment. 
The bioreactor (BR), HUVEC, and Conditioning Media (CM) used in study two 
and three contain the same components as mentioned in study one.  So forth, the 
preparation in making the medias also followed the same procedure as study one (see 
also Appendix A, and I,).  The main difference was in the quantity of media needed from 
study to study.  Table 6 shows the translation of media bottles to the specific quantity (in 
ml) of media used in each study.  
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Table 7. List of Sterilized Materials 
 
 
 
 
 
 
 
1 ePTFE Graft 
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Table 8. Media Quantities Required for Study Two and Study Three (1 bottle = 500 
ml) 
 
 
 
 
 
 
 
PART II:  BVM Protocol: Vessel 1 Preparation 
1. Wash hands, spray down gloved hands with IPA, spray down the hood, and 
maintain aseptic area. 
2. Retrieve Bioreactor media and conditioning media, spray down with IPA, and bring 
into hood. 
3. Bring in sterilized packaged bioreactor chamber under hood.  Pull out chamber from 
package by tugging on outside valve (Do not ever run hands over sterile chamber 
body once opened). 
4. Fill chamber with bioreactor media, go just over the fitting level. 
5. Bring in sterilized packaged ePTFE grafts into hood.  Open package carefully and 
dump graft into bioreactor chamber (1 graft per chamber).  Do not let graft fall onto 
hood surface or nonsterile area. 
Media Study Two Study Three 
Conditioning Media 1bottle 2 bottles 
Bioreactor Media 3 bottles 3 bottles 
HUVEC Media 1 bottle 2 bottles 
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6. Obtain sterile-sterile gloves from cabinet.  Insert right hand first carefully, use left 
hand to navigate the non-sterile bottom portion of the glove over right hand.  Then 
carefully use your gloved right hand to navigate left hand properly into glove.  Avoid 
any contact w/ nonsterile surfaces during this process! 
7. Insert fingers into chamber and secure grafts into fittings.  Twist the barbed fittings 
onto the female ends of the grafts, not the other way around. 
8. Dispose of sterile-sterile gloves and put on regular latex gloves.  Obtain sterilized 
packaged bioreactor chamber lids and open under sterile hood; again avoid 
contacting inner surface of the lid, instead use the lid flaps to grip the lid and 
navigate it onto the bioreactor chamber, snap the lid closed. 
9. Prepare reservoir chambers; obtain packaged reservoir tubing/pump tubing along 
with clean 50 ml media vials (1 per package).  Open tubing package under hood.  
Assemble accordingly to optimize distance of pump tubing relative to peristaltic 
pump (see diagram).  *Brown pump tubing should be attached to the inlet port side 
of the media vial cap. 
10. Fill media vial w/ 40 ml of conditioning media (CM). 
11. Allow CM to prime the tubing by opening the valves on the tubing and turning the 
media vial upside down. 
12. When it is seen that CM has flowed all the way back to the media vial, clamp off both 
ends of tubing.  Set aside media vials w/ properly attached tubing until the 
conditioning stage. 
13. Now it’s time to prime the attached ePTFE graft with CM. 
14. Obtain two troughs per ePTFE graft being primed (per bioreactor chamber), one for 
catching the fluid from the exit port, the other trough is used to hold the CM at the 
entrance port as you suction it up with a syringe pump. 
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15. Fill “inlet” trough with 6-7 ml of CM, and use syringe pump to suck up all the media. 
16. Before injecting CM with syringe pump, it is crucial to have valve orientations 
opened in the following order:  inlet stopcock (white) pointed away /opposite (left) 
from fluid flow, exit valve open (turned parallel to tubing), and lumen valve 
open/transmural valve closed. 
17. Insert syringe into inlet port and start slowly applying constant pressure on syringe; 
when media in syringe reaches 1-2 ml, close lumen valve to allow flow transmurally, 
and apply pressure to push remaining fluid transmurally through graft.  STOP 
pushing on the syringe right before the last bit of media is pushed through to avoid 
pushing air through the tubing and into the ePTFE graft pores. 
18. Now close off transmural valve, exit valve, and inlet valve to avoid spillage (in 
preparation for the next step). 
19. Now the assembled bioreactor with the primed ePTFE graft is ready for its first 
conditioning pump run. 
20. Bring in peristaltic pump beforehand into the large incubator; spray down with IPA 
before doing so. 
21. Transfer assembled bioreactor from underneath the hood and into the large 
incubator as well as the media reservoir assembly. 
22. Assemble bioreactor setup with media reservoir and tubing appropriately onto the 
peristaltic pump.  **Make sure gray tubing part is fitted into the pump trays correctly.  
This tubing should be attached to so that small intermediate tubing attaches to the 
inlet port of the bioreactor chamber. 
23. Now, with setup complete, open lumen and exit valve and make sure inlet stopcock 
is oriented upwards so as to flow through the tubing.  (Transmural valve should be 
closed initially). 
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24. Turn on peristaltic pump and then push start button.  Run pump at high speeds (150 
RPMs) for 10 minutes for luminal conditioning.  Make sure you see a drip in the 
media chamber.  After 10 minutes of pumping, stop pump. 
25. Now allow transmural flow conditioning (by closing off lumen valve).  Start pump 
again w/ transmural flow and run pump at slightly lower speeds for 5 minutes (70-
100 RPMs).  80 rpms was the operating speed.   
26. Stop pump, close off all valves, clamp off media reservoir tubing to avoid dripping 
media everywhere during the transfer stage of the bioreactor setup back underneath 
the hood.   
27. Now ready for cell sodding stage. 
 
PART III: Cell Sodding and Incubation 
28. Obtain your culture flasks (T225s) from small incubator, check cell confluency prior 
to sodding.  
Observations: 
 Vessel 1:  60% 
29. Use standard cell culture techniques to isolate cells to eventually get a pellet of 
HUVECs. 
30. First, aspirate out media from T225 flask, rinse w/ DCF-PBS, aspirate out again, 
than add 6 ml of trypsin-EDTA (this amount can vary) to flask.  Then added the 
same amount of CM (as trypsin used) to detrypsinize. Pipette solution up and down 
a few times to make sure most of the cells are captured. Beat flask with palm of 
hand for 5-10 minutes to further release cells (Check cells again under microscope 
to reaffirm presence of cells in media and that the trypsin worked). 
31. Pipette media from flask into a 50 ml media vial/conical. 
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32. Place conical inside centrifuge machine. 
33. Balance conical w/ another conical (could be cell media conical or just plain water). 
34. Run centrifuge for approximately 4 minutes on setting 4. 
35. Once complete, take conical out slowly to avoid dispersing pellet back into solution, 
and bring conical into hood! 
36. Now aspirate fluid from vial carefully, making sure not to suck up the pellet! 
37. Now resuspend pellet with 3 ml of HUVEC/EC media per bioreactor chamber.  If you 
plan on sodding multiple grafts with a single pellet, (for example if you want to sod 2 
grafts, resuspend pellet with 6 ml of HUVEC media, and evenly divide the HUVEC 
cell solution per chamber/3 ml per graft). 
38. With 10 ml pipette suck up all of the media with dispersed pellet, make sure the 
entire pellet has been resuspended. 
39. Now obtain two troughs again per bioreactor, add the crucial sucked up cell solution 
into the inlet trough located in front of the inlet port.   
40. Try and maintain sterility here; avoid running hands over trough once cell media has 
been dispersed. 
41. Now with media in trough, ready to sod.  Once again make the valves are oriented 
are correctly. 
42. Lumen valve should be closed!!  Exit valve should be open and be set on top of the 
exit trough.  Inlet port should be pointed away from graft (left) so that cells flow into 
ePTFE graft.   
43. Using a clean syringe, suck all media, avoid sucking up air. 
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44. Attach syringe to inlet port, slowly apply pressure: stop applying pressure near the 
end to avoid pushing air bubbles through the ePTFE graft pores! 
45. Once the graft has been sodded, “chase” the HUVEC cell solution injected by 
injecting 3 ml of HUVEC media into graft to ensure that the HUVECs were properly 
placed inside the interstities of the ePTE grafts.    
46. Now ready to transfer bioreactor setup back into large incubator and connect to 
pump and media reservoir (media reservoir should be switched out so it contains 
fresh HUVEC media instead of the previous CM media!). 
47. Close off exit valve and inlet stopcock to avoid spillage of media during transfer. 
48. Reassemble bioreactor system:  bioreactor chamber to media reservoir and media 
reservoir tubing into pump and back into the inlet port. 
49. Now start pump at very low speeds:  Maintain 10 rpm transmural valve flow for 1/ 2 
hr.   
50. Once a consistent circular flow has been established close incubator door and turn 
on CO2 tank (Not Necessary for 24hr cultures). 
51. After ½ hr, come back and open lumen valve (thus disallowing transmural flow). 
52. Ramp up flow speeds accordingly:  constant 15 rpm for additional hour. 
53. Peristaltic pump was shut down at this junction; vessel was cultured in static 
condition. 
54. Take down/fix vessel 24 hours later. 
Scaffold Fixing of BVM One for Study Two 
 
Since there were no flow ramp-ups for the studies contained within this chapter, 
the critical closing point came twenty-four hours later when the BVM was taken down 
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from the bioreactor culture system, and stored in 5 ml of glutalderhyde.   The pump was 
turned off to allow the bioreactor chamber and media reservoir to be removed from the 
peristaltic pump.  Finally, the vessels were put inside a small vial containing prepared 
glutalderhyde.  The vial was labeled with the time of take down and what ends of the 
graft were the distal and proximal end with respect to the position it was in within the 
bioreactor chamber.  
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Appendix C – Study Three BVM Setup - Summer ’10:  Sept. 1st, 2010 
PART I:  Culture Process 
Thawing HUVECs 
After thawing the HUVECs in the warm water bath, the cells were transferred into 
a T75 precoated with 12 ml of HUVEC media at 37°C.  The session concluded by 
returning the T75 containing HUVECs back into the Shel Lab incubator at normal 
cultural conditions.   
Passing Stages 
The third study consisted of three separate passages that would develop the P4 
HUVECs eventually into a P7 expansion. The first passing stage concluded with 
transferring the HUVECs from the single T75 into two newly prepared T75s with 12 ml 
of HUVEC media in each.  Cell confluency before passing was recorded at 90 % upon 
observation using the CKX31 Optical Microscope.  Different from the previous studies, 8 
ml of trypsin was used to dislodge the HUVECs followed by incorporation of 8 ml of 
HUVEC media for deactivation.  Later the HUVEC media solution was transferred 
evenly into each of the two T75s before being returned into the incubator. 
After 48 hours each T75 flask in study 3 was reevaluated for confluency.  In most 
circumstances if the cells did not appear very confluent (over 70 %), an additional 24 
hours of incubation was maintained to improve cell proliferation and expansion.  
However, at the time of recording each T75 flask appeared near 85% confluency.  Since 
the HUVECs appeared confluent, the goal of expanding the two T75s into four T75s 
was carried forward.   
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 With the T75s in incubation, the final passing stage consisted of passing each 
individual T75 into its own T225.  The end result was a 1 to 3 pass that would convert 
the four P6 T75s into four P7 T225s.  Confluency was recorded between 50-60 % 
amongst the four flasks; a figure that was lower than expected.  Hence, the passage 
was carried in hopes that the cells would proliferate adequately over the 72 hours up 
until the time of cell sodding on BVM setup day. 
 The passage was carried out following standard cell passaging protocol.  Two of 
the four T75s were removed at a time from the incubator and brought into the flow hood; 
upon which the HUVECs would be passed into the prepared prewarmed T225s.  Once 
the four T225s successfully contained the P7 HUVECS, the remaining four T75s were 
disposed of and all remaining media was returned to proper refrigeration.     
Feed Cells 
The 4 T75s in study 3 were refreshed with HUVEC media in the same manner as 
in the study 2.  Furthermore the quantity of HUVEC media replenished changed from 36 
ml to 12 ml per flask based on the fact that T75s were being used in this situation and 
not the larger T225s. The only other feeding stage for study 3 came after the third and 
finally passing stage.  In that instance 4 T225s were replaced with 36 ml of HUVEC 
media per flask.  At that point the cells were ready for the final passing stage and 
examination of HUVEC confluency after 24 hours.   
Preparation of ePTFE Grafts 
ePTFE grafts, 3.5 cm long and 2 mm in diameter were used as the BVM scaffold 
structures for study two and study three from Bard incorporation.  Similar to study one, 
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the graft material was mounted onto barbed fittings and then sutured around the fitting 
for proper closure and insulation.  Once the graft was prepped, it was inserted into an 
autoclave package with an indicator strip and autoclaved for 30 min at 250° F with an 
additional 30 minutes for drying inside the Ritter M9 Autoclave.  The graft was later 
retrieved before implantation inside the BVM model were they were denucleated and 
conditioned in a series of treatments in graded ethanols and CM.    
The main difference of the denucleation procedure between study two and study 
three came from the increased amount of degrading ethanol vials needed.  Since four 
vessels were prepared in this study, an additional set of 10 ml vials of appropriate 
alcohols and CM was made.  No deviations were made in regards to the time the 
ePTFE grafts were exposed to each alcohol; also 40 ml of CM was degassed in the 
depressurizing flask for the four grafts (10 ml per graft).  The result ended in four 
denucleated vessels placed inside the Shel Lab incubator at 37°C ready for setup day.  
Materials and Sterilization 
The bioreactor (BR), HUVEC, and Conditioning Media (CM) used in study three 
contain the same components as mentioned in the previous two studies.  So forth, the 
preparation in making the medias also followed the same procedure as mentioned in 
Appendix A, and I.  
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PART II:  BVM Protocol: Vessel 1 and Vessel 2 Preparation 
1. Wash hands, spray down gloved hands with IPA, spray down the hood, and 
maintain aseptic area. 
2. Retrieve Bioreactor media and conditioning media, spray down with IPA, and bring 
into hood. 
3. Bring in sterilized packaged bioreactor chamber under hood.  Pull out chamber from 
package by tugging on outside valve (Do not ever run hands over sterile chamber 
body once opened). 
4. Fill chamber with bioreactor media, go just over the fitting level. 
5. Bring in sterilized packaged ePTFE grafts into hood.  Open package carefully and 
dump graft into bioreactor chamber (1 graft per chamber).  Do not let graft fall onto 
hood surface or nonsterile area. 
6. Obtain sterile-sterile gloves from cabinet.  Insert right hand first carefully, use left 
hand to navigate the non-sterile bottom portion of the glove over right hand.  Then 
carefully use your gloved right hand to navigate left hand properly into glove.  Avoid 
any contact w/ nonsterile surfaces during this process! 
7. Insert fingers into chamber and secure grafts into fittings.  Twist the barbed fittings 
onto the female ends of the grafts, not the other way around. 
8. Dispose of sterile-sterile gloves and put on regular latex gloves.  Obtain sterilized 
packaged bioreactor chamber lids and open under sterile hood; again avoid 
contacting inner surface of the lid, instead use the lid flaps to grip the lid and 
navigate it onto the bioreactor chamber, snap the lid closed. 
9. Prepare reservoir chambers; obtain packaged reservoir tubing/pump tubing along 
with clean 50 ml media vials (1 per package).  Open tubing package under hood.  
Assemble accordingly to optimize distance of pump tubing relative to peristaltic 
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pump (see diagram).  *Brown pump tubing should be attached to the inlet port side 
of the media vial cap. 
10. Fill media vial w/ 40 ml of conditioning media (CM). 
11. Allow CM to prime the tubing by opening the valves on the tubing and turning the 
media vial upside down. 
12. When it is seen that CM has flowed all the way back to the media vial, clamp off both 
ends of tubing.  Set aside media vials w/ properly attached tubing until the 
conditioning step. 
13. Now it’s time to prime the attached ePTFE graft with CM. 
14. Obtain two troughs per ePTFE graft being primed (per bioreactor chamber), one for 
catching the fluid from the exit port, the other trough is used to hold the CM at the 
entrance port as you suction it up with a syringe pump. 
15. Fill “inlet” trough with 6-7 ml of CM, and use syringe pump to suck up all the media. 
16. Before injecting CM with syringe pump, it is crucial to have valve orientations 
opened in the following order:  inlet stopcock (white) pointed away /opposite (left) 
from fluid flow, exit valve open (turned parallel to tubing), and lumen valve 
open/transmural valve closed. 
17. Insert syringe into inlet port and start slowly applying constant pressure on syringe; 
when media in syringe reaches 1-2 ml, close lumen valve to allow flow transmurally, 
and apply pressure to push remaining fluid transmurally through graft.  STOP 
pushing on the syringe right before the last bit of media is pushed through to avoid 
pushing air through the tubing and into the ePTFE graft pores. 
18. Now close off transmural valve, exit valve, and inlet valve to avoid spillage (in 
preparation for the next step). 
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19. Now the assembled bioreactor with the primed ePTFE graft is ready for its first 
conditioning pump run. 
20. Bring in peristaltic pump beforehand into the large incubator; spray down with IPA 
before doing so. 
21. Transfer assembled bioreactor from underneath the hood and into the large 
incubator as well as the media reservoir assembly. 
22. Assemble bioreactor setup with media reservoir and tubing appropriately onto the 
peristaltic pump.  **Make sure gray tubing part is fitted into the pump trays correctly.  
This tubing should be attached to so that small intermediate tubing attaches to the 
inlet port of the bioreactor chamber. 
23. Now, with setup complete, open lumen and exit valve and make sure inlet stopcock 
is oriented upwards so as to flow through the tubing.  (Transmural valve should be 
closed initially) 
24. Turn on peristaltic pump and then push start button.  Run pump at high speeds (200 
RPMs) for 10 minutes for luminal conditioning.  Make sure you see a drip in the 
media chamber.  After 10 minutes of pumping, stop pump. 
25. Now allow transmural flow conditioning (by closing off lumen valve).  Start pump 
again w/ transmural flow and run pump at slightly lower speeds for 5 minutes (70-
100 RPMs).  70 rpms was operating speed.   
26. Stop pump, close off all valves, clamp off media reservoir tubing to avoid dripping 
media everywhere during the transfer stage of the bioreactor setup back underneath 
the hood.   
27. Now ready for cell sodding stage. 
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PART III: Cell Sodding and Incubation 
28. Obtain your culture flasks (T225s) from small incubator, check cell confluency prior 
to sodding.  
Observations: 
 Vessel 1:  60% 
 Vessel 2:  60 - 70% 
 Vessel 3:  80 - 90% 
 Vessel 4:  80 - 90% 
29. Use standard cell culture techniques to isolate cells to eventually get a pellet of 
HUVECs. 
30. First, aspirate out media from T225 flask, rinse w/ DCF-PBS, aspirate out again, 
than add 8 ml of trypsin-EDTA (this amount can vary) to flask.  Then add the same 
amount of CM (or greater amount than trypsin used) to detrypsinize.  (Use BR media 
if CM is low).  Pipette solution up and down a few times to make sure most of the 
cells are captured. Beat flask with palm of hand for 5-10 minutes to further release 
cells (Check cells again under microscope to reaffirm presence of cells in media and 
that the trypsin worked). 
31. Pipette media from flask into a 50 ml media vial/conical. 
32. Place conical inside centrifuge machine. 
33. Balance conical w/ another conical (could be cell media conical or just plain water). 
34. Run centrifuge for approximately 4 minutes on setting 4. 
35. Once complete, take conical out slowly to avoid dispersing pellet back into solution, 
and bring conical into hood!   
36. Now aspirate fluid from vial carefully, making sure not to suck up the pellet! 
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37. Now resuspend pellet with 3 ml of HUVEC/EC media per bioreactor chamber  If you 
plan on sodding multiple grafts with a single pellet (for example if you want to sod 2 
grafts, resuspend pellet with 6 ml of HUVEC media, and evenly divide the HUVEC 
cell solution per chamber/3 ml per graft). 
38. With 10 ml pipette suck up all of the media with dispersed pellet, make sure the 
entire pellet has been resuspended. 
39. Now obtain two troughs again per bioreactor, add the crucial sucked up cell solution 
into the inlet trough located in front of the inlet port.   
40. Try and maintain sterility here; avoid running hands over trough once cell media has 
been dispersed. 
41. Now with media in trough, ready to sod.  Once again make the valves are oriented 
are correctly. 
42. Lumen valve should be closed!!  Exit valve should be open and be set on top of the 
exit trough.  Inlet port should be pointed away from graft (left) so that cells flow into 
ePTFE graft.   
43. Using a clean syringe, suck all media, avoid sucking up air. 
44. Attach syringe to inlet port, slowly apply pressure: stop applying pressure near the 
end to avoid pushing air bubbles through the ePTFE graft pores! 
45. Once the graft has been sodded, “chase” the HUVEC cell solution injected by 
injecting 4 ml of HUVEC media into graft to ensure that the HUVECs were properly 
placed inside the interstities of the ePTE grafts.    
46. Now ready to transfer bioreactor setup back into large incubator and connect to 
pump and media reservoir (media reservoir should be switched out so it contains 
fresh HUVEC media instead of the previous CM media!). 
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47. Close off exit valve and inlet stopcock to avoid spillage of media during transfer. 
48. Reassemble bioreactor system:  bioreactor chamber to media reservoir and media 
reservoir tubing into pump and back into the inlet port. 
49. Now start pump at very low speeds:  Maintain 10 rpm transmural valve flow for one 
hour.   
50. Once a consistent circular flow has been established close incubator door and turn 
on CO2 tank. 
51. After one hour, come back and open lumen valve (thus disallowing transmural flow). 
52. Ramp up flow speeds accordingly:  10 rpm for additional 24 hours. 
53. Repeat process for other vessel(s) being sodded. 
54. Come back on scheduled predetermined days to ram up flow (If Necessary) 
accordingly and eventually take down/fix vessels.  (Leaks Present in first two 
vessels) 
 
PART IV:  BVM Protocol 2:  Vessels 3 and 4 
1-47. Same as BVM protocol 1. 
48.  Maintain 15 rpm transmural valve flow for 1 hr. 
49.  After 1 hour, pause the pump, and switch to luminal flow while keeping the same 
flow speed.  
50.  Ramp up flow speeds accordingly:  Maintain at 15 rpm for additional 24 hours. 
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Scaffold Fixing of BVMs One through Four for Study Three 
 
Twenty-four hours later the 4 BVMs were taken down from the bioreactor culture 
conditions and stored in 10 ml of glutalderhyde until BBI and histology imaging.  BVMs 1 
and 2 were first removed from the bioreactor chambers once the peristaltic pump was 
turned off.  The BR media contained in chamber 1 showed signs of continuous of 
leakage from the connection points of the bioreactor valves.  Furthermore, BVMs 3 and 
4 were removed without any notable discrepancies in the setup except that the BR 
media had an alteration in color, an indication of possible pH flux.  Each BVM was 
removed and preserved in glutalderhyde until further processing.  All vials were 
appropriately labeled with the time of take down, and the distal and proximal ends of the 
vessels. 
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Appendix D – Histology Protocol: Study One and Study Two  
1. Obtain sectioned slides desired for staining from appropriate slide casing. 
2. Warm up wax cover on slide until wax is clear; approximately 8-10 minutes. 
3. Cool down slides until some of the wax is observable again from its present 
translucent state. 
4. Staining Procedure is as follows. 
 a. 3-min:  Xylene 
 b. 1-min:  Air Dry 
 c. 2-min:  100% EtOH 
 d. 2-min:  95% EtOH 
 e. 20-min:  Air Dry 
 f. 4-min:  Hematoxylin 
 g. 1-min:  Water Distilled 
 h. 30 sec:  Clarifier 
 i. 1 min:  Bluing 
 j. 1 min:  95% EtOH 
 k. 80 sec:  Eosin 
 l. 1 min:  100% EtOH 
 m. 1 min:  Air Dry 
 n. 1 min:  Xylene 
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5. Stay gentle when transferring slides from one reagent to the next. 
6. After staining is complete, apply glue droplets to specific area of the slide, with other 
hand use forceps to cover slide with coverslip; avoid using too much glue for 
adhesion to avoid interference with stained vessel cross-section. 
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Appendix E - Histology Protocol Study Three 
1. Obtain sectioned slides desired for staining from appropriate slide casing. 
2. Warm up wax cover on slide until wax is clear; approximately 8-10 minutes. 
3. Cool down slides until some of the wax is observable again from its present 
translucent state. 
4. Staining Procedures are as follows. 
 a. 3-min:  Xylene 1 
 b. 3-min:  Xylene 2 
 c. 1-min:  Air Dry 
 d. 2-min:  100% EtOH 
 e. 2-min:  100% EtOH 
 f. 2-min:  95% EtOH 
 g. 2-min:  Air Dry 
 h. 4-min:  Hematoxylin 
 i. 1 min:  Distilled H2O 
 j. 30 sec:  Clarifier 
 k. 1 min:  Bluing 
 l. 1 min:  95% EtOH 
 m. 90 sec:  Eosin 
 n. 1 min:  100% EtOH 
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 o. 1 min:  Air Dry 
 p. 1 min:  Xylene 1 
 q. 1 min:  Xylene 2 
5. Stay gentle when transferring slides from one reagent to the next. 
6. After staining is complete, apply glue droplets to specific area of the slide, with other 
hand use forceps to cover slide with coverslip; avoid using too much glue for 
adhesion to avoid interference with stained vessel cross-section. 
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Appendix F – HUVEC Cell Average Counts (Study Two and Three)  
Study Two  
Vessel 1 – Proximal and Mid-Distal Counts 
 
 
 
 
Figure 45:  Here the BVM vessel at the proximal region shows consistent yet lower cell coverage 
relative to the mid-proximal regions from the vessels in study 1.  The cell coverage was observed in 
this region was 4-5 x 10
6
 cells/cm
2
. 
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Figure 50:  A mid-distal BBI shot of the BVM.  Due to the bending of the scaffold, the outer edges 
appear unfocused.  The cell average count is lower and more inconsistent in this region with respect 
to the mid-proximal area presented in chapter 2.  On average the areas of the grid indicate cell count 
is around 3-4 x 10
6
 cells/cm
2
. 
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Figure 64:  Shows vessel 1 at the distal end of inner wall with minimal cell coverage with a cell density 
of 0 -1 x 10
6
 cells/cm
2
.  The unfocused area of the image did not allow for an accurate assessment of 
the cell coverage in that location of the vessel. 
Study Three 
Vessel 1 – Mid-Distal Counts 
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Figure 68:  A few visible cells scattered in the proximal area of the vessel fragment with an average cell 
density of 0-2 x 10
6
 cells/cm
2
. 
Vessel 2 – Proximal Count 
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Figure 77:  Shows vessel 3 a little further along the vessel from Figure 76, there are slightly more focused and distinguishable cells in 
this capture.   Slightly more cell adhesion can be observed with these two images, however, the coverage remains too low to obtain 
any significant coverage count. 
Figure 71:  Shows the lack of continuity of HUVEC presence across the ePTFE graft near the proximal 
region.  Again counts here ranged from 1-2 x 10
6
 cells/cm
2
.   
Vessel 3 – Mid-Proximal and Distal Counts 
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Figure 70:  HUVEC presence across the ePTFE graft near the proximal region.   Cell adhesion 
presence for vessel 3 was a bit more prevalent then the first two vessels but still averaged around 1-2 x 
10
6
 cells/cm
2
. 
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Figure 75:  Shows the continuity of HUVEC presence across the ePTFE graft near the proximal 
region with a much higher cell average count then the previous vessels of study 3.  An average of 
the three areas fives a cell average around 5-6 x 10
6
 cells/cm
2
. 
Vessel 4 – Proximal and Mid-Distal Counts  
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Figure 79:  Here the bottom area of the mid-distal region of the vessel is flattened out with a pair of 
forceps to assist in impeding the graft from curving upwards too much.  A heavy cell population can be 
seen along the cut area of the graft with areas that were to numerous count individual cells, but an 
approximation gives an average around 7 x 10
6
 cells/cm
2
.  
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Appendix G – BBI (Bisbenzimide Imaging) Protocol  
1. Wrap nonsterile 15 mL conicals in foil.  Thoroughly label conicals for all samples.  
Also, keep track of sample orientations with respect to proximal and distal ends 
inside the conical. 
2. Make BBI solution:  Always keep stock solution wrapped in foil. 
a. Use small tube of stock and make a 1:1000 (10 µm in 10 dilution with milli-
Q-water.  
b. Mix by inverting. 
3. Cut sample with blade, be careful to not disrupt cell lining inside lumen.  Avoid 
squeezing, touching, and scraping as much as possible. 
4. Use washed forceps to place samples in corresponding 15 ml conicals; allow 
samples to soak for at least 15 minutes inside the BBI solution. 
5. Put away extra stock solution, clean up preparation area. 
6. With permission or help from Dr. Cardinal, use fluorescent microscope to obtain en 
face images. 
a. Log into Notebook. 
b. Set microscope to turret number four; the wide horizontal dial below 
eyepiece. 
c. Turn on Olympus lamp located to the right of the computer monitor. 
d. Turn on optiscan wheels; a green switch to right of Olympus lamp. 
e. Turn on camera switch located on the top of the microscope. 
 183 
200 
 
f. Set filter wheel 1 to 1, also set filter wheel 2 to 1 on prior keypad at located 
at the microscope base. 
g. Open shutter. 
h. Set prior keypad to shutter one. 
i. Sign into computer by clicking Dr. Cardinal’s account and enter correct 
password. 
j. Click Q capture pro located on the desktop. 
k. Dial objectives to desired magnification. 
l. Set thin bar below eyepiece on the microscope to the icon of an eye and 
camera. 
m. Increase number for lighter images; decrease number for darker images. 
n. If scaffolds or vessel conduits are too wet, blot the end of the scaffold with 
a Kimwipe. 
o. Take desired amount pictures across the length of the vessel; select 
capture or autocapture. 
p. Save Pictures. 
8. Shut down system by switching Olympus lamp off, as wells as the optiscan 
wheels and camera switch. 
9.   Log out of notebook. 
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Appendix H - Microbiological Testing Protocols 
BVM Microbiological Assessment Protocols 
Creating a New SOP 
Purpose:  To provide general guidelines for creating a new Standard Operating 
Procedure (SOP). 
Safety Precautions:  N/A 
Supplies:  N/A 
Remarks:  SOPs should be given a distinct title before approval by Dr. Cardinal to 
      prevent creation of duplicate SOP topics to ensure the SOPs are current with 
      lab practices. 
 
Procedure:  
1. After determining the necessity for a new SOP, create a draft copy of the 
SOP to be issued following the format:  Purpose, Safety Precautions, 
Supplies, Media/Reagents, Procedure, and References.  One or more of the 
sections may not be applicable to a new SOP. 
 
2. Submit an electronic copy to Dr. Cardinal.  Dr. Cardinal will check the 
formatting and issue a SOP final copy with appropriate number or designation 
if no changes are required. 
 
3. If changes are necessary, Dr. Cardinal will return the SOP to the preparer to 
incorporate any adjustments; the preparer will then resubmit the SOP to Dr. 
Cardinal for final review. 
 
4. If no changes are needed the preparer and reviewer will sign and print name 
on the original SOP document.  Dr. Cardinal will provide copies and keep 
master copy. 
 
Note:  Working copies of SOPs should be revised and submitted only electronically to 
Dr. Cardinal for further review. 
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References:  “Creating a New SOP” by Tony Piazza, 2008 QA/QC 
 
Aerobic Plate Count (APC) Petrifilm 
Purpose:  To ensure proper use of Aerobic Plate Count Petrifilm.  
Safety Precautions: 
1. Always wear gloves and appropriate lab attire when plating samples. 
2. Wash hands before and after plating samples and handling Petrifilm. 
3. Dispose of all plated materials and plates in the biohazard waste upon 
completion of analysis. 
Supplies:   
 Incubator 35°C ± 1°C   Sterile Pipets or Pipet tips 
 Refrigerator ≤ 8°C    Petrifilm Spreader 
 3M APC Petrfilm    Quebec Colony Counter (optional) 
 Sterile Gloves 
 
Remarks: 
1. Do not use Petrifilm after the expiration date; use the oldest lots of Petrifilm 
first. 
2. APC is also known as Total Plate Count (TPC), Standard Plate Count (SPC) 
or Heterotrophic Plate Count (HPC). 
3. All plating work should be performed within the laminar flow hood. 
4. Unopened packages of Petrifilm must be stored in the refrigerator at ≤ 8°C. 
5. If a package is opened, seal the remaining unused portion by the folding the 
end over and taping shut (do refrigerate package once opened). 
6. DO NOT USE buffers containing citrate, bisulfate, or thiosulfate; these 
chelating agents and antioxidants can inhibit microbial growth. 
7. Adjust pH of samples between 6.6 and 7.2 before plating on Petrifilm.  For 
acidic products use 1N NaOH, for alkaline products use 1N HCL. 
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Procedure: 
 Inoculation 
1. Prepare sample and materials underneath laminar flow hood 
accordingly. 
2. Place petrifilm plate on a level surface and lift top of film. 
3. Holding pipet perpendicular to the plate, place 1 mL of drawn sample 
onto the center of the bottom film. 
4. Release top film and allow it to drop.  Do not roll top film down. 
5. With ridge side down, place the spreader on top of film over inoculum 
(sample). 
6. Gently apply pressure on spreader to distribute inoculums over circular 
area defined by spreader.  Do not twist or slide spreader. 
7. Lift spreader and wait at least one minute for gel to form.  The Petrifilm 
is now ready for incubation. 
  
Incubation 
1. Label Petrifilm accordingly and place Petrifilm in incubator, clear side 
up, in stacks of 10 or less. 
2. Incubate at 35°C ± 1°C for 48 hours. 
  
Interpretation and Identification of Aerobic Microorganisms  
1. Colonies on Petrifilm will mostly appear as red colonies, regardless of 
size or color intensity. 
2. Count each speck as a Colony Forming Unit (CFU). 
3. The preferable counting range on an APC Petrifilm is 25-250 colonies. 
4. If the colony count is more than 250, estimate the count.  Determine 
the average number of colonies in one square centimeter (1 cm2) and 
multiply it by 20 to obtain the total count per plate. 
5. Report results as CFU/g for products (media) and CFU/50 sq cm for 
equipment/swab contact surfaces and CFU/ sq m for sponges. 
 
References:  3M Aerobic Plate Count Petrifilm Package Insert 
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Coliform Count & E.Coli Plate Count - Petrifilm 
Purpose:  To ensure the proper use of Total Coliform and E. coli Petrifilm 
Safety Precautions: 
1. Always wear gloves and appropriate lab attire when plating samples. 
2. Wash hands before and after plating samples and handling Petrifilm. 
3. Dispose of all plated materials and plates in the biohazard waste upon 
completion of analysis. 
Supplies: 
 Incubator 35°C ± 1°C   Sterile Pipets or Pipet tips 
 Refrigerator ≤ 8°C    Petrifilm Spreader 
 3M APC Petrifilm    Quebec Colony Counter (optional) 
 Sterile Gloves    pH meter (optional) 
 
Remarks: 
1. Do not use Petrifilm after the expiration date, use the oldest lots of Petrifilm 
first. 
2. All plating work should be performed within the laminar flow hood. 
3. Unopened packages of Petrifilm must be store in the refrigerator at ≤ 8°C. 
4. If a package is opened, seal the remaining unused portion by the folding the 
end over and taping shut (do refrigerate package once opened). 
5. DO NOT USE buffers containing citrate, bisulfate, or thiosulfate; they can 
inhibit growth. 
6. Adjust pH of samples between 6.6 and 7.2 before plating on Petrifilm.  For 
acidic products use 1N NaOH, for alkaline products use 1N HCL. 
7. DO NOT USE this plate alone for the detection of E. coli 0157:H7.  Like most 
other E.coli/Coliform media, this plate will not specifically indicate the 
presence of the 0157 strain. 
 
Procedure: 
 Inoculation 
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1. Prepare sample and materials underneath laminar flow hood 
accordingly. 
2. Place Petrifilm plate on a level surface and lift top of film. 
3. Holding pipet perpendicular to the plate, place 1 mL of drawn sample 
onto the center of the bottom film. 
4. Release top film and allow it to drop.  Do not roll top film down. 
5. With ridge side down, place the spreader on top of film over inoculums 
(sample) 
6. Gently apply pressure on spreader to distribute inoculum over circular 
area defined by spreader.  Do not twist or slide spreader. 
7. Lift spreader and wait at least one minute for gel to form.  The Petrifilm 
is now ready for incubation. 
 
 Incubation 
1. Place Petrifilm in incubator, clear side up, in stacks of 10 or less. 
2. Incubate at 35°C ± 1°C for 48 hours. 
3. Total Coliforms can be read at 24 hours. 
 
 Interpretation and Identification of Total Coliform (TC) 
1. Coliform colonies will appear as red and/or blue colonies with gas 
production (corresponding gas bubbles) surrounding the colonies.  If 
gas production is not present it is not a coliform. 
2. Each colony with gas is considered a Colony Forming Unit (CFU). 
3. The preferable counting range on an EC/Coliform Plate is 25-250 
colonies. 
4. If the colony count is higher than 250, count at least three individual 
grids and average the number and multiply by 20 to obtain the total 
count per plate.   
5. Report results as CFU/g for products (culture media), CFU/50 sq cm 
for swab samples and CFU/sq m for sponge samples. 
  
Interpretation and Identification of E. coli (EC) 
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1. E. coli colonies will appear as blue colonies with gas production 
(corresponding gas bubbles) surrounding the colonies.  If gas 
production is not present it is not E. coli. 
2. Each blue colony with gas is considered a Colony Forming Unit (CFU). 
3. The preferable counting range on an EC/Coliform Plate is 25-250 
colonies. 
4. If the colony count is higher than 250, count at least three individual 
grids and average the number and multiply by 20 to obtain the total 
count per plate.   
5. Report results as CFU/ml for cultural media or water, CFU/50 sq cm for 
swab samples and CFU/sq m for sponge samples. 
6. E. coli colonies can be confirmed through further AOAC SOPs as 
directed. 
 
References: 3M E.coli/Coliform Count Petrifilm Package Insert and Interpretation Guide 
 
Sterility Testing of Glassware, Equipment, and Media 
Purpose:  To assure the sterility of laboratory glassware, equipment, and media. 
Safety Precautions: 
1. Wash hands before and after performing microbiology procedures. 
2. Dispose of media used for sterility checks in biohazard waste. 
 
Supplies: 
 Aerobic Plate Count Petrifilm 
 Pipets 
 Sharpie Marker 
 Incubator 
 
Reagents: 
 Sterile Phosphate Buffer Solution 
 Non-selective Media 
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 Sterile Dilution Water 
 Fluid Thioglycolate Broth 
 
Remarks: 
1. Always log in results of sterility testing in the QA/QC notebook. 
2. Perform sterility testing on each new batch of culture media made. 
 
Procedure: 
 Rinse Filtration Technique for Utensils, Containers, and Media Bottles 
1. Fill the container to be tested approximately one quarter of the way full with 
sterile phosphate buffer solution. 
2. Cap the container and shake it thoroughly so the buffer solution coats all 
parts of the container.  
3. Continue to shake for 2-3 minutes. 
4. Pipet out 1 ml of buffer onto an aerobic plate count Petrifilm. 
5. Place Petrifilm in incubator at 35°C for 24 hrs. 
6. While incubating test film, place a blank aerobic plate count Petrifilm with 1 ml 
of sterile phosphate buffer solution under the same test conditions to confirm 
no growth on blank film. 
7. After incubation, remove Petrifilm and check results.  Record results in 
appropriate QA/QC notebook. 
 
Sterility Testing of Media and Media Bottles 
1. Randomly choose 4 sterile media bottles from the laboratory supply and 
divide them into two sets of 2 bottles in each set. 
2. Pour 25 ml of one culture media into the bottle, label bottle. 
3. Place bottle in incubator at 35°C for 24 hrs. 
4. After the completion of incubation, plate 25 ml of warmed media into 225 ml 
of BFB media.  Shake thoroughly. 
5. Repeat process with DI water in TE lab or PBS that is used in cell passages. 
6. Plate 1 ml of diluted media/BFB solution onto an APC Petrifilm. 
7. Incubate Petrifilm at same conditions for an additional 24 hrs. 
8. No growth should be seen on Petrifilm. 
 
Sterility Testing of Culture Flasks Culture/Test Tubes 
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1. Randomly select 3 sterile tubes from the laboratory supply. 
2. Fill tubes ½ full with fluid thioglycolate. 
3. Incubate tubes at 35°C for 24 hrs.   
4. No growth should be present at the end of the incubation period. 
 
References: “Compendium of Methods for the Microbiological Examination of Foods,” 
3rd     ed., 1992 
 
Swab Contact Method 
Purpose:  To ensure proper sampling procedures for presence of Aerobic 
      microorganisms, total coliforms, and E.coli through the swab contact method. 
 
Safety Precautions: 
1. Wash hands before and after performing microbiology procedures. 
2. Dispose of swab tube after plating in biohazard waste. 
 
Supplies: 
 Letheen Swab Tubes 
 Water Resistant Marker 
 Sterile Gloves 
Remarks: 
1. Do not open the swab tube until you start sampling. 
2. Samples should be taken just prior to lab analysis or should begin within 24 
hours of sampling. 
 
Procedure: 
1. Select equipment, table or hood surface, floor, wall or any used object in the 
TE lab. 
2. For reference, mark outside of the sterile vial with surface swabbing 
description. 
3. Put on a new pair of rubber gloves. 
4. Open swab vial and carefully remove swab without touching the swab end. 
5. Hold the swab handle to make a 30° angle contact with the surface. 
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6. Rub the swab end slowly and thoroughly over approximately 50 cm2 of 
surface three times, reversing the direction between strokes. 
7. Return the swab to the solution vial, rinse briefly in the solution. 
8. Swab four more 50 cm2 areas of the SAME surface/object being sampled, as 
above, rinsing the swab in the solution after each swabbing.   
9. After all areas of the surface or object have been swabbed, return the swab to 
the vial, ensuring the cap is tight. 
10. Repeat steps 1 through 9 above for each additional surface to be swabbed. 
11. Samples need to be analyzed within 24 hours. 
12. If sample is not immediately processed, place sample(s) into a cooler or 
fridge to maintain sample condition over time. 
 
Plating 
 
1. After sample is obtained, remove swab from tube and carefully hold 
with one hand while preventing swab tip from touching tube or hand. 
2. Using 10 ml pipet, carefully transfer 1 ml of media sample onto 
appropriate EC/TC and or APC Petrifilm.  Label Petrifilm with sample 
area description. 
3. Transfer Petrifilm into 35°C incubator for 48 hours for further analyses.  
 
References: “Compendium of Methods for the Microbiological Examination of Foods,” 
3rd ed., 1992 
 
Environmental Sponge Sampling Procedure 
Purpose:  To ensure proper sampling procedures for presence of Aerobic 
      microorganisms, total coliforms and E.coli through the sponge contact 
      method. 
 
Safety Precautions: 
1. Do not wear loose clothing or open-toed shoes when sampling. 
2. Wash hands before and after sampling. 
3. Wear gloves at all times when sampling. 
4. Be careful when sampling around operating equipment. 
5. Be aware sponges may contain sensitive microbes and handle carefully at all 
times. 
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6. Never touch facial area when sampling. 
 
Supplies: 
 Hydrasponge 5cm x 5cm sponges 
 Sterile paper towels 
 Sterile rubber gloves 
 Sterile whirlpak bags, 27 oz. 
 Sterile pipet, 10 ml 
 
Reagents: 
 20% solution of bleach 
Remarks: 
1. Change gloves after sampling each site or before touching a new sampling 
sponge. 
2. Do not open whirlpak bags until you are at the designated sampling site. 
3. Keep whirlpak closed between sampling sites. 
 
Procedure: 
1. Preparation work should be done as close to the sample area as possible. 
2. Disinfect setup area with 20% solution of bleach.  Wipe clean with paper 
towels.  Make sure to wear rubber gloves 
3. Wash hands and put on sterile gloves.  Be sure to avoid touching the external 
surface of the gloves with your hands. 
4. Open packet and remove sponge. 
 
Sampling 
1. Environmental sponge sample should be conducted under floor mats, cracks 
in the wall, in areas of peeling paint, under tables, in crevices of equipment, 
drains, etc. 
2. Hold the sponge aseptically with the sterile gloves and vigorously rub it over 
the area to be sampled. 
3. A square meter (1 m2) may be sampled. 
4. After swabbing, place sponge in a sterile whirlpak bag and seal. 
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5. A composite of up to 5 sponges from different locations can be taken and ran 
as one composite sample.  If the sample results are positive, each site will be 
tested separately. 
6. Record the following information on the whirlpak bag: 
1. Date 
2. Area Sampled 
3. Sampler’s initials 
7. Conduct all the above steps in preparation and sampling sections for all 
sponge samples taken. 
8. Place whirlpaks in cooler with icepacks or fridge ≤ 8°C for up to 24 hours if 
sample is not immediately plated.   
 
Plating 
 
1. After sample is obtained, dilute sponge with 25 ml of BFB media. 
2. Squeeze sponge thoroughly to help flush any present microorganisms into 
BFB selective media. 
3. Using 10 ml pipet, carefully transfer 1 ml of media sample onto appropriate 
EC/TC and or APC Petrifilm.  Label Petrifilm with sample area description. 
4. Transfer Petrifilm into 35°C incubator for 48 hours for further analyses.  
 
 
References:   “Compendium of Methods for the Microbiological Examination of Foods,” 
3rd ed., 1992 
 
General Preparation of Media 
Purpose:  To ensure proper preparation of BFB and cultural media in the microbiological 
       lab. 
Safety Precautions: 
 1.  Wear gloves and a lab coat at all times. 
 2.  Use aseptic technique.  
 3.  Do no open autoclave to remove media until pressure gauge or display has 
     reached 0 psi. 
4.  Do not use cracked or chipped glassware. 
 
Supplies: 
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Erlenmeyer Flask   pH meter 
 Media Bottles   Autoclave, 121°C 
 Test tubes    Cultural media Kits 
 Plastic Bottles   Glass pipettes 
 Autoclave Tape   Degassing Flask 
 Marking Pen    Vacuum Pump  
 
Reagents: 
 Media 
 Distilled or Deionized Water 
 1N NaOH 
 1N HCL 
 
Remarks: 
1. Gloves should be worn at all times because media powders are very 
hygroscopic.  Also, make sure that all lids are closed tightly after use. 
2. Do not use powdered media that is beyond expiration date. 
3. BFB media unlike cultural media can be made outside of a laminar flow hood. 
 
Procedure: 
 BFB  
1.  For BFB media, check media container for directions on stock solution 
formula. 
2. 60 ml of stock solution needs to be added to every 50 L of deionized 
water. 
3. Once mixed with stock solution, if necessary, adjust the media to the 
proper pH using the pH meter.  Use NaOH 1 N or HCL 1 N solution to 
adjust the pH. 
4. Log in newly prepared media into a logbook in the following format:  
           (e.g. M071508A) 
                    M = media 
                              07 = month of the year 
                              15 = day of the year 
                              08 = the year 
                              A = the preparation of the day (A represents the first preparation of 
       any media on that day, B would be the second, etc.) 
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Cultural Media 
1. Every cultural media used in the TE lab has a specific formula and SOP. 
2. Always prepare media under laminar flow hood with airflow constantly on. 
3. Use appropriate pipettes, degassing media flask, flask filter, and correct 
number of bottles as needed. 
4. Do not prepare cultural media without correct working knowledge of aseptic 
techniques and at minimum one training session with experienced 
researcher. 
 
References:  Refer to the direction labels on the individual media kits or reference sheet 
in the TE lab and or media bottles. 
 
Specifications, Sterilization & Cleaning of Laboratory Glassware and Plasticware 
Purpose:  To assure the quality and cleanliness of laboratory glassware and 
      plasticware. 
 
Safety Precautions: 
 1.  To prevent cuts, always discard cracked or chipped glassware. 
Procedure: 
 Specifications 
1. Glassware should be of high quality, low alkali, borosilicate glass. 
2. Plasticware should be free of defects and contain no toxic residues. 
3. Glassware or plasticware with chipped or broken edges, or etched 
surfaces will be discarded. 
4. Glassware and plasticware should be randomly checked on a bi-weekly 
basis for alkalinity and acidity by using bromothymol blue pH indicator.  pH 
of glassware should be between 6.5 and 7.5. 
 
 General 
 
1. Use hot water when cleaning laboratory glassware or plasticware. 
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2. Use approved laboratory detergent. 
3. Wear gloves at all times when washing glassware or plasticware. 
4. Clean all surfaces of the glassware and plasticware thoroughly using a 
brush. 
5. Rinse glassware at least 8 times with running tap water followed by three 
rinses of distilled water to ensure that all soap residues are removed. 
 
 Removal of “Milk Stone” and other Residue Deposits 
  
1. Wash and rinse glassware following the general procedures. 
2. Place glassware in an acid-dichromate cleaning solution for 24 hours.  
Avoid getting solution on self.  Wear protective equipment at all times. 
3. After 24 hours, remove glassware.  Rinse thoroughly 12 times in running 
tap water and 3 times in distilled water. 
4. After rinsing, test to see if all of the solution has been removed from the 
glassware.  Place one drop of bromothymol blue pH indicator on the 
glassware.  Glassware should have a pH between 6.5 – 7.5. 
5. If acid is detected, rinse glassware several more times and repeat pH test. 
6. If acid is not detected, rinse off bromothymol blue with distilled water and 
allow glassware to dry. 
 
References: “Compendium of Methods for the Microbiological Examination of Foods,” 
 3rded., 1992 
 
Handling of Media & Reagents 
Purpose:  To assure the quality of media and reagents used within the laboratory. 
Safety Precautions:  Always wear rubber gloves while handling media. 
Supplies:  N/A 
Remarks: 
1. All media will be used on a first in – first out basis.  The oldest lot of media 
will be always be used first. 
2. Any media that are older than the manufacturers’ expiration date, or do 
not pass quality control tests will be discarded immediately. 
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3. All media, reagents, bottles, tubes, plastic sleeves, etc. will be marked 
with the date of receipt, date of expiration and date of opening. 
 
Procedure: 
 Receipt of Media and Reagents 
1. Upon receipt, the manufacturer’s name and number (lot, series, ID, etc.) 
will be verified to be the same on the invoice or packing list and the 
material’s consumer. 
2. The expiration date on the container shall be checked to ensure that 
expired or soon to be expired material has not been received. 
3. The material’s container shall be marked with the receipt date. 
4. The received material shall be placed in the appropriate designated 
storage area. 
 
Storage of Media 
1. Store dehydrated media in the manufacturer’s packaging, tightly capped 
bottles or tightly closed plastic liners in a cool, dry and dark area.  If 
specified by the manufacturer, refrigerate the media. 
2. Keep no more than six months to a year’s supply on hand.  Use older 
stocks first and do not use any media that has exceeded the 
manufacturers’ expiration date. 
3. Dehydrated media and reagents should be free floating powders or 
crystals.  If a change is noted in this property or its color, the item in 
question should be discarded. 
4. Media that contains dyes should be protected from light.  Store them in a 
dark area, using a dark glass bottle or wrap the bottle in foil or brown 
paper. 
5. All media prepared by the laboratory shall be stored in accordingly. 
6. Each rack of prepared media shall be labeled with the type media, date 
prepared and the expiration date. 
7. For pre-prepared media, consult package inserts for the manufacturer’s 
specific shelf life or the shelf life will be three months from the date of 
manufacturer, whichever is shorter. 
 
Opening of Media and Reagents 
1. Upon opening of the media or reagent, the container shall immediately be 
marked with the date of opening and the expiration date may need to be 
 199 
216 
 
revised.  The expiration date shall be either the actual manufacturer’s 
expiration date or a date six months from the date of opening, whichever 
is earlier.  If revised, the new expiration date shall be marked on the 
container. 
2. Additionally, media shall be inspected for volume, tightness of closure, 
clarity, color, consistency and completeness of label.  Any discrepancies 
shall be noted in the media/reagent control notebook. 
3. Any media whose integrity is questionable due to color, clarity or fails 
testing shall be discarded immediately. 
 
References: “Compendium of Methods for the Microbiological Examination of Foods,” 
3rded., 1992 Standard Methods for the Examination of Water and 
Wastewater, 18th Edition. 
 
Cleanliness Testing of Researchers Hands & Gloves  
Purpose:  Provide for consistent sampling and analysis of hands and gloves for 
      cleanliness using sponges as a measure of testing. 
 
Safety Precautions:  Use of sterile rubber gloves or sterile tongs is required to prevent 
 cross contamination of personnel and samples. 
 
Supplies: 
1. Use (5cm x 5cm) sterile sponge placed in individual craft paper bags, or 
alternatively, commercially available, prehydrated sponges (5cm x 5cm) 
2. Sterile whirl-pak bags are suitable to contain the sponges after sampling. 
3. Sterile nutrient broth or 0.1% peptone water may be used as the rinse 
solution. 
4. Sterile tongs or sterile gloves may be used to hold the sponge aseptically 
during sampling. 
 
Remarks:  N/A 
Procedure: 
1. Moisten the sponge (if non-hydrated) with 10 ml of sampling fluid (rinse 
solution). 
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2. While holding the sponge aseptically with tongs or sterile gloves swab the 
surface of the hand vigorously rubbing the sponge over hand area. 
3. After sampling, place the sponge aseptically in a sterile bag and transport 
it to the laboratory under refrigeration. 
 
Plating and Analysis 
1. For quantitative analyses 50-100 ml of diluent is added to the bag 
containing the sponge.  The sponge is vigorously massaged with diluent 
for 1-2 minutes to release the microorganisms.  Aliquot of the diluent is 
removed from the bag and dilute further if required, and plated onto the 
desired petrifilm for the microorganisms.  Number of microorganisms per 
unit surface can be calculated on the basis of the area swabbed (1m2), 
and the amount of diluent used and size of aliquot plated. 
2. For example: 
*If 50 colonies are obtained from 1 ml aliquot derived from sponge in 100 
ml of diluent that swabbed 1 m2 (sq m) the count per m2 will be: 
  5000 cfu/m2 
  Or 0.5 cfu/cm2 
*To compare effectively of rinse solution, the same method can be used 
for hands and gloves before and after dipping hands or hands with gloves 
into disinfecting rinse solution.   
 
References: “Compendium of Methods for the Microbiological Examination of Foods,” 
  3rd ed., 1992 
 
 
Heterotrophic Plate Count/Pour Plate Method 
Purpose:  To estimate the number of live heterotrophic bacteria in water and measure 
      changes during water treatment and distribution of water in cell culture uses.  
 
 
Safety Precautions: 
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1. Wear rubber gloves appropriate to the hazards involved. 
2. Dispose of all materials in the biohazard waste upon completion of this 
analysis. 
3. Wash hands after performing this analysis or when leaving the 
microbiology lab. 
 
Supplies: 
 Incubator, 35°C ± 0.5°C 
 Sterile Petri Dishes 100 mm x 15 mm 
 Sterile Gloves 
 Sterile Pipets 1 ml 
 Quebec Colony Counter 
 
Remarks: 
 1.  Do not use any prepared or dehydrated media after the expiration date. 
 2.  Always run appropriate controls when conducting SPC analysis. 
 3.  Check newly prepared lots of SPC agar for sterility before use. 
 4.  After water samples have been collected initiate analysis as soon as possible. 
 5.  Duplicate samples shall be done for all samples.  They shall be run using 
      Standard Plate Count Agar.  
6.  Control blanks for media, dilution water, plates, pipets and other materials 
     shall be included per sample.      
           7.  Control air blanks (sedimentation) shall be done at least monthly.  Air blanks 
     shall be exposed to the laboratory air for 15 minutes and then incubated per 
     this SOP.  The number of colonies shall not exceed 15 colonies/plate15 
     minute exposure to be acceptable. 
 
 
Procedure: 
 Preparation of Standard Plate Count Agar   
  Tryptone  5.0g 
  Yeast Extract           2.5g 
  Glucose  1.0g 
  Agar             15g 
  DI Water  1L 
 
1. Mix appropriate amount of media in a liter of deionized water until evenly 
dispersed. 
2. Heat with repeated stirring and boil for one minute to dissolve completely. 
3. Place foil over the top of the container. 
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4. Autoclave for 15 minutes at 121°C, pH of SPC should be 7.0 ± 0.2 after 
autoclaving. 
5. After autoclaving, remove container of agar and place into incubator at 44-
46°C until needed for plating.  SPC Agar may be stored up to 48 hours 
before use. 
6. Do not re-sterilize plating medium. 
7. Log the preparation of the agar into the media/reagent prep book.  Include 
the following information: 
 a)  Date 
 b)  Type of media prepared 
 c)  Preparer’s Initials 
 d)  Manufacturer’s Name, Lot #, Expiration Date 
 e)  Amount of agar used 
 f)  Amount of agar prepared 
 g)  Lab number 
8. Log in the incubator logbook the time the agar is put into the incubator. 
 
Plating the Samples 
1. For most potable water samples, plates suitable for counting will be 
obtained by plating 0.1 ml of undiluted sample and 1 ml and 0.1 ml of 102 
dilution. 
2. All plating work must be done within the laminar flow hood. 
3. Slowly pour the agar over the sample (Approximately 15-20 ml) and swirl 
gently. 
4. Cover the plate immediately and allow agar to solidify. 
5. Maintain remaining melted medium in water bath between 44-46°C until 
used. 
6. Plates are now ready for incubation. 
 
Incubation of SPC Agar Plates 
 
1. Once the SPC plates have solidified, place them in the incubator at 35°C ± 
0.5°C for 48 hours. 
2. Log the samples into the incubator logbook. 
3. Plates may be removed after 24 hours for an initial colony count, but must 
be placed back in the incubator for remaining 24 hours. 
 
Counting of SPC Plates 
 
1. Turn plate upside down so you are looking at the bottom of the petri dish. 
2. Count the number of colonies you see growing on the agar surface. 
3. Counts should be recorded in CFU/plate. 
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4. Count plates should contain 30-300 colonies/plate.  If the count are less 
than 30 or greater than 300, refer to the requirements of the Standard 
Methods of 18th Edition for the Examination of Water and Wastewater, 
Section 9215A.8 
 
 
References: Standard Methods for the Examination of Water and Wastewater 18th 
Edition 
 
Staph Count on Petrifilm 
Purpose:  To ensure proper use of the Petrifilm Staph Count system. 
Safety Precautions:   
1. Always wear gloves and lab coat when plating samples. 
2. Wash hands after plating samples and handling Petrfilm. 
3. Wash hands prior to leaving the laboratory area. 
Supplies: 
 Incubator   Staph Express Count Plate 
 1 ml Sterile Pipets  Staph Express Disk 
 Sterile Buffer Tubes  Petrifilm Spreader 
 
Reagents: 
 Sterile Butterfield’s Buffer 
Remarks: 
1. A positive and negative control will only be necessary if S. Aureus or a sub 
species needs to be identified in the TE lab.  Confirmations will not be 
performed at this junction. 
2. Do not use plates and disks after expiration date. 
Express Count Plates – storage requirements: 
  a. Store unopened pouches at 8°C or colder (allow pouch to come to room 
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    temperature before opening). 
  b. Store resealed pouches in a cool dry place for no longer than 1 month. 
       Do Not Refrigerate 
  c. If the laboratory temperature exceeds 25°C (77°F) or the humidity 
    exceeds 50%, then store the resealed pouches in a freezer. 
3. Express Disk – storage requirements: 
a. Store unopened pouches at 8°C or colder 
  b. As the disks are sensitive to moisture and light, remove only those disks 
    that will be used immediately.  Store resealed pouches in a sealable 
    container in freezer for no longer than 6 months. 
4. Do not use plates or disks that show discoloration. 
 
Procedure: 
1. Prepare a 1:10 or greater dilution of media or swab tube.  Weigh or pipette 
food into an appropriate container such as stomacher bag, dilution bottle, 
or other sterile container. 
2. Add appropriate quantity of sterile Butterfield’s phosphate-buffered dilution 
water. 
3. Blend or homogenize sample per current procedure. 
4. Adjust the pH of the sample to between 6.0 – 8.0.  For acidic products 
adjusts pH with 1 N NaOH.  For alkaline products adjust pH with 1 N HCL. 
5. Place Petrifilm plate on level surface.  Lift top film.  With the pipet 
perpendicular to petrifilm plate, place 1 ml of sample onto center of the 
plate. 
6. Carefully roll top film down to avoid entrapping air bubbles.  Do not let top 
film drop. 
7. Gently apply pressure on spreader to distribute inoculums over circular 
area before gel forms.  Lift spreader; do not twist or slide spreader.  Wait a 
minimum of one minute for gel to solidify. 
Note:  Spread the sample on each individual plate before inoculating the 
           next.  This is important as the gel forms quickly and you may not be 
able to spread the sample if you inoculate more than 1 plate at a 
time. 
8. Remove the spreader and leave the plates undisturbed for at least one 
minute to permit the gel to form. 
9. Incubate plates in a horizontal position with the clear side up in stacks of 
no more than10 plates.  Incubate the plates for 24 ± 2 hours at 35°C ± 
1°C, or 37°C ± 1°C. 
10. Count the Staph Express plates with a standard colony counter or other 
illuminated magnifier.  Do not count colonies which appear on the foam 
dam because they are removed from the selective influence of the 
medium. 
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11. Observe the colony colors: 
 a. If no colonies or only red-violet colonies are present after 24 ± 2 hours, 
    count red-violet colonies as S. Aureus, the test is complete.  Use of the 
    Petrifilm Staph Express disk is not necessary. 
 b. If any colony colors besides the red-violet are present, use a Petrifilm 
         Staph Express disk. 
12. Remove an individually packaged Petrfilm Staph Express disk from its 
pouch and allow it to come to room temperature.  Then remove the disk 
from its individual package by peeling the package to expose the disk tab, 
grasping the tab, and pulling the disk out. 
13. Lift the top film and place the disk in the well of the plate so that the tab 
remains outside the well. 
 Note:  Occasionally the gel may split when the top film is lifted. 
Performance of the Petrifilm Staph Express plate is not affected by 
gel splitting because the disk is coated on both sides.   
14. Lower the top film. 
15. Apply pressure by sliding a gloved finger firmly across the entire disk area 
(including edges) to ensure uniform contact of the disk with the gel and to 
eliminate any air bubbles. 
 a. If too much pressure is applied, the gel may be disturbed, and zones 
    may not be distinct. 
      b. If too little pressure is applied, the gel may dry, and zones may not 
    form. 
16. Place the disked Petrifilm Staph Express plates in a stack of more than 10 
plates and incubate at 35°C ± 1°C or 37°C 1°C for at least 60 minutes and 
no longer than 3 hours.  Check the plates periodically; the Dnase reaction 
may give final results in less than 3 hours. 
17. Remove plates from incubator. 
18. Count all pink zones whether or not colonies are present.  Pink zones are 
usually associated with S. aureus but may indicate S. hyicus, or S. 
intermedius.  Colonies not associated with pink zones are not S. Aureus 
and should not be counted.  If the entire disked area is pink with no 
distinct zones, large numbers of S. aureus are present.  Record the results 
as too numerous to count and dilute the sample further to obtain a more 
accurate count. 
19. Isolate colonies for further identification, if necessary. 
References: 3M Petrifilm Staph Express Count System insert 
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Standard Plate Count 
Purpose:  To assure proper plating, incubation and interpretation of the Standard Plate 
Count using the pour plate method. 
Safety Precautions: 
1. Always wash hands thoroughly before and after performing 
microbiological procedures and when leaving the laboratory. 
2. Wear gloves appropriate to the hazards involved. 
3. Always follow aseptic techniques. 
4. Dispose of all hazardous materials in the biohazard waste upon 
completion of the analysis. 
Supplies: 
 Incubator 35°C ± 0.5°C  Rubber Gloves  
 Incubator 44-46°C ± 0.5°C  Sterile Pipets 
 Sterile Petri Dishes   Quebec Colony Counter 
 
Media:  Standard Plate Count Agar (SPC) or Plate Count Agar (PCA), 44-46°C 
Remarks: 
1. Do not use any prepared media after the expiration date. 
2. Always run the appropriate blank control when conducting SPC analysis. 
3. SPC is also known as Total Plate Count (TPC), Heterotrophic Plate Count 
(HPC) or Aerobic Plate Count (APC). 
4. Check newly prepared lots of SPC agar for sterility before use. 
5. This method can be used for analysis of product, water, media, and 
laboratory sedimentation plate samples. 
6. For each series of water samples being tested for HPC, duplicate sample 
tests shall be run. 
7. Do not test any water with an elapsed time greater than 30 hours between 
sampling and commencement of testing. 
8. Controls should be run for each series of samples – media, sterility, 
dilution, blanks, air and pipet. 
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9. Remove media from incubator and allow it to cool slightly just prior to 
pouring the plates. 
10. All plating work, with the exception of laboratory sedimentation plates, 
must be done within a laminar flow hood. 
 
Procedure: 
 Plating of Media Samples 
1. Prepare your samples according the “Microbiology Sampling Preparation.” 
2. Place 1.0 mL or 0.1 mL of sample or dilution into a sterile Petri dish and 
cover. 
3. Repeat step 2 for all dilutions that need to be plated. 
4. Remove the SPC agar from the incubator or warm water bath and allow to 
cool for 10-15 minutes.   
5. Slowly pour the SPC agar into the Petri dishes containing the sample 
(approximately 15-20 mL).  Cover the plate immediately. 
6. Swirl the Petri dishes gently in a figure 8 motion to ensure that the sample 
is distributed evenly in the agar. 
7. Allow the agar to solidify before turning the plate over for incubation. 
  
Plating of Water Samples for HPC 
1. For most potable water samples, plates suitable for counting will be 
obtained by plating 1.0 mL (100 dilution) and 0.1 mL (10-1) of the undiluted 
sample. 
2. Place 1.0 mL and/or 0.1 mL of sample into a sterile Petri dish and cover. 
3. Slowly pour the SPC agar into the Petri dishes containing the samples 
(approximately 15-20 mL).  Cover the plate immediately. 
4. Swirl the Petri dishes gently in a figure 8 motion to ensure that the sample 
is distributed evenly in the agar. 
5. Allow the agar to solidify before turning the plate over for incubation. 
  
Laboratory Sedimentation Plates 
1. Slowly pour approximately 15-20 mL of SPC agar into the Petri dish. 
 208 
225 
 
2. Let the Petri dish stand uncovered and undisturbed for 15 minutes on the 
laboratory counter top, (the test can also be performed in the TE lab 
room). 
3. After 15 minutes has elapsed, cover the plate and incubate as follows. 
 
 Incubation of SPC Agar Plates 
1. Once the SPC plates have solidified, invert the plates and place them into 
the incubator at 35°C for 48 ± 3 hours.  Do not stack plates greater than 4 
high. 
2. During incubation, maintain humidity in the incubator so the plates lose no 
more than 15% moisture.   
3. Plates may be removed after 24 hours for an initial colony count; then they 
must be placed back into the incubator for the remaining 24 hours. 
  
 Counting of SPC Plates 
   
1. View the plate through the bottom of the Petri dish. 
2. Count the number of colonies you see growing on the agar surface. 
3. All counts shall be recorded as CFU/ml and CFU/Plate/15 mins (lab 
sedimentation).  Be sure to account for any dilutions that were made in the 
sample when recording counts on the appropriate paperwork. 
4. All counts not between 25-250 (media) and 30-300 (water) need to be  
recorded as estimates. 
5. For any plates that are higher than noted above, average the number of 
colonies in one square (1 cm2) of the Quebec Colony Counter and multiply 
by 50 to obtain the total count per plate. 
 
References:  Compendium of Methods for the Microbiological Examination of Foods, 4th 
Ed. Standard Methods for the Examination of Water and Wastewater, 20th 
Ed. 
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Appendix I - Media recipes 
Endothelial Cell Media (EC Media kit from Lonza: Stored at -20° C) 
 10 ml Fetal Bovine Serum (FBS) 
 0.2 ml Hydrocortisone 
 2 ml hFGF-β 
 0.5 ml VEGF 
 0.5 ml R3-IGF-1 
 0.5 ml Ascorbic Acid 
 0.5 ml hEGF 
 0.5 ml GA-1000 
 0.5 ml Heparain 
 1 bottle M199 (500 ml) 
 
Bioreactor Media 
 1 bottle M199 (500 ml) 
 56 ml FBS 
 ml L-glutamine 
 ml Pencilin/Streptomyosin (P/C) 
 0.6 ml Fungizone 
 2.8 ml Hepes buffer (clear solution) 
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Appendix J – Microtome Protocol 
1. Fill warm water pot with distilled water and allow warming up. 
2. Put embedded wax blocks of vessel cross section in fridge for 20 minutes  
between 3 - 5ºC prior to cutting. 
3. Use microtome handle and engage brake system when slicer is not being used. 
4. Set slicer setting to 7 µm to obtain sections.   
5. If sections decompose or wither set slicer to higher settings to obtain uniform and 
structured slices.  
6. Slowly work the slicer back down to thinner cross sections to obtain desired 
cutting size for histology. 
7. Preserve as much as the sample as possible for future use if needed. 
8. After slices have been obtained, use forceps to transfer wax slices into the warm 
water bath. 
9. Transfer slice onto to the rough part of the staining slide. 
10. Caution:  Never let mandrel come out to far, if uncertain of this ask an 
appropriate supervisor or trained individual. 
11. Navigate sample onto rough side of the staining slide with forceps from warm 
water bath. 
12. Use brushes to thoroughly clean all equipment.  
13. Transfer slide to slide case for histology staining. 
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Appendix K – HUVEC Density Values for BVM Studies 
Study One 
Vessel A 3.0 x 106       (Cells/cm2) 
Vessel B 3.0 x 106       (Cells/cm2) 
Vessel C 3.4 x 106       (Cells/cm2) 
Vessel D 3.4 x 106       (Cells/cm2) 
Vessel E 4.0 x 106       (Cells/cm2) 
Vessel F 4.0 x 106       (Cells/cm2) 
 
 
                        
The resuspension density for the vessels was found by dividing the expected cell count 
times the confluency observed by the amount of EC media used to resuspend the 
pellet; in study one 5 ml of EC media was used per pellet. 
 
Vessel A 1.4 x 106       (Cells/cm2) 
Vessel B 1.6 x 106       (Cells/cm2) 
Vessel C 1.6 x 106       (Cells/cm2) 
Vessel D 1.6 x 106       (Cells/cm2) 
Vessel E 2.0 x 106       (Cells/cm2) 
Vessel F 2.0 x 106       (Cells/cm2) 
 
 
 
Study Two 
Vessel 1          2.5 x 106       (Cells/cm2)                        
                          
The BVM had a final cell resuspension density of 8.3 x 105 cells/ml.  The amount of cells 
was multiplied by the observed confluency and divided by exposed the surface area of 
the lumen (2.36 cm2).  
 
Study Three 
Vessel 1          3.0 x 106    (Cells/cm2) 
Vessel 2          3.0 x 106    (Cells/cm2) 
Vessel 3          3.4 x 106    (Cells/cm2) 
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Vessel 4          3.4 x 106    (Cells/cm2) 
 
Vessel 1          2 x 106       (Cells/ml) 
Vessel 2          2 x 106       (Cells/ml) 
Vessel 3          3 x 106       (Cells/ml) 
Vessel 4          3 x 106       (Cells/ml) 
 
 
BVMs 1 and 2 had final cell resuspension densities of 2.0 x 106 cells/ ml.  For BVMs 3 
and 4, the vessels were sodded with a density of 3 cells/ cm2 with a resuspension 
density value for the amount of cells introduced into the vessel at 3 x 106 cells/ml; based 
on the amount of EC media used to resuspend the HUVECs.   
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